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ABSTRACT OF DISSERTATION

Molecular Mechanisms Regulating Optic Fissure Fusion During Zebrafish Eye
Development
Vertebrate retinal development requires timely and precise fusion of the optic
fissure. Failure of this event leads to congenital vision impairment in the form of
coloboma. Recent studies have suggested hyaloid vasculature to be involved in OF
fusion. In order to examine this link, we analyzed optic fissure fusion and hyaloid
vasculogenesis in the zebrafish pax2a noi mutant line. We first determined that pax2a-/embryos fail to accumulate F-actin in the optic fissure prior to basement membrane (BM)
degradation. Furthermore, using 3D and live imaging we observed reduced OF hyaloid
vascularization in pax2a-/- embryos. When examining the connection between pax2a loss
of function and hyaloid vasculature, we observed significant reduction of talin1
expression, a regulator of hyaloid vasculature. In addition, cranial VEGF expression was
found to be reduced in pax2a-/- embryos. Pharmacological inhibition of VEGF signaling
phenocopied the pax2a-/- vasculature, F-actin and BM degradation phenotypes. Lastly, we
determined that optic fissure associated hyaloid vasculature is a source of mmp2,
mmp14a and mmp14b expression and showed that mmp2 is functionally necessary for
degradation of optic fissure BM. We compared transcriptomic profiles between pax2a-/and wildtype (WT) embryos. We sought to validate and investigate those targets which
were thought to be of importance to the molecular machinery involved in fusion,
particularly those involving the actin cytoskeleton and angiogenesis. This analysis
uncovered a novel connection between regulation of angiogenesis and fusion. Loss of
pax2a resulted in increased expression of an anti-angiogenic protease, ADAMTS1. 3D
confocal and live imaging of retinal hyaloid vascularization in Tg[kdrl:mCherry]
embryos indicated a significant deficit in ADAMTS1 mRNA injected embryos and
phenocopied the pax2a mutant phenotype. We have also uncovered preliminary evidence
that certain actin associated proteins are also differentially regulated, particularly rhoassociated protein kinase (ROCK). Taken together we propose a pax2a driven mechanism
that ensures proper and timely hyaloid vasculature invasion of the OF by negatively
regulating ADAMTS1 expression. This enables the timely hyaloid vascularization of the

retina which in turn directly signals to initiate fissure fusion via cytoskeletal
rearrangements and providing the BM remodeler mmp2.
KEYWORDS: Optic fissure fusion, coloboma, basement membrane, F-actin, hyaloid
vasculature, pax2
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INTRODUCTION
The most challenging thing that will ever occur to you happened long before you
had a conscious thought. You became you by completely building yourself from a single,
solitary cell. Development of an organism is no easy feat, it begins with a single cell
which divides into many. These cells then undergo specialization to become unique cell
types. During this time, cells will interact with one another in their environment to
coordinate this complex process. And finally, cells will move and arrange themselves into
the proper spatial order to form all the structured organs and tissues in the body. Cell
movements that shape tissues and organs, known as morphogenesis, is a beautifully
complex process. Each tissue and organ in the body has a specialized way in which it
creates its unique form. This process must be tightly regulated to ensure that the end
result is a completely functional organ, failure could result in catastrophic consequences.
Morphogenetic movements are able to create three-dimensional tissues from a twodimensional sheet of cells through an intricate process of cellular coordination. Whereby
cell-cell communication, signaling pathways, and morphogen gradients work in concert
to perform a very precise task resulting in cell differentiation, proliferation, and death. A
common by-product of morphogenetic movements resulting in three-dimensional tissues
are gaps, fissures, or holes in those developing tissues. Filling these gaps is therefore an
essential step of morphogenesis, failure to do so will affect tissue integrity, and often has
disastrous consequences on the function of that tissue. The mechanism that development
uses to fill these holes is epithelial fusion, a joining of epithelial cells. Epithelial fusion is
a mystifying mechanism, it has been studied for over a century and yet there is still little
insight into the direct cellular mechanics of this process. The overarching goal of my
1

dissertation has been to examine the molecular mechanisms behind epithelial fusion
during early development.
1.1 Cellular Movement During Morphogenesis
1.1.1

Morphogenesis

Morphogenesis, an elusive process in which genetics lead to geometry, is
involved in the six fundamental stages of vertebrate development. The six stages of
vertebrate development begin with fertilization, where fusion of two gametes begins the
intricate process resulting in an organism. The second stage is cleavage, where rapid cell
division occurs resulting in a multi-cellular embryo. Once cleavage has created over 100
cells the embryo is then termed a blastula which contains two layers, the blastoderm and
the fluid- or yolk-filled blastocoel. After formation, the blastula undergoes gastrulation
where the 2 or 3 germ layers are created, ectoderm, endoderm, and mesoderm in
organisms containing three germ layers. Next in development is somitogenesis, the
formation of somites which differentiate into skeletal muscle, vertebrae, and dermis. The
final stage of embryonic vertebrate development is organogenesis, where the organs of
the embryo develop. Morphogenesis is the process by which tissues undergo organization
and shape change to create the three-dimensional organs in the body. Each structure in
the body has its own set of “code” which regulates the shape and therefore function of
each individual organ. The genetic code that directs morphogenesis results in the
coordinated movement of cells, these cells move in unison as a sheet which can undergo
many types of morphogenetic movements. There are five main classes that can be used to
describe the various morphogenetic movements during development; convergent
extension, epiboly, involution, ingression, and invagination.
2

1.1.2

Convergent Extension

Convergent extension is the process by which cells will converge along one axis,
narrowing the tissue, and extend outwards across a perpendicular axis (Figure 1.1 A).
This process is a way to achieve elongation of tissue without further growth. This process
is utilized amongst vertebrate and invertebrate species, and has been particularly well
studied during the body axis elongation of the notochord [1]. Cell movement during
convergent extension is unique from cellular migration. However, during convergent
extension the cellular movements are a polarized movement between neighboring cells
resulting in tissue remodeling [2]. During convergent extension there are two axes of
polarization that guide the mediolateral intercalating movements, and the force generated
from these movements are exerted onto the neighboring cells, not the extracellular matrix
(ECM) [2]. There are two modes with which the intercalation of cells during convergent
extension can occur. The first is the cell crawling mode, most notably associated with
convergent extension of mesenchymal cells like the notochord [1]. Here membrane
protrusions at both ends of the elongated cell, which closely resemble actin based
lamellipodia, are used to crawl in between neighboring cells resulting in intercalation [1].
The second is the cell contraction mode, and it is associated with convergent extension of
epithelial tissue [1]. In this mode actomyosin accumulates at the cell-cell junctions which
then generates a contractile force between the cells resulting in shrinkage of the cell
membranes which provides enough force to move neighboring cells [3]. One of the most
vital molecular pathways governing both modes of convergent extension is that of the
planar cell polarity (PCP) pathway, which is composed of cytoplasmic proteins
3

Dishevelled and Prickle, as well as transmembrane proteins Frizzled, Vangl, and Celsr
[4]. Interestingly, studies have shown that Rho and its downstream effector Rhoassociated protein kinase (ROCK) transduce the signals from the PCP components
resulting in the cytoskeletal dynamics of actin polymerization and actomyosin contraction
required for both modes of convergent extension [5, 6].

1.1.3

Epiboly

Epibolic movements involve the spreading and thinning of tissue through
coordinated movement of an entire sheet of epithelial cells to enclose the deeper layers of
the embryo (Figure 1.1 B). There are many different ways in which epiboly can be
accomplished; cell division, cell shape change, cell intercalation, or a combination
thereof [7]. Epiboly has been extensively studied during zebrafish gastrulation [8].
During epiboly, cells will dome outward at the area of the blastula and will undergo cell
shape and location changes in order to extend vegetally towards the opposite pole,
eventually encapsulating the entire embryo. There are two characteristics of epibolic
movement, radial intercalation and the coordinated flattening of cells to allow for the
spreading of the epithelial sheet. Radial intercalation is unique from that of mediolateral
intercalation in that cells will exchange places throughout an entire multi-layered tissue
instead of within the same plane. Radial intercalation does not require the polarization of
cells and therefore does not use the PCP pathway as does mediolateral intercalation. The
radial intercalations during epiboly require the use of cell adhesion molecules for proper
formation, specifically E-cadherin [9]. Zebrafish half-baked/E-cadherin mutants show
that cells will still intercalate but will not remain and these cells will travel back to their
4

starting position [9]. The proposed driving mechanism behind the cell shape changes
which provide the tension needed for epiboly to complete has been shown to be through
the recruitment of actin and myosin II to the margins of the enveloping layer [10]. It is
proposed that myosin II is required after 50% epiboly has been reached in order to
constrict the encapsulating layer and complete the envelopment of the embryo through a
“purse-string mechanism” [11].

1.1.4

Involution

Involution involves the concerted inward movement of a sheet of cells from a
growing external layer. These cells spread themselves along the internal surface of the
remaining outer layer (Figure 1.1 C). Involution is involved in the formation of many
processes including amphibian gastrulation, where migrating marginal cells involute at
the dorsal lip of the blastopore. These involuting cells will create many structures
including the archenteron, the prechordal plate, and the notochord. Involution also occurs
during Drosophila head involution, where through dramatic cell shape changes the
anterior tissues of the embryo are internalized [12]. The particular genes and pathways
involved during involution are poorly understood and those that are known appear to be
tissue/cell type specific [13]. An example of this is during the involution of cells through
the dorsal lip in amphibians. A forkhead gene, MocuFH1, seems to control the involution
of the presumptive notochord and mesenchymal cells [14]. When treated with antisense
oligodeoxynucleotides, these two populations of cells fail to undergo involution at the
dorsal lip [14]. However, the presumptive muscle cells are unaffected by the treatment,
and involute in through the dorsal lip as usual [14].
5

1.1.5

Ingression

Ingression is conceivably one of the most studied morphological process. During
ingression epithelial cells transform into migrating mesenchymal cells (Figure 1.1 D). To
do so they change many properties about themselves, they change their cellular
architecture, their motility, as well as their adhesive properties. One example is during
primitive streak development during gastrulation. During primitive streak development
epithelial cells lose their apico-basal polarity, as well as their adherent junctions [15].
Once again, cytoskeletal changes are crucial for ingression to occur, these cells must
ingress out of the epithelium and become migratory within each individual cell which
heavily depends on cytoskeleton function [16]. The beginning of cytoskeletal changes
occurs by apical constriction as well as a disorganized basal cytoskeleton [16]. Finally,
through the activity of matrix metalloproteases, the basement membrane of these cells are
broken down [17]. Perhaps one of the most well-known examples of ingression is that of
neural crest cells, which emigrate from the epithelium and migrate to other locations in
the developing embryo. During neural tube development the neural plate epithelium rolls
upward to form a cylindrical structure. Once the apposing sheets contact one another and
begin to fuse, the cells located directly next to the fusing tissue near the dorsal midline
undergo ingression, commonly referred to as epithelial to mesenchymal transition (EMT)
[18]. These neural crest cells go on to contribute to the formation of a number of tissues
in the developing embryo. Many signaling pathways have been associated with EMT
such as TGF-β, FGF, EGF, HGF, Wnt/beta-catenin, Notch Ras-MAPK, and Hedgehog
[19].

6

1.1.6

Invagination

Invagination, much like involution, involves the inward movement of cells.
Unlike involution, invagination is the bending of a sheet of cells inward to create a
pocket, as if being poked from the exterior surface (Figure 1.1 E). Invagination occurs
during the development of many tissues and can be accomplished through two different
types of mechanisms, axial and orthogonal [20]. Axial invagination occurs at a singular
point and invaginates along the axis that the tissue will form, such as the initiating phase
of gastrulation where the blastula cells invaginate to form the ectoderm and endoderm
[20]. Orthogonal invagination occurs along a line instead of a singular point which
creates a furrow, the axis of which is perpendicular to the area of invagination, as seen
during the formation of the neural tube [20]. Broadly, there are two molecular
mechanisms that can direct invagination, the cytoskeleton and the extracellular matrix.
These two mechanisms have been shown to work both independently as well as in
concert during development [21, 22]. The cytoskeleton is often used to drive apical
constriction through the activation of Shroom, RhoA, ROCK, and actin-myosin
contractility which result in a cytoskeleton driven invagination event [23]. The
extracellular matrix, on the other hand, is used to stiffen the basal lamina which results in
a resistance of the basal surface to deform [24]. To accomplish this, cells often swell their
extracellular matrices by secreting a large chondroitin sulphate proteoglycan [24]. These
proteoglycans can absorb water causing the matrix to swell. Due to this differential
swelling the matrix buckles inward resulting in invagination of the sheet of cells [24].
One example of these two molecular mechanisms of invagination occurring
simultaneously is during neural tube development. During neural tube folding there are
7

two distinct curvatures in the tissue, one being convex at the dorsolateral hinges, while
the median hinge point is concave. The median hinge point shows apical constriction
through use of the cytoskeleton, while the dorsolateral hinges are basal in origin through
use of the ECM [25, 26].

1.2

Epithelial Fusion During Retinal Morphogenesis

1.2.1

Epithelial Fusion

All the various types of morphogenetic movements are crucial for proper
development of an organism. However, these morphogenetic movements are just the
initial steps in forming a functional three-dimensional organ. Often times, as a result of
these cellular movements, gaps, fissures, or holes are created in the tissue. Filling these
gaps is an essential process of morphogenesis. Failure to do so will affect tissue integrity,
and often has disastrous consequences on the function of the organ. The mechanism
which development uses to fill these gaps is called epithelial fusion. Epithelial fusion can
be observed during the formation of many organs including, neural tube, heart, palatal
shelf, urethra, uterine ligament, diaphragm, eyelid, optic fissure, and even dorsal closure
in Drosophila. Epithelial fusion is susceptible to disturbance which results in congenital
malformations. For example, failure of the neural tube to close results in several different
disorders, including spina bifida, and anencephaly [27]. Failure of the epithelium to fuse
in the heart results in many congenital heart defects [28]. Failure of the palatal shelf to
fuse results in cleft palate [29]. And failure of the optic fissure to fuse results in coloboma
[30]. Many of these congenital defects present themselves as part of syndromes, such as
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CHARGE syndrome, where those affected experience colobomas, heart defects, and
more [31]. This suggests that there are shared common mechanisms amongst fusion
events, thus understanding mechanisms regulating one fusion event might be applicable
to other fusion events as well.

1.2.2

Retinal Morphogenesis
1.2.2.1 Eye Field Specification

Vertebrate eye development is a highly conserved process which shares many of
the same mechanisms amongst all vertebrate species [32]. Eye development begins with
the specification of the eye field in the diencephalon. The specification of the eye field
relies on the expression of a network of key transcription factors Six3, Rx, and Pax6 [33].
Six3 is one of the earliest transcription factors in eye specification, and is required
for the repression of Wnt activity in the diencephalon [34]. Overexpression of Six3 results
in the formation of ectopic eyes in fish [35]. Loss of function of Six3 in mouse knock-out
models result in the loss of markers anterior to the midbrain coupled with the expansion
of markers posterior to the midbrain [36]. Congruently, overexpression of Wnt signaling
represses Six3 expression resulting in the same loss of eye field specification as Six3
mutants [37].
Pax6 has been considered the master eye regulating gene, though in more recent
studies it is suggested that this title belongs to Six3 [38]. Pax6 mutant mice initially
develop primitive eye structures but are unable to properly develop and disappear as
development progresses [39]. Pax6 has the ability to activate transcription of Six3 and is
9

suggested to be the reason why ectopic expression of Pax6 has the ability to induce eye
formation [40].
A class of retinal homeobox transcription factors known as Rx are also required
during eye field specification. Rx genes are involved in the control of proliferation
through regulation by Six3 and Optx2 [33]. Loss of function of Rx3 in zebrafish results in
failure of optic vesicle evagination and thus complete absence of the retina [41].
Together Six3, Pax6, and Rx are required to restrict the expression of Otx2 [42].
Otx2 appears to be required to set up the eye field transcription network of Six3, Pax6,
and Rx, but once this network has been established Otx2 expression is down-regulated in
the eye field region [43]. It is suggested that Otx2 acts permissively during eye
development to confer competence of the eye field region since it has been shown that
Six3 can only induce ectopic eye formation within the Otx2 expression domain [35].

1.2.2.2 Eye Field Division
Once the eye field has been specified, it must then undergo division into two
symmetrical primordium to eventually create the optic vesicles. To achieve this division
members of the Shh-, Tgf-𝛽-, and Fgf- families are secreted within this region [44].
Without proper regulation of these factors the eye field fails to undergo division and
results in cyclopia, the formation of a single eye [44]. It is suggested that due to these
secreted factors prospective hypothalamic cells migrate anteriorly through the eye field
physically separating the eye field into the two symmetrical primordium [45].
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Shh is a crucial morphogen for patterning of the eye primordium [46]. Through
Fgf signaling the eye primordium is capable of responding to Shh signaling which must
be tightly regulated [46]. As stated previously, absence of Shh results in cyclopia,
alternatively, over expression of Shh result in the over development of proximal
structures at the consequence of distal structures [47].

1.2.2.3 Evagination
Morphogenesis and proliferation usually go hand in hand, however, this appears
to not be the case with optic vesicle evagination. Evagination of the optic vesicles is
achieved through different mechanisms dependent upon species. In mouse, it is proposed
that extensive cell shape changes are the driving force of evagination [48]. In zebrafish,
migration of the retinal progenitor cells (RPCs) seem to be the driving force [49]. Cells
immigrate to this region where they intercalate and epithelialize resulting in growth of the
optic vesicle [50]. The optic vesicles then continue extending out from the diencephalon
due to the continuous intercalation of newly arriving RPCs [51]. These migrating RPCs
display a specific migratory pattern determined by signaling and cell adhesion molecules,
and in zebrafish the migratory behavior seems to rely heavily on Rx3 [52]. At the onset
of neurulation Rx3 positive RPCs show a delayed migration pattern in comparison to
non-RPCs [49]. In the absence of Rx3, RPCs still form but they remain at the midline and
fail to migrate outwards towards the lateral regions [51].

11

1.2.2.4

Optic Cup

The formation of the optic cup from the optic vesicle requires morphogenetic
movements to create the bi-layered spherical structure. This is achieved through
invagination of the optic vesicle once it reaches the overlying surface ectoderm. At this
point the optic vesicle invaginates to create the optic cup which is attached to the optic
stalk leading back to the forebrain. The overlying surface ectoderm invaginates to create
the lens placode. It was previously thought that formation of the optic cup required the
lens placode in order to form, but recent findings have shown that contact with the
surface ectoderm is only required to initiate the invagination process through temporal
regulation [52]. Once the optic vesicle reaches the surface ectoderm the optic cup will
continue to form in the absence of the lens placode as observed through ablation
experiments [53].
The invagination of the optic cup relies heavily on cell shape changes to direct the
cellular movements [54]. This is achieved through basal constriction of the cells creating
a triangular shape [54]. In the absence of Opo, a transmembrane protein responsible for
controlling the location of focal adhesions, basal constriction fails to occur resulting in
failure of the optic cup to form [54]. The basal constriction of these cells results in rim
involution, whereby cells traverse the outer layer moving inward around the rim of the
optic cup into the inner layer of the optic cup resulting in the bi-layered spherical optic
cup [55]. Once the optic cup has formed it is comprised of an outer layer of retinal
pigmented epithelium (RPE), an inner layer of neural retinal cells, retinal ganglion cells
and their axons which traverse the length of the optic stalk to the forebrain, and a fissure
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along the ventral length of the optic stalk. After fusion of this fissure the optic stalk
becomes the optic nerve, and retinal morphogenesis has completed.

1.3

Fusion of The Optic Fissure
1.3.1

Optic Fissure Fusion

As a consequence of the formation of the three-dimensional retinal sphere from a
flat sheet of cells is the formation of a fissure along the ventral length of the optic stalk.
This fissure allows for migratory mesenchymal cells to enter the retina to establish
vasculature networks onto the back of the lens. This vasculature is known as the hyaloid
vasculature, and is a temporary circulatory system required for ocular development. In
most species this circulatory system will degenerate once mature blood vessels begin to
grow [56]. The optic fissure will undergo epithelial fusion to attach the adjacent lobes to
sheath the retinal ganglion cell axons. The timing of fusion of the optic fissure varies by
species, in humans this occurs between the 5th and 7th week of gestation, in zebrafish
fusion occurs between 32 and 72 hours post fertilization (hpf) [57]. Like many other
epithelial fusion events, when fusion fails to occur it results in congenital disorders. In the
case of the optic fissure the result is coloboma.

1.3.2

Coloboma

Coloboma is a leading cause of pediatric blindness accounting for approximately
10% of all cases worldwide [58]. Approximately 1 child in every 10,000 births are
diagnosed with coloboma, though incidence seems to be at a higher rate on the Indian
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subcontinent. Coloboma is a spectrum disorder and can present itself to varying degrees.
Depending on the location and degree to which the fissure was able to fuse will
determine the amount of visual acuity the affected individual will have [58]. A large gap
in the more proximal regions of the fissure will expose a significantly larger portion of
the retinal ganglion cell axons to the external environment resulting in neuronal death and
complete blindness in the affected eye [59]. While a small gap at the most distal regions
of the fissure will mildly affect visual acuity [59]. There are many different coloboma
classifications depending on the structure that has been affected. One of the most
common classes of coloboma is iris coloboma, these are most commonly in the ventral
region of the iris resulting in a keyhole like shape in the pupil. Lens coloboma are when a
section of the lens is missing, and large lens colobomas can result in the displacement of
the lens. Macular coloboma is when a portion of the macula, region of the retina
responsible for central vision, is missing resulting in partial loss of vision. Optic nerve
coloboma can appear with retinal or choroidal colobomata and can result in retinal
detachments. While surgery can be performed to correct the appearance of colobomas
and to repair retinal detachment, unfortunately, any visual loss experienced is permanent
and is unable to be corrected. Fusion of the optic fissure doesn’t occur simultaneously, it
is a step wise process that begins in the medial regions of the fissure and “zippers”
proximally and distally from this location. Due to this, failure of fusion could occur at
any localized point resulting in a broad spectrum of effects on those who have this
disorder [59]. Coloboma can also be unilateral affecting only one eye, or bilateral
affecting both eyes. It is even suggested that cases of colobomata are underreported as
small lesions in the proximal regions could go unnoticed with adequate vision function
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[58]. Most of the work done on understanding coloboma investigates the spatial and
temporal control of gene patterning preceding, during, and after optic fissure fusion.
From this previous work several genetic pathways have been elucidated including
BMP/TGF-𝛽, retinoic acid (RA), SHH, FGF, Wnt/𝛽-catenin, and a whole host of
transcription factors.

1.3.3

Transcription Factors and Sonic Hedgehog

Most causes for coloboma are due to genetic abnormalities. However, for nonsyndromic instances of coloboma in humans over 70% percent of individuals do not have
an identified genetic cause [58]. Identification of the genetic cause in syndromic
coloboma, however, is much higher [58]. Mutations in the transcription factors pax2 and
pax6 (paired box) can result in coloboma, mutations in pax2 accounts for approximately
50% of individuals with renal coloboma syndrome [60]. It has been reported that 92
mutations have been found in the pax2 gene, and one particular mutation has been
reported 57 times in individuals with coloboma [61]. Even though pax2 has been closely
associated with coloboma little is known about how this transcription factor functions or
what its targets are. Sox2, Sox4, and Sox11 (SRY-related HMG-box genes) have also
been associated with coloboma [62]. It has been shown that Sox4 and Sox11 limit sonic
hedgehog (shh) signaling in the ventral region of the optic cup and when mutated in
zebrafish results in expression of shh in the ventral region leading to coloboma [62].
Transcription factors associated with the periocular mesenchyme (POM) have also been
linked to coloboma, in particular pitx2 [63]. POM cells are a sub-population of cranial
neural crest cells which migrate to the eye and develop many structures in the anterior
15

segment of the eye. POM cells are also partly responsible for the establishment of the
hyaloid vasculature in the retina [64]. Many of these POM associated transcription
factors have been observed to cause coloboma in the zebrafish model, however, these
mutations are rare within human patients [64]. Many other transcription factors have also
been linked to coloboma, for a comprehensive list of genes associated with coloboma see
Table 1.1.

1.3.4 Bone Morphogenetic Protein/Transforming Growth Factor Signaling in Optic
Fissure
Bone morphogenetic proteins (BMP)/Transforming Growth Factor-𝛽 (TFG-𝛽) are
a class of growth factors known for coordinating tissue architecture during
morphogenesis. To date two particular BMP’s have been shown to be required for optic
fissure morphogenesis, BMP4 and BMP7. Sonic Hedgehog (SHH) restricts the
expression of BMP4 to the dorsal regions of the retinal tissue [65]. BMP4 thus dorsally
induces the expression of certain T-box transcription factors known for their repressive
capabilities [65]. BMP4 also restricts a well-known eye patterning gene, Vax2, from the
dorsal regions of the retina [66]. Tgfβ signaling can trigger changes to the extracellular
matrix (ECM) and is also inhibited by BMP signaling [67]. In both mouse and zebrafish
loss of Tgfβ2 results in coloboma [68]. It was specified that Tgfβ signaling in the optic
fissure induces the expression of BMP4 antagonists to allow Tgfβ signaling to induce
changes to the ECM permitting the fusion of the optic fissure [68]. BMP7 controls the
formation of the optic fissure, and controls the early expression of Pax2 [69]. In mouse,
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loss of BMP7 results in an absent hyaloid artery as well as microphthalmia/anophthalmia
and failure of optic fissure formation [69].

1.3.5

Fibroblast Growth Factor Signaling in Optic Fissure

Fibroblast Growth Factor (FGF) signaling is required during eye development as
it regulates the formation of the eye field as well as specifies the neural retina [70].
Research into FGF signaling usually focuses on its receptors as the genetic redundancy of
FGFs is large, in mice alone there are 22 different FGF genes [70]. In mice, Fgfr1/Fgfr2
mutants display a coloboma phenotype and is considered to be caused by a loss of Pax2
expression [71]. Also in mice, it has been shown that mutations in the FGF genes which
result in the activation of Ras-ERK signaling result in coloboma due to a loss of Pax2 in
the optic fissure [72]. In humans, most instances of coloboma due to FGF mutations are a
part of syndromes. Coloboma is observed in those with Noonan syndrome which is a
result of a gain of function mutation in Ras/MAPK signaling [73]. Coloboma has also
been observed in two families that have COMMAD syndrome which is the result of a
mutation within the MITF gene [74].

1.3.6

Retinoic Acid Pathway in the Optic Fissure

Retinoic acid (RA) is responsible for establishing the dorsoventral axis in the
retina. It upregulates Vax2 while simultaneously inhibiting Shh [75]. Retinoic acid also
plays a role in the upregulation of both Foxc1 and Pitx2 in the POM [76]. Retinoic acid
also acts in collaboration with the Hippo-YAP pathway in the regulation of migratory
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neural crest cells, and both have been shown to be involved in optic fissure
morphogenesis [77]. Mutations in several genes regulated by Hippo-YAP and Retinoic
acid affect optic fissure closure, RBP4, PTCH1, ALDH1A3, and the RA synthesis gene
STRA6 all result in colobomatous defects in human patients [78-80]. In both zebrafish
and humans, mutations in Yap1 result in optic fissure closure defects [81]. Studies in yap
mutant medaka fish show a loss of actinomyosin contractibility [77]. It is suggested that
this loss of contractibility is the reason why zebrafish yap mutants have a loss of the
ventral retinal pigmented epithelium (RPE) which affects the movement of cells around
the optic fissure during closure [77]. The RA pathway has also been linked to coloboma
through environmental causes by a maternal dietary deficiency in vitamin A (retinol)
[82]. Amongst many different species such as pigs, rats, and even humans a maternal
deficiency in vitamin A has resulted in offspring with congenital eye defects including
coloboma [82]. Research has shown that eye defects can be rescued by adding an
exogenous active metabolite of retinol, retinoic acid, in vitamin A deficient subjects,
indicating that vitamin A operates through the RA pathway [83].

1.3.7

Wingless-related Integration Site/𝛽-catenin in the Optic Fissure

Wingless-related Integration Site (Wnt)/𝛽-catenin is a well known signal
transduction pathway which has been shown to be tightly regulated in optic fissure
closure. The Wnt/ 𝛽-catenin pathway requires tight regulation in the optic fissure as it has
been shown that an up- and down-regulation of the pathway results in optic fissure
defects [84, 85]. In mice the up-regulation of Wnt signaling by a mutation in Wnt
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repressor Foxg1 results in a reduction of expression in Pax2 within the optic fissure
resulting in coloboma [84]. Alternatively, in mice the down-regulation of Wnt signaling
through a mutation in Wnt receptor Fzd5 resulted in an over expression of Pax2 in the
optic fissure leading to coloboma [85]. Altering Wnt signaling has also been shown to
affect other key genes and pathways in the optic fissure including Vax2, BMP, and RA,
and all result in optic fissure defects [86]. However, mutations in the Wnt pathway are
very rare amongst the human population. To date, the only mutation in humans found is
in the Wnt receptor Fzd5 gene [87]. It was found in a large family with isolated coloboma
where an autosomal dominant frameshift mutation in Fzd5 was thought to cause effects
on the actin cytoskeleton within the optic fissure [87].

1.4

Molecular Mechanisms in Optic Fissure Fusion
With 70% of isolated coloboma cases being idiopathic [58], it suggests that the

most advantageous method of understanding coloboma would lie in understanding the
molecular mechanisms governing optic fissure fusion. Little is understood about the
molecular mechanisms involved in optic fissure fusion. However, though little is known
about each mechanism involved it has been shown that there are three crucial molecular
machineries required for optic fissure fusion, the basement membrane, actin cytoskeleton,
and endothelial cell migration [88] (Figure 1.2).

1.4.1

Basement Membrane

The basement membrane is a specialized type of extracellular matrix. The
basement membrane is one of the few common features shared amongst all multicellular
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animals, appearing very early on in their evolution [89]. This thin, tough, and flexible
sheet of molecules is a crucial component of all epithelium. This sheet of molecules
provides a multitude of functions to the epithelium. It is a barrier that distinguishes the
boundaries of developing tissues [90]. The basement membrane provides the architecture
of the epithelium, while also being a crucial component of cell-to-cell signaling [90].
Many other functions of the basement membrane involve determining cell polarity,
promoting proliferation, cell survival, and differentiation, and also acts as a highway for
migrating cells [90]. The basement membrane is made cell-autonomously and excreted
from the cell to form its basement membrane [90]. The major components of the
basement membrane are part of a class of ancient extracellular matrix macromolecules,
laminin, collagen IV, perlecan, and nidogen [90].

1.4.1.1 Laminin
Laminin is the primary organizer of the basement membrane, in early
development laminin is mostly the sole constituent of the basement membrane [91].
Laminins are a large family of proteins, there are at least 16 different isoforms expressed
in mammals [91]. Each of these laminins contain three inter-coiled polypeptide chains, an
𝛼, 𝛽, and 𝛾, which form a cross shaped structure (Figure 1.3). Each laminin isoform has
its own polypeptide chain composition allowing them to associate in many different
combinations, and as such the compositions of the laminins have a high level of cell type
specificity [91]. Laminin will spontaneously organize itself into a network in vitro
through interactions between its three short arms [91]. It is believed this is the mechanism
through which it uses to organize itself in vivo while simultaneously using the long arm
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to tether itself to receptors on the cell surface. It is thought that laminin is the scaffold
which allows for the recruitment of all other basement membrane components [91]. The
most studied laminin family member is laminin-111 (also known as laminin 1) named to
correspond with its three polypeptide chains 𝛼1, 𝛽1, and 𝛾1. The globular domain at the
head of the 𝛼 chain of laminin-111 binds to integrins on the cell surface. The globular
domain at the head of 𝛽 and 𝛾 chains promote self-assembly, while nidogen also has a
binding site on the second globular domain on the 𝛾 chain. The long arm of the laminin
molecule can bind to integrins, dystroglycan, and perlecan. The 𝛾1 chain is a component
of most laminin heterotrimers, as such, mice lacking a functional 𝛾1 chain do not survive
past embryogenesis due to a lack of a basement membrane [92].

1.4.1.2

Collagen IV

Like laminin, collagen IV has many different isoforms, 𝛼1(IV)- 𝛼6(IV). It
consists of three independently synthesized protein chains, these long chains then twist
together creating a superhelix (Figure 1.3). This superhelix has interruptions in more than
20 different regions to allow multiple bends in the protein. Collagen IV molecules
interact through their terminal domains to assemble into the basement membrane. The
NH2 terminus binds to three other collagen IV molecules creating a quaternary
assemblage of the molecules. This structure creates a flexible and felt-like network which
gives the basement membrane its tensile strength. Unlike laminin, collagen IV does not
seem to be required for the deposition and formation of the extracellular matrix as mice
with null mutations in the Col4a1/2 which lack functioning 𝛼 chains develop normally up
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to E9.5 [93]. However, collagen IV has been shown to be required for the maintenance,
integrity, and functionality of the basement membrane as the Col4a1/2 null mutation
caused lethality in the mice at E10.5-11.5 due to severe structural deficiencies in the
basement membrane [93].

1.4.1.3 Nidogen
Previously known as entactin, nidogen is a small sulfated monomeric
glycoprotein consisting of three globular domains. Nidogens’ second globular domain
has the ability to bind both collagen IV and perlecan, while its third globular domain has
the ability to bind to the 𝛾 chain of laminins (Figure 1.3). Due to these domains it has
been proposed that nidogen acts as the cross-link between the laminin and collagen IV
networks [94]. There are two known nidogen homologs in humans, nidogens 1 and 2.
The two homologs appear to be redundant, loss of one functioning nidogen only presents
subtle abnormalities [94]. However, loss of both copies of nidogen have been shown to
result in severe abnormalities in mice [95]. Through deletion of the nidogen binding site
on the laminin 𝛾 chain it was shown that nidogen is not detected in the basement
membrane of most tissues showing that it fails to connect to the basement membrane
without a laminin binding site, further validating that nidogen acts a cross link in the
extracellular matrix [95].
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1.4.1.4 Perlecan
Perlecan, a heparin sulfate proteoglycan, is a major component of basement
membranes (Figure 1.3). Perlecan is also thought to be involved in the cross link between
the laminin and collagen IV networks [96]. Perlecan also binds multiple growth factors
that promote cell survival and differentiation [96]. It has also been observed that perlecan
interacts with integrins, laminins, and dystroglycans to anchor the basement membrane to
epithelial cells [97]. Like collagen IV, perlecan does not appear to be crucial to the
formation of the basement membrane but is required for the maintenance of the basement
membrane, especially in areas which undergo high levels of mechanical stress.
Homozygous perlecan mutants form a normal basement membrane, however, in areas of
high mechanical stress such as in the contracting myocardium, the basement membrane
deteriorates in that region [98].

1.4.2

Basement Membrane During Optic Fissure Fusion

The basement membrane is crucial component of optic cup morphogenesis,
without laminin the evagination of the eye field fails to occur [99]. Laminin a1, b1, and
c1 mutants all display to some extent defects in the development of the optic cup [99].
Equally as important, however, is the precise timing and control of the degradation of the
basement membrane in key regions during development. One such region that basement
membrane degradation is crucial is in the optic fissure. One of the critical functions of the
basement membrane is to act as a barrier to the external environment, however, this
barrier is detrimental for fusion of epithelial tissues [90]. Many studies have shown that
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failure to remove the basement membrane in the region of the optic fissure results in
colobomas. In rats, a deficiency of RA signaling at later retinal development stages
results in the retention of the basement membrane in the optic fissure and leads to
coloboma [83]. Pax2 and Vax2 mutants also show a retention in their basement
membranes in the optic fissure which also leads to coloboma [88, 100]. Previous work in
our lab has shown the main constituents of the zebrafish optic fissure basement
membrane. These include collagen 4a1 and 4a2, perlecan, nidogen 1a, 1b and 2a, and
laminins a1, a4, b1, c1 and c3 [101]. It was determined that nidogen removal appears to
be a key component to the degradation of the basement membrane [101]. It is
hypothesized that removal of nidogen exposes the proteolytic sites on the other basement
membrane components allowing for their degradation [101]. It is also possible that by
affecting basement membrane integrity by the removal of nidogen this allows for
protrusions involved in fusion to form [101]. While it has been known that removal of the
basement membrane in the region of the optic fissure must occur to allow for fusion, it
still remains poorly understood whether removal of the basement membrane is an active
or passive process in the mechanisms underlying optic fissure fusion.

1.4.3

Basement Membrane Breakdown

There are a broad class of proteins known as metalloproteinases that have the
ability to breakdown the basement membrane. These metalloproteinases are a major
component of basement membrane breakdown and remodeling, not just during
embryogenesis but throughout the life of an organism. There are three large families of
metalloproteinases including matrix metalloproteinases (MMPs), a disintegrin and
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metalloproteinases (ADAMs), and a disintegrin and metalloproteinases with
thrombospondin motif (ADAMTS). MMPs are the largest family of metalloproteinases,
so far over 20 human MMPs have been discovered. MMPs are crucial during
organogenesis and branching morphogenesis and are the main enzymes involved in
basement membrane degradation. Combined, MMPs have the ability to degrade all
components of the basement membrane. Most MMPs are soluble proteins, though a few
of the most recently discovered MMPs are membrane anchored and they have wide
substrate specificities. All MMPs have a pro-domain and a catalytic domain, and some
have a variable number of structural domains added. ADAMs, like MMPs, can be
secreted or are single pass transmembrane proteins. ADAMs have a pro-domain, a
metalloproteinase, disintegrin, cysteine-rich and a characteristic transmembrane domain.
Not all ADAMs possess a functional protease domain, those that do are classified as
sheddases because they cleave the extracellular portions off of transmembrane proteins.
ADAMTS family of proteins is very closely related to ADAMs, they contain all the same
domains as ADAMs except instead of a transmembrane domain they contain a
characteristic thrombospondin motif. Unlike ADAMs and MMPs, ADAMTS are secreted
enzymes. MMPs, ADAMs, and ADAMTS have a broad spectrum of substrate specificity,
this contributes to the development and maintenance of many tissues and they participate
in many physiological processes. These remodeling enzymes contribute to an
extraordinary amount of processes including bone remodeling, angiogenesis, immunity,
and wound healing to just name a few [102-104]. The enzymatic activity of these
metalloproteinases is tightly controlled at the transcriptional level, by pro-peptide
activation and by inhibition through tissue specific inhibitors of metalloproteinases.
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Dysregulation of metalloproteinase activity leads to many pathological conditions such as
inflammation, cancer, arthritis, dwarfism, and more [105-107].

1.4.4

Actin Cytoskeleton

Actin, which makes up the cellular cytoskeleton, is the most abundant protein in
most eukaryotes and in some cell types, comprising approximately 15% of the cellular
protein content [108]. The actin cytoskeleton is a dynamic network of proteins made up
of actin and actin binding proteins. Actin is highly conserved amongst eukaryotes where
the amino acid sequences of actin are upwards of 90% identical. The actin cytoskeleton
has a diverse range of functions depending on the cell. Actin filaments organize
underneath the plasma membrane and provide strength and shape to the cell. In
vertebrates, there are three isoforms of actin an 𝛼, 𝛽, and 𝛾, 𝛽- and 𝛾- actin are most often
found together in most non-muscle cells while 𝛼-actin is expressed only in muscle cells.
The actin cytoskeleton is made up of asymmetrical globular or G-actin subunits which
are tightly associated with an ATP or ADP molecule. The G-actin subunits then assemble
in a head-to-tail manner which forms a right handed helix. This tight structure is about 8
nm wide and is called filamentous or F-actin. Due to the asymmetrical nature of G-actin
the formation of F-actin has structurally different ends which are polarized and has an
arrowhead like appearance. F-actin has a slow growing end termed minus end, and a fast
growing end termed plus end. The subunits are positioned so that their nucleotide binding
site points toward the minus end. The kinetic rate of association and dissociation is much
higher, approximately 10 times higher, at the plus end. While individual actin filaments
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are relatively flexible, in living cells these actin filaments interact with accessory proteins
which cross-link the filaments together to form bundles. These actin filament bundles
create extensive structures that are quite rigid. How these bundles are formed depends on
the actions of actin binding proteins, which create specific cytoskeletal structures
depending on the cell and the function needed by that cell. There are over 100 different
actin binding proteins which can regulate assembly, disassembly, and/or spatial
organization of actin filaments. The actin cytoskeleton creates many different structures
which include microvilli, adhesion belts, the cell cortex, stress fibers, contractile rings,
lamellipodia, and filopodia. These structures can then go on to perform its specialized
function which can be classified into three broad categories, spatial organization of the
cell, physical and biochemical connections to the external environment, and cell
movement. During epithelial fusion the actin cytoskeleton has shown to be crucial in
order for proper fusion to occur by creating specialized actin structures and through cell
signaling.

1.4.5

Actin Cytoskeleton During Epithelial Fusion
1.4.5.1 Lamellipodia and Filopodia in Epithelial Fusion

The actin cytoskeleton has a diverse range of functions during epithelial fusion.
Two specialized actin structures are thought to be of particular importance to achieve
fusion, lamellipodium and filopodium. Lamellipodia were previously termed “ruffles”
due to the ruffled like appearance of the protrusions formed [16]. Lamellipodia are made
up of an actin dendritic network at the leading edge of the cell shown to be important in
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mechano-sensing and thought to be the physical motor behind the pulling force in cell
migration (Figure 1.4) [109]. Lamellipodia form from the nucleation of actin filaments,
and most often the nucleating protein is the Arp2/3 complex [110]. Arp2/3 complex is
made up of seven subunits, and the Actin-Related Proteins 2 and 3 closely resemble
monomeric actin and aids the nucleation of new actin filaments [110]. The Arp2/3
complex binds to the sides of existing actin filaments and creates a new actin filament at
a 70 degree angle from the original actin filament [110]. The activity of small GTPases
from the Rho superfamily are required for the formation of both lamellipodia and
filopodia. Lamellipodia formation requires the activation of Rac1, this then activates
WAVE/Scar proteins which then in turn activate the Arp2/3 complex [111].
In stark contrast to lamellipodia, filopodia are finger-like structures made up of
tightly bound parallel bundles of F-actin (Figure 1.4). However, as with lamellipodia, the
growing end of the filopodium is pointed towards the plasma membrane. The formation
of filopodia has been shown to depend upon the activation of the cdc42 pathway [112].
This results in the activation of proteins from the ENA/WASP family, which prevent the
growing actin filaments from getting capped at their growing ends [112]. Formins can
also become activated through these small GTPases. Formins create unbranched actin
filaments by continuous barbed end nucleation and elongation [113].
One of the best studied examples of lamellipodia and filopodia involvement in
epithelial fusion is during dorsal closure in Drosophila [114]. During Drosophila dorsal
closure actin based protrusions emanate from the leading edge of the closing epithelial
sheets and moves the sheet of cells towards the midline [114]. Once the epithelial sheets
appose one another the sheets fuse together in zippering-type fashion [114]. Filopodia
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extend across the gap between epithelial sheets and appears to sense the environment to
find the location where it should make contact, as filopodia have been observed to ignore
cells closest to it in favor of other more distant cells [114]. It has been observed that once
cells directly appose one another lamellipodia and filopodia interweave at the cell-cell
interface [114]. It also appears that filopodia penetrate through the plasma membrane of
the apposing cell creating the initial cell-cell contacts and adhesions [114]. In line with
these observations, inhibition of cdc42 and Rac1 results in blocking the formation of the
actin filaments observed at the leading edges and results in a failure to close the dorsal
epithelial sheets during Drosophila development [115]. There has also been evidence of
lamellipodia and filopodia involvement in cranial and neural tube closure. In mice a
conditionally ablated Rac1 results in failure of epithelial fusion in the cranial and neural
tube regions. Rho associated kinase (ROCK) is a down-stream effector from the
activation of Rho GTPases. ROCKI and ROCKII both play roles in actin filament
assembly by inhibiting actin depolymerization. Mice deficient in ROCKI exhibit a
disorganization of the actin cytoskeleton in the eyelid epithelium and the umbilical ring
[116]. Due to this deficiency of ROCKI these mice fail to close the eyelid resulting in an
open eye phenotype, as well as failure to close the ventral body wall resulting in
omphalocele [116].

1.4.5.2 Integrins and Cell Signaling in Epithelial Fusion
Integrins are a superfamily of transmembrane cell adhesion receptors that form a
heterodimer made up of an alpha and beta subunit. In zebrafish there are at least 17
different integrin or integrin-like genes encoding 9 different alpha subunits and 8
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different beta subunits. Integrins are the main receptors which bind and respond to the
extracellular matrix, making them crucial during development [117]. Integrins act in two
very critical methods, they act as cell adhesion molecules as well as signal transducers
[117]. Integrins usually have low affinity for their binding targets and have a high
concentration on the cell surface [117]. This creates a large number of weak adhesions
which allow for easily reversible attachments [117]. Integrins also transmit signals to the
cell about the extracellular matrix with which it is bound and communication from the
cell can transmit to the integrins inhibiting or enhancing their ability to bind to their
target [117]. The interactions between the cell and the extracellular matrix is
accomplished through the interactions between integrins and the actin cytoskeleton [117].
Integrins bind to scaffolding proteins which then bind to actin creating a crosslink
between integrins and the actin cytoskeleton [117]. Several scaffolding proteins are
known to interact between actin and integrin, some of which include talin, α-actinin, and
filamin [117].
It has been observed that both integrins and their scaffolding binding partners are
crucial during epithelial fusion. During mouse neural tube closure integrin 𝛽1 is required
during the “zippering” process of fusion [118]. Integrin 𝛽1 is activated at the site of the
zippering creating a focal anchorage at a shared point in the basement membrane creating
novel cell-cell junctions [118]. When this integrin is lost these focal adhesions fail to
develop and as such the neural tube fails to fuse resulting in spina bifida [118].
Interestingly it has been found that the scaffolding protein talin is directly linked to optic
fissure fusion. It was shown that talin mutants fail to break down the surrounding
basement membrane in the lobes of the optic fissure up to at least 72 hours post
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fertilization [119]. As a result these zebrafish failed to close the fissure and consequently
developed coloboma [119]. Talin has been purported to be the most crucial aspect of
integrin adhesion complexes [120]. In Drosophila it was observed talin was required for
all integrin adhesive functions, and similar results were found in mice lacking both talin
genes [121]. This suggests that inside-out and outside-in communication between the
actin cytoskeleton and the basement membrane surrounding the lobes of the optic fissure
is crucial.

1.4.6

Hyaloid Vasculature

The eye is a highly metabolic organ, consuming more oxygen than even that of
the brain. To provide the eye with the oxygen and nutrients it needs during early eye
development, two vasculature networks are initially formed, the choroidal and hyaloid
vasculature (Figure 1.5). Both vasculature networks originate from the same source, the
ophthalmic artery which is derived from the carotid. These two vasculature networks thus
form through angiogenesis, meaning they bud off from the primordial vessel. The
choroidal vasculature network is formed posterior to the eye where it surrounds the optic
cup. This network is closely associated with the retinal pigmented epithelium (RPE). The
RPE constitutively expresses Vascular Endothelial Growth Factor (VEGF) which is
crucial for maintaining the endothelial to epithelial association required for the
maintenance of this vasculature network. Alternatively, the hyaloid vasculature forms in
the anterior portion of the eye between the retina and the lens. The hyaloid vasculature
takes advantage of the optic fissure to establish this network. After entering through the
optic fissure the hyaloid artery will move through the vitreous and will eventually contact
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the posterior end of the lens. After contact the hyaloid artery will begin to branch across
the posterior side of the lens forming the tunica vasculosa lentis. The hyaloid vasculature
is avenious and in order for drainage to occur the hyaloid network must form connections
to the choroidal vasculature. The initial hyaloid artery is formed from a mesoderm
derived endothelial cell lining and periocular mesenchyme (POM) derived pericytes
[122]. However, after the initial formation of the hyaloid network it becomes solely
mesoderm derived [122]. Several genetic markers of POM have shown expression in the
migrating endothelial cells entering through the optic fissure to form the hyaloid
vasculature, including Sox10, Pitx2, and FoxC1 to date [64, 123, 124]. In most animals
the hyaloid vasculature regresses and is simultaneously replaced by retinal vasculature.
However, zebrafish maintain the hyaloid vasculature which undergoes remodeling,
moving away from the lens and towards the retina as the vitreous forms [125]. It is
suggested that due to the closer proximity of the lens and retina in zebrafish it is more
favorable to remodel rather than remake as is done in mammals [125]. It was widely
believed for many years that these migrating endothelial cells were a passive process
during optic fissure fusion, but more recent studies have found that these cells directly
contribute to the fusion process [119].

1.4.6.1 Factors in Hyaloid Vasculature Establishment
One of the most well-known and studied factors that control the migration,
establishment, and maintenance of the hyaloid vasculature is VEGF. VEGF is a highly
potent angiogenic factor comprising five members of this gene family, VEGF-A through
D and PGF, and has three receptors VEGFR1 through 3. Through many different studies
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across many different species it has been shown that lack of VEGF expression,
particularly that of VEGF-A, results in a loss of hyaloid vasculature [126-128].
Conversely, it has also been shown that overexpression of VEGF-A results in
hypertrophy of the hyaloid vasculature and has consequences on the hyaloid vasculature
regression required during mammalian development [129]. In mammals failure of the
hyaloid vasculature to regress results in persistent hyperplastic primary vitreous [130].
This failure to regress is often from the inability to attenuate VEGF functioning [130].
VEGF can bind and essentially store itself to the extracellular matrix, interestingly VEGF
can be cleaved by metalloproteinases which separates the matrix binding domain from
the receptor binding domain [131]. Many therapies, including the treatment of cancer,
have been deployed which use anti-angiogenic molecules to sequester VEGF ligands or
inhibit VEGF function [132]. This therapy has also been deployed to treat persistent
hyperplastic primary vitreous due to failure of hyaloid regression [133]. Many other
genes also play a role in hyaloid vasculature development including ECM - cell
membrane and lens gene expression, including MAGP1, Syn2, Mab21l2, and Laminin
alpha 1 [134]. When these genes are knocked down all result in hyaloid vasculature
defects [134].

1.4.6.2 Angiocrine Signaling by Endothelial Cells
Endothelial cells are not just a passive conduit for the circulation of blood, but can
also provide instructive signals during organogenesis. During embryogenesis migrating
endothelial progenitor cells invade into developing organs and create organ-specific
vascular niches which will release tissue specific growth factors (angiocrine factors)
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derived from the endothelium [135]. Angiocrine factors have been shown to be crucial
during wound repair, a similar epithelial fusion event [136]. During wound repair it has
been shown that capillary networks are in close physical proximity to hematopoietic,
mesenchymal, neuronal, epithelial, stem and progenitor cells which allow for the
instructive paracrine and juxtacrine factors provided by these tissue-specific endothelial
cells [137]. Of particular interest is the angiocrine signaling that occurs in the
development of the blood-retina barrier. The blood-retina barrier is established by the
maturation of the retinal pigment epithelium (RPE), choroidal endothelial cells, and the
basement membrane that lies between both cell types, Bruch’s membrane [138]. Through
co-culture experiments it was observed that choroidal endothelial cells secrete factors that
remodel the basement membrane of the RPE, the integrin receptors sense this change in
the basement membrane and start a signaling cascade through RhoGTPases which result
in the modulation of RPE tight junctions as well as the fortification of the RPE barrier
[138]. While angiocrine signaling has not been associated with optic fissure fusion to
date, there is some evidence that hyaloid endothelial cells somehow contribute to
basement membrane breakdown in the region of the optic fissure. Zebrafish cloche
mutants, which reportedly lack all early vasculature, fail to break down the basement
membrane in the beginning stages of optic fissure fusion, though it was ultimately stated
to not result in coloboma as the basement membrane was eventually degraded [119].
Requirement of the hyaloid vasculature in optic fissure fusion is also corroborated by
optic cup transplantation experiments, without the presence of the hyaloid vasculature
ectopic eyes failed to undergo optic fissure fusion [139]. These experiments suggest an
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angiocrine dependent mechanism during optic fissure fusion, where endothelial cells
provide direct contribution to the fusion process.

1.5

Rationale, Hypothesis, and Specific Aims
Although optic fissure fusion has been studied for well over a century the direct

molecular mechanisms governing this event are still poorly characterized. We know that
the basic machinery involves the basement membrane, the actin cytoskeleton, and
migrating endothelial cells, but how these components interact, what they do, and how
they function are not understood. It has only been within the last decade that it was
discovered that hyaloid vasculature is not just a passive process taking advantage of the
optic fissure but is part of the molecular machinery driving this fusion event. The purpose
of this dissertation was to form a comprehensive analysis on the behaviors of the
molecular mechanisms of optic fissure fusion, in particular that of the hyaloid vasculature
involvement in fusion. The overarching hypothesis of this dissertation was that the
basement membrane, actin cytoskeleton, and the hyaloid vasculature are intimately linked
to one another to drive optic fissure fusion, and the migrating endothelial cells are a key
player during this process and is hypothesized to be due to the angiocrine signaling that
these cells provide. This dissertation will show the first evidence, to date, of angiocrine
signaling during optic fissure fusion provided by the migrating endothelial cells
establishing the hyaloid vasculature. Additionally, we show how the other two molecular
mechanisms, basement membrane breakdown and the actin cytoskeleton, behave and
what they could possibly contribute to this process. This discovery was accomplished
through the following aims:
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1.5.1
I.

Specific Aims

Characterize the basement membrane, actin cytoskeleton, and hyaloid vasculature
in wild-type eye development.
•

Use whole mount immunohistochemistry and fluorescently tagged
proteins to image the behaviors of these molecular mechanisms over the
course of eye morphogenesis in the wild-type line of zebrafish.

II.

Characterize the basement membrane, actin cytoskeleton, and hyaloid vasculature
in Pax2 mutant eye development.
•

Use whole mount immunohistochemistry and fluorescently tagged
proteins to image the behaviors of these molecular mechanisms over the
course of eye morphogenesis in the coloboma model, Pax2 mutants, line
of zebrafish.

III.

Determine the consequences to optic fissure fusion in the absence of the hyaloid
vasculature.
•

Use a vasculature specific drug inhibitor, DMH-4, to eliminate the hyaloid
vasculature during eye development and assess the consequences to the
basement membrane, the actin cytoskeleton, and ultimately optic fissure
fusion.

•

Using DMH-4, assess the temporal requirement of the hyaloid vasculature
cells during optic fissure fusion.

IV.

Investigate endothelial cell contribution of metalloproteinases through angiocrine
signaling resulting in the breakdown of the basement membrane.
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•

Use fluorescent whole mount in situ hybridization and qPCR in wild-type,
pax2 mutant, and DMH-4 treated embryos to investigate any vasculature
provided metalloproteinases during optic fissure fusion.

V.

Determine the consequences to optic fissure fusion from the inhibition of mmp2.
•

Use a mmp2 drug inhibitor, ARP101, to diminish mmp2 during eye
development and assess the consequences to the basement membrane thus
optic fissure fusion.

•

Using ARP101, assess the temporal requirement of mmp2 during optic
fissure fusion.

VI.

Determine transcriptional differences between wild-type and pax2 mutant eyes.
•

Perform eye dissections, RNA extraction, and illumina sequencing on
wild-type and pax2 mutant eyes at 48 hours post fertilization.

VII.

Investigate the transcriptional differences between wild-type and Pax2 mutant
embryos regarding actin cytoskeleton and hyaloid vasculature transcripts
•

Use whole mount in situ hybridization and qPCR to validate transcripts of
interest from the RNA sequencing data.

VIII.

Investigate ADAMTS1 anti-angiogenic properties during the establishment of the
hyaloid vasculature
•

Perform mRNA injections into wild-type embryos to cause the overexpression of ADAMTS1 and assess the consequences to the hyaloid
vasculature and the basement membrane.
Aims I, II, III, IV, and V are in Chapter 2
Aims VI, VII, and VIII are in Chapter 3
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Table 1-1 Genes Associated with Coloboma. Adapted from [58, 140]
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Table 1.1 Continued
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Figure 1-1Morphogenetic Movements.
Models depicting the five main methods of morphogenetic movements. Red arrows indicate the direction of
force generated on the tissue. A. Convergent extension, three layers of cells (blue, purple, and yellow)
intercalate into one sheet. B. Epiboly, a sheet of cells (purple and blue) spreads to envelop the embryo. C.
Involution, cells (blue) turn inward creating an underlying layer. D. Ingression, cells (blue) lose contact
with neighboring cells undergoing epithelial to mesenchymal transition and exiting the tissue. E.
Invagination, cells (blue) bend inward to form an in-pocketing.
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Figure 1-2Basic Model of Optic Fissure Fusion.
Diagram depicting the three major molecular mechanisms involved in optic fissure fusion in order of which they occur.

Laminin

Nidogen

Collagen IV

Perlecan

Integrins

Cell

Figure 1-3 Basement Membrane
Diagram showing the four major components of the basement membrane. Laminin, perlecan, and collagen
IV are capable of self-assembly (red arrows). Nidogen can bind to all other three components of the
basement membrane, and perlecan can bind to both laminin and collagen IV. Laminins anchor the
basement membrane to the cell via integrin binding.
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Lamellipodia

Filopodia

Figure 1-4 Lamellipodia and Filopodia
Diagram depicting lamellipodia formed through dendritic actin polymerization, and filopodia formed
through tight parallel bundles of actin polymerization.
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Choroidal Vasculature

Lens
Retina

Hyaloid Vasculature

Figure 1-5 Completed Superficial Embryonic Vasculature
Schematic depicting the completed embryonic superficial vasculature network. Red indicates artery, blue
indicates vein. Arrows show direction of blood flow.
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MATERIALS AND METHODS

Zebrafish and embryo maintenance
Zebrafish were maintained using husbandry procedures approved by University of
Kentucky IACUC committee. Embryos were kept at 28.5oC in E3 embryo media. AB and
TL strains were used as wild-type, Tg[kdrl:mCherry] transgenic line was used to
visualize retinal vascularization [141], Tg[rx3:GFP] was used to visualize retinal cells
[142].
Pax2noi embryos were a gift from Dr. Gregory-Evans. Genotyping analysis was
conducted by amplifying the region of gDNA with the noi mutation using the forward
primer: 5’- CTCGCTCTGCCTCCATGATTG3-’and the reverse: 5’GGCACTGAAAGAGCACAGG -3’. The resultant 460bp amplicon was digested with
TaqI (NEB) which would recognize and digest the WT allele sequence but not the mutant
allele.
Cloche (clom39) mutant line was a gift from Dr. Mason Posner. Embryos were
phenotyped for heart edema and genotyped as described by Reischauer et al., 2016 [143].

Immunohistochemistry (IHC)
Dechorionated embryos were fixed with 4% PFA in PBS at room temperature for
3h and washed with PBST 4 times for 5 minutes. Embryos were then permeabilized with
Proteinase K, 30𝜇g/mL 10 minutes for 24-28 hpf, 50𝜇g/mL 15-20 minutes for 32-48 hpf
and 75𝜇g/mL 20 minutes for 56-72 hpf, washed 2 times in PBST for 5 minutes and
blocked overnight at 4oC with 10% sheep serum, 0.8% Triton X-100 and 1% BSA in
PBS. Primary mouse anti-laminin antibody (ThermoFisher – 1:100) in blocking buffer
(1% sheep serum, 1% BSA and 0.8% Triton X-100 in PBS) were incubated overnight at
4oC and washed 5 times in PBST for 15 minutes. Secondary antibody, goat anti-rabbit
(Alexa Fluor® 488 – Abcam – 1:1000), DAPI 1:1000, and phalloidin (Alexa Fluor® 555
- 1:50) were incubated overnight at 4oC in the dark. Tg[kdrl:mCherry] embryos were

treated with proteinase K as described above and stained with DAPI 1:1000 overnight.
The embryos were washed 2 times in PBST for 15 minutes and visualized using a Nikon
C2+ confocal microscope equipped with a 40X (1.15NA) water immersion objective.
Embryos were embedded in 1.2% low melting point agarose on glass bottom 35mm
dishes (Fluorodish, World Precision Instruments). Images were captured in steps of 3.5
microns for a total of 31.5 microns using Nikon Elements software. Image adjustment,
such as cropping and brightness/contrast was performed using Adobe Photoshop.

Analysis of Fluorescence signal
Fiji software (https://fiji.sc) was used to measure the fluorescence intensity of
laminin and phalloidin signal from raw image data. In order to account for variability in
staining, normalization values were measured for laminin and actin pixel intensity where
an area directly outside of the choroid fissure was measured and a ratio was generated
between the two values (Appendix 2.1B). In cases where the fissure edges were farther
apart then the size of the box used for analysis, the box was divided into two and used to
measure fluorescence intensity on each side of the fissure. Measured values from both
boxes was added and then normalized. For Tg[krdl:mCherry], 3D reconstructions of the
optic fissure were generated and individual cells were counted (from the opening of the
OF through the back of the lens).

Statistics
Student’s t-test was used to compare individual time points. One-way ANOVA
was used to analyze across treatments. Graphs are displayed as mean +/- standard
deviation. Analysis was performed using Prism8 graphing software (GraphPad).

Total RNA Sequencing
WT and Pax2-/- embryos were dissected and collected at 48 hpf and RNA was
extracted from dissected eyes using trizol. Pax2a-/- embryos were phenotyped by distinct
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heart defects only observed in pax2a-/- embryos, as verified by previous genotyping
experiments. Dissected eyes were suspended in 1 mL of trizol and sheared with a 22gauge needle. Samples were incubated at room temperature for 5 minutes, then 200 𝜇L of
chloroform was added and vortexed for 1 minute. Samples were then centrifuged at
12,000 g for 15 minutes at 4℃. Aqueous phase was removed and put into fresh RNAse
free tube. 3 𝜇L of Glycoblue was added to samples and vortexed for 5 seconds. 500 𝜇L of
100% Isopropanol was then added and vortexed for an additional 10 seconds. Samples
then were incubated at room temperature for 10 minutes. Samples were then centrifuged
at 12,000 g for 10 minutes at 4℃. Supernatant was removed and 1 mL of 75% EtOH was
added and vortexed for 10 seconds. Samples were then centrifuged at 7,500 g for 5
minutes at 4℃. Supernatant was removed and samples then underwent a pulse
centrifugation and any remaining supernatant was removed. Samples were then air-dried
for 7 minutes at room temperature under a fume hood. 20 𝜇L of RNAse free ddH2O was
added to the samples and mixed until pellet dissolved. Samples were finally incubated at
60℃ for 12 minutes and then stored at -80℃.
The RNA then underwent a DNase treatment using the DNA-free Kit. 2 𝜇L of
10X DNaseI Buffer, and 1 𝜇L of rDNaseI was added to the entire 20 𝜇L sample. Samples
were incubated at 37℃ for 20 minutes, and then 2 𝜇L of DNase Inactivation Reagent was
added. Samples were then incubated at room temperature for 2 minutes, mixing samples
3 times. Samples were centrifuged at 10,000 g for 1.5 minutes. Supernatant was then
removed and placed into fresh RNase free tube and stored at -80℃.
Purified total RNA was sent to Applied Biological Materials Inc. for Illumina
sequencing (PE150bp, 30-40 million reads/sample). Bioinformatic analyses were
completed using RSEM. Those transcripts which had a greater than 0.95 posterior
probability of being differentially expressed were considered significant. Panther
(http://pantherdb.org) was used for gene ontology and pie chart generation.

47

Whole-mount in situ hybridization (WISH)
Whole-mount in situ hybridization was performed as previously described [144].
RNA probes were generated using PCR with T7 promoter sequence linkers and
subsequently transcribed [DIG or FITC labeled] using T7 polymerase (Roche). Primer
sequences are all found in Table 2.1. Images were captured using a Nikon Digital sight
DS-Fi2 camera mounted on a Nikon SZM800 stereo scope using Elements software.
Dissected eyes from 24, to 72hpf embryos were mounted in 70% glycerol and imaged
under DIC using a Nikon TiE compound microscope equipped with a 20X (0.7NA)
objective and Elements software. Image adjustment, such as cropping and
brightness/contrast was performed using Adobe Photoshop.

qPCR analysis
32hpf embryos were anesthetized with tricane, tail tips were collected for
genotyping and the heads, dissected just posterior of the eyes, were fixed in RNAlater.
After genotyping, embryos corresponding to WT and pax2a-/- were pooled, 5-10
embryos, and total RNA isolated using a RNAaqueous kit (Ambion). DMSO and DMH4
treated embryos were harvested in the same fashion absent any genotyping. qPCR was
performed as previously described [145]. Primer sequences are all found in Table 2.1.

2 color fluorescent in situ hybridization
FWISH was performed as previously described [146]. Images were collected
using a Nikon C2+ confocal microscope with a 20X (0.95NA) objective and images were
adjusted for brightness and contrast using Adobe Photoshop.

Live imaging analysis
Live imaging of Tg[kdrl:mCherry] embryos was conducted using a Nikon C2+
confocal microscope equipped with at 20X (0.95NA) water immersion objective. 22 hpf
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embryos were imbedded in 1.1% low gelling agarose in 1-inch glass bottomed Flourodish
cell culture dishes (World Precision Instruments) and covered in embryo media, 3-amino
benzoic acidethylester (tricaine) to anaesthetize the embryos and 1-phenyl 2-thiourea
(PTU) to inhibit pigmentation. Z-stacks 75𝜇m thick with a step size of 2.5𝜇m were
captured over the course of 6 hours at 10 minute intervals. The time lapse data were
reconstructed in 3D using Elements software. Image adjustment, such as cropping and
brightness/contrast was performed using Adobe Photoshop. After imaging, embryos were
removed and genotyped.

Inhibitor treatments
Embryos were incubated in embryo media with 5, 25, 50, or 100 𝜇M of DMH-4
(Sigma Life Science) in DMSO starting at 12hpf. Fresh DHM4 containing media was
added every 12hpf for timepoints past 24hpf. For ARP101 (Tocris) treatments embryos
were dechorionated and treated with 10, 15, 20, 25 or 30𝜇M ARP101 in fish water from
24 to 48hpf, unless stated otherwise.

Cloning and mRNA synthesis.
Full coding domain sequences for adamts1 (NCBI reference sequence
XM_021475923.1), were amplified from 24hpf zebrafish cDNA using primers 5’CTCGAGTCAACAGGGAGTCAGATTGC-3’ for adamts1, cloned into pGEMT
(Promega), digested with AsiSI/XhoI, BamHI/XhoI respectively and subsequently cloned
into pCS2+. All constructs were verified by sanger sequencing (Eurofinsgenomics).
mRNA was synthesized from linearized pCS2 constructs using SP6 mMessage
mMachine kit (Ambion) and purified using YM-50 Microcon columns (Amicon,
Millipore).
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Alt-R-crRNA CRISPR injections
Alt-R mmp2 crRNA, tracrRNA was pre-designed and synthesized by IDT.
Duplex formation and dilution with Alt-R Cas9 v.3 enzyme was carried out as described
by Hoshijima et al. 2019 [147].

Ethics Statement
The use of zebrafish in this study was approved by the University of Kentucky
IACUC committee, Institutional PHS Assurance #D16-00217 (A3336-01) with a protocol
number: 2015-1370.
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Table 2-1 Primer Sequences
WISH
Gene

Primer Sequences

Pax2a probe
FORWARD

ATGGATATTCACTGCAAAGCAG

Pax2a T7 probe
REVERSE

TAATACGACTCACTATAGGGCTAGTGGCGGTCATAGGCAGTG

tln1 probe
FORWARD

GCTATCGCTGTCACCGTTCAG

tln1 T7 probe
REVERSE

TAATACGACTCACTATAGGGGATGCCTTTGGTCATGCGGATG

mmp2 probe
FORWARD

ATGATGTCCGTTAAGTTTTTC

mmp2 T7 probe
REVERSE

TAATACGACTCACTATAGGGCTCAGGACAGAATCCGTAAGT

mmp14a probe
FORWARD

ATGTTACCGAAACTGCAGACG

mmp14a T7 probe
REVERSE

TAATACGACTCACTATAGGGCACTCGCCAGAACCACTTTTC

mmp14b probe
FORWARD

ATGATCTGGAGCGGGTTTACG

mmp14b T7 probe
REVERSE

TAATACGACTCACTATAGGGGAACCACTTACCCTTAAACAC

vegfAA probe
FORWARD

GAAGTTAATTTTAGCGGATTCG

vegfAA T7 probe
REVERSE

TAATACGACTCACTATAGGGGTGATAGCAGCGACACACATTG

vegfAB probe
FORWARD

GCATGGGATTACTTCTGTGATG

vegfAB T7 probe
REVERSE

TAATACGACTCACTATAGGGCTTCATGTCCGTTCTCAAGTC

vegfC probe
FORWARD

ATGCACTTATTTGGATTTTCTG

vegfC T7 probe
REVERSE

TAATACGACTCACTATAGGGCACACATTTGGTGCGGTTGAG
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Table 2.1 Continued
rorb probe
FORWARD

CTCAGCACCCTCAACCACGAG

rorb T7 probe
REVERSE

TAATACGACTCACTATAGGGTCATTTGGGCATGACGGCGGC

kdrl probe
FORWARD

CAAGTGGCTAAAGGCATGGAG

kdrl T7 probe
REVERSE

TAATACGACTCACTATAGGGGACGGGTGGTGTGGAGTAACG

ROCK1 probe
FORWARD

GAGATTATGAACCGTAAGGAC

ROCK1 T7 probe
REVERSE

TAATACGACTCACTATAGGGTTAGCTGGGCTTTCCTGGGAC

ROCK2b probe
FORWARD

CACTCCATCATCAAATACCAG

ROCK2b T7 probe
REVERSE

TAATACGACTCACTATAGGGTCACCTGTTCTTGCTGGAGGG

qPCR
Gene

Primer Sequences

Primer Sequences2

tln1

TTGGGGCAATTCCAGCAAAC

TGCTTCGCACAGGTTGTTAG

cldn5b

TACATCGTCGCAGGCTTGTT

GATGCTGCCCATCCGATGTA

tjp1a

CACAGAAGCAAGAGCCTGGA

AAAACCCGGTGCCCTGTG

flt4

CAGTCCAAAACAGCCAGCAC

CAACTCCACAGGCGAGTCTT

vegfaa

CAACGCGTATCGCAGCATAAT

AAGGCTCACAGTGGTTTTCTT

vegfab

TGTTGTATGTGACGGTGGGG

GCAAAACCGTGGTTCCAGAC

vegfc

TGGAGAAAGACGCTGTGCAT

TGCACTGAAGCTCCTCACTG

mmp2

TCAGGGTCGAGATGATGGGT

GAAAAGGAGCTCATGGGGACA

mmp14a

ACGCAGCTTATGAACGCAAT

TCCTGTGCCAAGCTCCTTAA

mmp14b

TCTTCAAAGGGGACAGGCAT

CACCAGTTCCCAGTTCTCCT

ROCK1

CAGGAAAGCCCAGCTAACCA

CGTGTGAGGTTATTGCAGAGG

ROCK2a

GGGAAGTCCAGCTGGTTAGG

TCCTCCCAGAAGAAGGCAGA

ROCK2b

CTGACGAGGCATATCCAGCC

CTGCTCACGACCACATACTTC
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HYALOID VASCULATURE AND MMP2 ACTIVITY PLAY A ROLE DURING OPTIC
FISSURE FUSION IN ZEBRAFISH.
Megan L. Weaver, Warlen P. Piedade, Nishita N. Meshram, and Jakub K. Famulski
Contributions: Warlen P. Piedade contributed to figures 3.2, 3.3, and 3.5.
Nishita Meshram contributed to figures 3.2, 3.3, 3.4, and 3.5.

3.1

ABSTRACT
Vertebrate retinal development requires timely and precise fusion of the optic

fissure (OF). Failure of this event leads to congenital vision impairment in the form of
coloboma. Recent studies have suggested hyaloid vasculature to be involved in OF
fusion. In order to examine this link, we analyzed OF fusion and hyaloid vasculogenesis
in the zebrafish pax2a noi mutant line. We first determined that pax2a-/- embryos fail to
accumulate F-actin in the OF prior to basement membrane (BM) degradation.
Furthermore, using 3D and live imaging we observed reduced OF hyaloid vascularization
in pax2a-/- embryos. When examining the connection between pax2a loss of function and
hyaloid vasculature, we observed significant reduction of talin1 expression, a regulator of
hyaloid vasculature. In addition, cranial VEGF expression was found to be reduced in
pax2a-/- embryos. Pharmacological inhibition of VEGF signaling phenocopied the pax2a/-

vasculature, F-actin and BM degradation phenotypes. Lastly, we determined that OF

associated hyaloid vasculature is a source of mmp2, mmp14a and mmp14b expression
and showed that mmp2 is functionally necessary for degradation of OF BM. Taken
together we propose a pax2a driven mechanism that ensures proper and timely hyaloid

vasculature invasion of the OF in order to facilitate availability of the BM remodeler
mmp2.

3.2

INTRODUCTION
Ocular development is a highly conserved process amongst vertebrate species.

Assembly of the hemispherical, retinal structure from an initially flat sheet of cells
requires many complex morphogenetic movements. One such morphogenetic movement
involves the invagination of the optic vesicle which results in a fissure forming at the
ventral region of the developing retina. This fissure, known as the choroid or optic fissure
(OF), enables hyaloid vasculature cell migration into the developing retina and
subsequent establishment of the hyaloid vasculature. Hyaloid vasculature is a temporary
circulatory system required for ocular development, and in most cases will degenerate
once mature blood vessels begin to grow [125, 148-150]. As soon as the hyaloid
vasculature has been established, the two opposing retinal epithelial sheets of the OF will
undergo fusion. Thereby, they encase the ganglion cell axons localized in the optic stalk
and complete retinal morphogenesis. Failure of OF fusion leads to a congenital blinding
disorder known as coloboma [151-153]. Coloboma is a prevalent cause of pediatric
blindness, accounting for approximately 10% of cases worldwide [152, 154]. This makes
it one of the leading causes of pediatric blindness. Coloboma is a spectrum disorder
presenting unilaterally or bilaterally and ranging in severity from minor visual
impairment, to complete blindness in the affected eye [155]. This spectrum of severity is
associated with the location and degree to which the OF was able to fuse and the severity
of subsequent loss of ganglion cell axons [153].
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Coloboma has been studied for many decades in many different species. Work
over this time has led to a general outline of the signaling and morphogenetic pathways
required for proper OF formation and fusion (recently reviewed in [156]). In particular,
opposing action of bone morphogenetic protein (BMP) and sonic hedgehog (Shh)
signaling establishing the dorsal-ventral pattern of the optic vesicle and ensuring proper
expression of optic stalk and OF regulators pax2, vax1 and vax2 [157, 158]. However,
the actual molecular mechanisms driving OF fusion remains largely unknown. The
process of epithelial tissue fusion is not unique to the eye and occurs throughout
development, encompassing neural tube closure, palatal shelf formation and eyelid
development [159]. Epithelial fusion has been studied for over a century, and is known to
involve transcriptional regulation, cell signaling pathways and morphogen gradients [160,
161]. The actin cytoskeleton is thought to be a crucial component of the machinery
driving epithelial fusion in many tissues [162]. The importance of the actin cytoskeleton
during epithelial fusion involves lamellipodial and filopodial projections between the two
opposing epithelia. These help to “zipper” the cells together to form a single continuous
sheet. When lamellipodial and filopodial projections are precluded, epithelial fusion often
fails [163]. Lamellipodia and filopodia have been observed during OF fusion almost 3
decades ago [164-166]. However, the functional and regulatory mechanisms behind these
projections remain unknown. Another cellular mechanism known to be directly involved
in epithelial fusion is the degradation of the basement membrane (BM). During epithelial
fusion, the BM acts as a physical barrier restricting the establishment of cell-cell contacts,
which must be removed in order to complete fusion. Recent work from several labs,
working on different species, has characterized progressive removal of the BM during OF
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fusion [88, 119, 167, 168]. However, the molecular mechanisms facilitating this process,
in particular BM degradation, also remain largely unknown. It was recently suggested
that hyaloid vasculature cells migrating through the OF could potentially signal or
facilitate BM degradation [119]. Hyaloid vasculature nourishes the developing retina and
lens while connecting to the choroid vasculature for proper blood flow [125]. Hyaloid
vasculogenesis takes advantage of an open OF so that vasculature cells can migrate into
the developing optic cup. Once OF fusion is completed, hyaloid vasculature is fully
established. James et al. 2016, showed that mutations in zebrafish talin1 (tln1), an actin
cytoskeleton scaffolding protein known to be required for endothelial cell migration
[169], result in OF fusion defects. Theirs, and previous studies also indicated that cloche
mutants, which lack all early hyaloid vasculature, have delayed BM breakdown in the
region of the OF [119, 170]. Since the hyaloid vasculature requires an open fissure to
complete establishment of its network, it has been proposed that migrating hyaloid
vasculature cells may regulate the timing of fissure fusion. This mechanism could
potentially involve vasculature-mediated activation of the fusion machinery within the
retinal rim cells, or direct supply of molecular factors, such as matrix proteases [171]. In
support of this hypothesis, recent optic cup transplantation experiments in zebrafish
embryos confirm that in the absence of hyaloid vasculature, ectopic retinal OFs fail to
initiate fusion [139]. Hence, there is a clear link between OF fusion and hyaloid
vasculature.
In our current study, we have undertaken a detailed analysis of zebrafish OF
fusion in the pax2a-/- coloboma model [172]. This included characterizing the timing of
BM degradation, cytoskeletal responses, morphological apposition and hyaloid
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vascularization. When comparing pax2a+/+ and pax2a-/- eyes we discovered decreased OF
hyaloid vascularization and OF fusion failure. In particular we found that pax2a-/embryos exhibit a decrease in tln1, hyaloid vasculature makers as well as VEGFaa,
VEGFab and VEGFc expression. Modulation of vascularization via pharmacological
inhibition of VEGF signaling phenocopied the pax2a-/- hyaloid vasculature and coloboma
phenotypes. Mechanistically, we also show that hyaloid vasculature is a source of mmp2,
mmp14a and mmp14b and that mmp2 activity is necessary for OF BM degradation.
Taken together, we propose a novel pathway for the regulation of OF fusion where pax2a
mediates proper timing and abundance of hyaloid vasculature cell recruitment to the OF
and subsequent vasculature supplied mmp2-dependent BM degradation.

3.3

RESULTS
3.3.1

Optic fissure basement membrane degradation is preceded by F-actin
accumulation.

Several recent studies have undertaken a detailed time course to map out the exact
timing of OF fusion in numerous species, including zebrafish [88, 119, 167, 168].
Overall, in zebrafish, the data point to ~32-36hpf as the time of OF fusion initiation, as
observed by BM degradation. To decipher the molecular mechanisms regulating OF
fusion we also performed a detailed time course analysis of OF BM degradation using
laminin immunohistochemistry (IHC) while additionally analyzing F-actin. Our goal was
to determine whether changes in F-actin levels in the OF were correlative with fusion.
James et al, 2016 had recently suggested that infiltrating vasculature endothelial cells
migrating through the fissure could be a source of signal for fissure fusion. In fact, they
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had shown that interactions between vasculature and the fissure resulted in an increase of
F-actin [119]. As such, we first performed whole mount IHC for laminin deposition in
embryos starting at 24hpf. We sampled every 4 hours up to 48hpf and then at 56 and
72hpf (Figure 3.1A). To analyze the progression of the fusion process, we quantified the
laminin signal within the OF from 3D confocal scans. We quantified distal, medial and
proximal regions of the fissure (Appendix 2.1A). Regions of the BM outside the OF and
juxtaposed to the developing lens were used to normalize the laminin signal (Appendix
2.1B). When comparing results from the three regions we did not observe significant
differences in the distribution of laminin or F-actin (Appendix 2.1C). Going forward we
focused on quantifying laminin signal in the central proximal region (medial) of the
fissure (Figure 3.1C). This region has been previously shown to represent the site of
fusion initiation, is known to interact with hyaloid vasculature and is easily identified in
24-72hpf embryos [119]. In agreement with recent studies in zebrafish, we found that OF
fusion initiates at ~32-36hpf and does so in a central region of the fissure, subsequently
proceeding proximally and distally. From observing distance between the fusing lobes of
the retina in our time course for OF laminin status, Figure 3.1A, we observed apposition
to complete between 36-44hpf (Figure 3.1A). By 48hpf, we observed most of the laminin
signal was removed from the OF, and by 72hpf, little to no laminin persists in the region
(Figure 3.1A, C).
To track F-actin levels during fusion we stained the laminin labeled embryos with
phalloidin and quantified the signal within the fissure. To normalize phalloidin staining
intensity we used an interior region of the retina (Appendix 2.1B). Our analysis revealed
an increase in OF associated F-actin signal between 24-32hpf, preceding the time that
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BM degradation is initiated (Figure 3.1D). The observed increase of F-actin signal
correlates with the timing of hyaloid vasculature migration (24-32hpf) into the fissure.
The nature of our assay did not precisely identify the cellular source of F-actin but it
likely predominantly consisted of retinal rim and hyaloid vasculature cells. Taken
together, we conclude that BM degradation is preceded by an increase of F-actin within
the OF.

3.3.2

Optic fissure fusion mechanics are disrupted upon loss of pax2a function.

In order to test our hypothesis that an increase in F-actin is involved in the
initiation of OF fusion we compared our findings to an established model of coloboma,
the pax2a noi line [172]. Pax2 is required for OF fusion in several model systems and has
been documented in human coloboma cases [173-175]. The noi mutation is predicted to
result in a loss of pax2a function due to a premature stop codon at position 198 [176].
Originally characterized for their no-isthmus phenotype, pax2anoi/noi embryos (referred to
as pax2a-/- from this point on) elicit a fully penetrant unfused OF [177, 178].
Unfortunately, homozygous mutants are not viable and do not enable the study of
coloboma at juvenile or adult stages. We hypothesized that examining the molecular
events leading to OF fusion in the pax2a noi system would inform us whether these
events are functionally important. Similar to our WT study, we examined apposition,
laminin and F-actin levels throughout the time of OF fusion (Figure 3.1B, D, Appendix
2.2). In stark contrast to WT, pax2a-/- embryos did not exhibit a significant decrease in
laminin signal between 32-48hpf. In fact, as expected, laminin appeared to be largely
retained in the OF of pax2a-/- embryos up to 72hpf (Figure 3.1B,C). Previous studies in
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pax2a null mice had also indicated failure of BM degradation and retention of laminin
[175]. While there is a moderate decrease in laminin signal in pax2a-/- embryos from 3236hpf (p=>0.0001), there was no significant loss of laminin signal between 36-48hpf.
This result is significantly different in WT embryos (p=>0.0001) which display a major
decrease in laminin signal during this time. IHC images clearly show that laminin persists
in the pax2a-/- fissure up to and including 72hpf (Figure 3.1B). When examining OF Factin levels in pax2a-/- embryos we did not detect the expected increase between 24 and
32hpf (Figure 3.1D). In fact, up to 48hpf F-actin levels measure significantly lower than
in WT embryos. Similar results were also observed when quantifying distal and proximal
regions of the fissure (Appendix 2.1D). Our data therefore suggest that the absence of OF
F-actin accumulation between 24 and 32hpf, correlates with failure to initiate fusion.
Lastly, when examining retinal lobe distance in pax2a-/- embryos we did not observe any
significant defects in the degree of apposition up to 48hpf (Appendix 2.2). Taken
together, we conclude that in the absence of pax2a, F-actin fails to accumulate in the OF
and this correlates with the failure to degrade the BM. Based on our findings, we
therefore conclude that retinal lobes still become apposed by 48hpf in pax2a mutants. In
summary, we propose that accumulation of F-actin is necessary for the initiation of OF
BM degradation. We therefore next sought to investigate the source of OF F-actin
accumulation.
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3.3.3

Loss of pax2a function leads to reduced hyaloid vasculature within the optic
fissure.

Work by James et al. 2016, suggested that F-actin accumulation in the OF may
result from interaction between retinal rim cells and invading hyaloid vasculature. To test
this possibility, we examined hyaloid vasculature in pax2a-/- Tg[kdrl:mCherry] embryos.
Using 3D in vivo time-lapse confocal microscopy we recorded migration of mCherry
expressing cells through the OF from 24 to 30hpf (Figure 3.2A). At 24hpf, both WT and
pax2a-/- embryos contain mCherry expressing cells within the fissure. However, over the
next six hours of imaging it is apparent that pax2a-/- embryos have significantly fewer
mCherry expressing cells pass through the OF (Figure 3.2A). To visualize this effect, we
fixed WT and pax2a-/- Tg[kdrl:mCherry] embryos at 24, 32, 36 and 48hpf to collect and
render 3D confocal stacks (Figure 3.2B). Starting as early as 32hpf, we noticed a clear
reduction in the number of vasculature cells within the OF and retina. Furthermore, we
counted the number of mCherry positive cells found within the OF at 32 and 36hpf
(Figure 3.2C). The data indicated that in pax2a-/- embryos there is a significant reduction
in the number of mCherry expressing cells at both 32 and 36hpf (Figure 3.2C).
Additionally, using 3D rendering, we noted that in 48hpf pax2a-/- embryos the hyaloid
vasculature established in the back of the lens is reduced in size and lacks proper
connections to the newly forming choroidal and superficial vasculature systems. In the
previously aforementioned study, James et al. 2016 also showed that tln1 is necessary for
hyaloid vasculature recruitment to the OF and subsequent fusion. Since pax2a-/- embryos
lack BM degradation, fail to initiate F-actin accumulation and have reduced hyaloid
vascularization (Figure 3.1,2), we sought to examine tln1 expression in this model. To
examine tln1 expression status we performed whole mount in situ hybridization (WISH)
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for tln1 comparing WT siblings to pax2a-/- mutant embryos. WT expression of tln1 was
observed in the OF between 28 and 48hpf coinciding with pax2a expression (Figure
3.2D, Appendix 2.3). In pax2a-/- embryos, OF tln1 expression appears significantly
reduced compared to WT while retaining similar expression in periocular regions (Figure
3.2D). Tln1 expression is also reduced in the mid brain-hind brain boundary, another
region of strong pax2a expression (Figure 3.2D, Appendix 2.3A). Our WISH data was
further supported by qPCR results showing a significant decrease in tln1 expression at
32hpf (Figure 3.2E). Finally, to verify our observations were indicative of reduced
hyaloid vasculature we also analyzed expression of additional vasculature markers flt4,
tjp1a and cldn5b [64, 179]. qPCR comparison of 32hpf WT and pax2a-/- embryo heads
indicated a significant decrease of flt4, tjp1a and cldn5b expression, validating our
observation of overall reduced vasculature in mutant embryos (Figure 3.2E). Overall, our
data indicate that pax2a-/- embryos exhibit decreased expression of tln1 and impaired
hyaloid vascularization of the OF.

3.3.4

Inhibition of VEGF signaling impairs optic fissure fusion mechanics.

Based on our discovery of impaired OF hyaloid vasculature in pax2a-/- embryos,
we next examined whether this phenomenon is associated with failure of OF fusion.
Hence, we turned our attention to vascular endothelial growth factor (VEGF) signaling.
VEGF, the ligand for vascular endothelial growth factor receptor (VEGFR), is a prime
candidate for regulating the migration and proliferation of hyaloid vasculature cells. In
support of this notion, when examining expression patterns for VEGF ligands, vegfaa, ab,
and c we found vegfaa, ab, and c to be expressed in the head and periocular regions
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(Figure 3.3A). In order to test for a link between the loss of pax2a function and VEGF
signaling we analyzed vegfaa, ab and c expression in pax2a-/- embryos. Fluorescent
wholemount in situ hybridization (FWISH) at 32hpf indicated a decrease of vegfaa, ab
and c expression in the cranial regions of mutant embryos (Fig 3A). These results were
also supported by qPCR (Figure 3.3B). Our data therefore suggest that a decrease in
VEGF signaling may be a factor responsible for reduced hyaloid vascularization of the
OF in pax2-/- embryos. This finding may also explain the severe vascular phenotypes
pax2a-/- embryos develop, in particular heart edema and other cardiac misfunction.
In order to test whether VEGF signaling plays a direct role in hyaloid
vascularization of the OF and subsequently fissure fusion we sought to inhibit VEGF
activity. We therefore took advantage of a dorsomorphin derivative, DMH4, which has
been shown in zebrafish to selectively inhibit VEGF signaling independent from BMP
[180]. Based on published working concentrations, we conducted a dose response to
examine DMH4 effects on hyaloid vasculature using Tg[kdrl:mCherry] as a readout
[180]. Treatment of embryos from 12-24hpf, ranging from 1-100𝜇M, resulted in a dose
dependent reduction of mCherry signal in the developing retina (Appendix 2.4A). We
decided to use the 100𝜇M concentration for subsequent experiments as this concentration
was able to completely inhibit vascularization of the retina up to 56hpf without any
significant impact on overall embryo health (Appendix 2.4B,C). Embryos were treated
starting at 12hpf and examined for fissure fusion status via whole mount laminin IHC at
24, 32, 36, 48, 56 and 72hpf (Figure 3.3C). 3D confocal imaging revealed a persistence
of laminin signal within the fissure up and including 72hpf in all embryos examined
(Figure 3.3C). This was in contrast to DMSO treated embryos which exhibited no defects
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in OF fusion (Appendix 2.4D). Long term treatment with 100𝜇M DMH4, 56hpf+, did
result in a degree of retinal toxicity (Appendix 2.4B). To circumvent this effect, we also
treated embryos from 12-72hpf with 25 and 50𝜇M DMH4 (Appendix 2.4B). Toxicity
appeared reduced at the lowest concentration, 25𝜇M, while still eliciting a failure of OF
fusion phenotype in 87.5% of treated embryos (Figure 3.3D, Appendix 2.4E). Observed
retention of OF laminin signal at 48hpf in DMH4 vs DMSO treated embryos generated
an overall pattern of results very similar to what we observed in pax2a-/- (Figure 3.3E).
While DMH4 treatment did result in a significant reduction of OF laminin signal from
36-48hpf (p=<0.0002), OF laminin levels of DMH4 treated embryos were significantly
higher than DMSO controls at 48hpf (Figure 3.3E). When measuring the degree of retinal
lobe apposition at 48hpf, we saw no negative effects of DMH4 treatment. This suggests
that the observed failure of OF BM degradation is unlikely to result from optic cup
morphogenesis delay (Appendix 2.2). However, it remains possible that apposition is
initially delayed by DMH4 treatment yet completes by 48hpf. In addition to laminin, we
also imaged and quantified OF F-actin levels during DMH4 treatment (Figure 3.3F).
Similar to pax2a-/- embryos, DMH4 treatment prevented the accumulation of OF F-actin
between 24-32hpf (Figure 3.3F). This was in contrast to DMSO treated embryos which
exhibited the expected accumulation of F-actin in the fissure between 24-32hpf.
To show timing specificity of our DMH4 treatments we also performed a time
course analysis. When treating embryos with DMH4 starting at 12hpf we observed total
inhibition of fissure fusion, indicated by retention of OF laminin signal at 48hpf.
However, when DMH4 was added at later time points, 24, 28 or 32hpf we observed a
corresponding decrease in fissure fusion failure (Figure 3.4A,B). Interestingly, starting
64

DMH4 treatment at 32hpf had little effect on OF fusion. To correlate our DMH4 time
course treatment to hyaloid vasculature, we imaged vasculature using the
Tg[kdrl:mCherry] line (Figure 3.4C). Starting DMH4 treatment at 24 or 28hpf
significantly reduced the number of hyaloid vasculature cells in the OF at both 32 and
36hpf and by 48hpf, little to no vasculature was observed (Figure 3.4C). Quantification of
hyaloid cells within the fissure at 32 and 36hpf supported these observations (Figure
3.4D). Importantly, the degree of OF hyaloid vascularization correlated with the rates of
OF fusion failure observed (Figure 3.4B). Significant reduction directly correlated to an
increase in fusion failure (Figure 3.4B). On the other hand, delay of DMH4 treatment
until 32hpf did not eliminate all hyaloid vasculature in the OF at 48hpf and correlated
with increased rates of OF fusion (Figure 3.4B). Sufficient hyaloid vasculature
recruitment to the OF is therefore critical at early stages of OF fusion, 24-28hpf.
Lastly, in order to confirm the source of tln1 in the OF as hyaloid vasculature, we
assessed tln1 expression after DMH4 treatment. Fluorescent whole mount in situ
hybridization (FWISH) indicated a significant decrease of tln1 but not pax2a expression
in DMH4 treated embryos (Figure 3.4E). qPCR analysis supported our observation
(Figure 3.4F). This suggests that tln1 is most likely expressed by the vasculature cells
within the OF. Based on these findings, we conclude that inhibition of VEGF signaling
results in failure of F-actin accumulation and basement membrane breakdown due to the
absence of hyaloid vasculature cells in the OF.
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3.3.5

Hyaloid vasculature is a source of mmp2 necessary for OF BM degradation.

The above data confirm and support a model where hyaloid vasculature drives or
initiates the OF fusion process. However, a missing key to this model is the mechanism
by which vasculature cells induce fissure fusion. James et al 2016, along with others,
have suggested vasculature cells may be a source of BM degradation enzymes, such as
matrix metalloproteases (mmp). To investigate this further, we used WISH to examine
mmp expression within the OF between 24-48hpf. Our examination of mmp expression
indicated that mmp2, 14a and 14b were expressed within the fissure between 28-36hpf
(Appendix 2.5A and Famulski lab unpublished data). Mmp2 had recently been associated
with OF fusion in the mouse while evidence from an mmp2 metalloproteinase activity
probe in zebrafish indicated mmp2 activity is present in the developing eye and likely OF
[181, 182]. mmp14 is an activator of mmp2 and its co-expression with mmp2 within the
fissure suggests mmp2 is in fact active [183, 184]. To test whether mmp2 fits within our
model we assayed mmp2, mmp14a and mmp14b expression in pax2a-/- and DMH4 treated
embryos. In both cases, OF expression of mmp2, mmp14a and mmp14b was reduced as
observed by FWISH and confirmed by qPCR (Figure 3.5A, B, Appendix 2.5B). This
suggested that all three may be expressed by the hyaloid vasculature cells. To assess this,
we performed two color FWISH for mmp2 and kdrl. Confocal imaging verified that
mmp2 expression is co-localized with that of kdrl within the OF (Figure 3.5C).
Conversely, when performing two color FWISH for mmp2 and rorB, a retina specific
probe, we did not detect co-localization of the signals. We therefore conclude that the
source of mmp2 in the OF is most likely hyaloid vasculature cells.
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Finally, to determine whether mmp2 activity is necessary for OF fusion we
treated embryos with ARP101, a specific mmp2 inhibitor previously shown to be
effective in zebrafish [185]. Treating embryos with ARP101 from 24-48hpf inhibited OF
BM breakdown in a dose dependent manner (Figure 3.6A, Appendix 2.6A,B). When
compared to DMSO, embryos treated with 15 or 20𝜇M ARP101 either completely or
partially retain their OF BM up to 48hpf (Figure 3.6B). To ensure that inhibition of
mmp2 activity is not affecting hyaloid vasculature migration into the OF we imaged
Tg[kdrl:mCherry] DMSO or ARP101 treated embryos from 24-48hpf. OF associated
vasculature appeared unchanged at 32, 36 and 48hpf (Figure 3.6C). Furthermore,
quantification of hyaloid cells within the fissure at 32 and 36hpf indicated that inhibition
of mmp2 activity does not have any effects on OF vascularization (Figure 3.6D). Lastly,
we also examined pax2a expression in ARP101 treated embryos and did not observe any
negative effects (Appendix 2.6C). We therefore concluded that mmp2 activity is
necessary for BM breakdown in the OF. To determine when mmp2 activity is required
we performed a time course of the ARP101 treatment starting between 24-32hpf and
assayed BM status at 48hpf (Figure 3.6E). Treatments started later than 30hpf had little to
no effect on OF BM degradation, indicating that mmp2 activity is optimally required
between 24-30hpf (Figure 3.6E). This finding also correlates with the observed timing of
mmp2 expression in the OF (Appendix 2.5A). However, because we cannot determine
exactly how quickly ARP101 inhibits enzymatic activity in our assay, active mmp2 may
persist in the OF longer than 30hpf. Lastly, in addition to pharmacological inhibition of
mmp2 function, we also sought to examine the consequences of mmp2 gene inactivation.
To do so, we employed the recently introduced Alt-R-crRNA/Cas9 system which has
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been shown to provide highly effective CRISPR mediated F0 gene knockouts in zebrafish
[186]. Injection of a pre-designed mmp2 crRNA duplex with Cas9 enzyme resulted in
~53% of embryos displaying a coloboma like phenotype at 72 hpf (Appendix 2.7).
Confocal imaging of laminin staining indicated a partial failure in OF BM degradation
and persistence of a minor fissure. The observed phenotype was similar to but not as
pronounced as observed in pax2-/- embryos at 72hpf. This may result from incomplete F0
phenotypes. As such, future examination of germline transmitted loss of function alleles
of mmp2 will be necessary to fully examine the functional consequence on OF fusion.
Taken together, we propose that mmp2 activity is part of the mechanism involved in OF
BM degradation and subsequent fusion of the fissure.

3.4

DISCUSSION
Studies of OF fusion dating back several decades have been suggesting a direct

connection between the fusion process and hyaloid vasculature found within the fissure.
In fact, this hypothesis has been recently strengthened by data showing that a reduction of
hyaloid vasculature in the fissure, or removal of optic vesicles from sources of
vasculature inhibits or significantly delays fusion [119, 139]. In our study, we have
characterized a pax2a driven mechanism that ensures proper vascularization of the OF
and expression of BM remodelers mmp2, 14a and 14b. In conclusion, our findings further
validate the notion that hyaloid vasculature is an active and necessary component of the
machinery driving OF fusion in zebrafish.
Several recent reports, including this one, have comprehensively characterized OF
fusion timing [88, 119, 167, 168]. Work from zebrafish, mice and chick all point to an
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orderly progression involving: 1) retinal growth and cellular rearrangement leading to
nasal and temporal retinal lobe apposition, 2) invasion of the fissure by endothelial and
neural crest cells forming the hyaloid vasculature system, 3) cellular signaling, either
between retinal rim cells or between rim cells and the migrating vasculature cells, 4)
degradation or removal of the basement membrane to enable physical connection of the
rim cells and subsequent formation of a continuous retinal epithelial sheet via repolarization and cell-cell adhesion. Step 1 has been nicely characterized in a few recent
publications outlining the flow of retinal cells and morphological formation of the fissure
[68, 187, 188]. For step 2, several reports have carefully characterized the formation of
the hyaloid vasculature system, including migration of hyaloid vasculature precursor cells
into the fissure as soon as it forms [125, 148, 149]. Importantly, perturbation of this
process, or removal of the developing eye from its source, has been shown to lead to
fissure fusion failure [119, 139]. To date, steps 3 and 4 are the least understood. Recent
work from our lab has characterized the composition of core BM components within the
fissure [167]. Additionally, work from other labs has identified several molecular
components associated with cell-cell adhesion and epithelial sheet fusion to function
within the fissure, including 𝛽-catenin, n-cadherin, and netrin [84, 119, 168, 189-191].
However, the timing and the molecular mechanism organizing and regulating these
components remains uncharacterized. Finally, the elephant in the room has always been
the identity of the BM degradation mechanism. To date, only adamts16 has been
functionally examined in context of fissure fusion while mmp2 activity was detected
during mouse OF fusion and mmp23bb was implicated in the fusion process from
transcriptomic data [182, 191, 192].
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While attempting to address the mechanistic aspects of steps 3 and 4 using the
pax2a noi model we first uncovered a relationship between F-actin and BM degradation.
Work by James et al. 2016 suggested that F-actin accumulation may be indicative of
hyaloid cell interaction with retinal rim cells. During our detailed time course analysis,
we discovered that BM degradation is in fact preceded by an increase in F-actin signal
within the OF (Figure 3.1). When assayed in pax2a-/- embryos the F-actin accumulation is
absent while the hyaloid vasculature in the OF is also diminished. The timing of F-actin
accumulation coincides with the active migration of hyaloid vasculature cells through the
fissure (Figure 3.2). Furthermore, we showed pharmacologically, via VEGF inhibition,
that hyaloid vasculature is necessary for the accumulation of F-actin and OF BM
degradation. Transcriptionally, we showed that the decrease in hyaloid vasculature in
pax2a-/- embryos coincides with a significant decrease in tln1 expression. Tln1 is a key
regulator of endothelial cell migration, recently shown to be directly involved in OF
fusion [119]. In fact, loss of tln1 function has been previously shown to decrease OF
associated vasculature and inhibit BM degradation [119]. In our study, we detected a
significant decrease in tln1 expression upon VEGF inhibition (DMH4 treatment),
suggesting that tln1 expression within the OF is associated with hyaloid vasculature.
Tln1 is known to be a direct link between the actin cytoskeleton and the BM via integrin
[193, 194], and has been associated with the formation of adhesion junctions [195, 196].
One could therefore hypothesize several different models for its role in OF fusion. We
predict that tln1 is regulating the ability of hyaloid vasculature cells to migrate properly
through the OF, however we cannot rule out the possibility that tln1 directly participates
in the OF fusion process. The absence of tln1 expression is most likely a correlation to
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the decrease of hyaloid vasculature cells within the fissure of pax2a-/- embryos. In support
of this we observed a significant decrease in tln1 expression upon DMH4 inhibition and
therefore absence of hyaloid vasculature in the OF. As such, the decrease in tln1
expression is likely indicative of decreased numbers of hyaloid vasculature cells which
require tln1 expression for proper migration into the fissure and or proliferation.
Our study strongly supports the notion that vasculature plays an integral part in
OF fusion. Proper execution of angiogenesis is therefore a potential mechanism to ensure
timely vascularization of the OF. The deficiency of hyaloid vasculature in pax2a mutant
embryos may therefore result from a decrease in VEGF signaling. Using WISH and
qPCR we detected a significant decrease in cranial vegfaa, ab and c expression. VEGF
signaling is critical for angiogenesis and proper vasculogenesis throughout the embryo, a
decrease in its activity is therefore likely to result in a series of deficiencies, including
hyaloid vascularization of the OF. These findings supported the observation that pax2a
mutants suffer from severe heart malfunction and subsequent edema and hemorrhage.
The mechanisms of how pax2a regulates VEGF signaling remains unknown at this time
and will need to be investigated in future studies. The observed decrease in VEGF
expression does not directly correlate to regions of pax2a expression, which therefore
suggests indirect regulation or negative VEGF feedback signaling during early
development in the absence of pax2a function. In addition, phenotypes resulting from
reduced VEGF signaling and therefore vasculogenesis may stem from subsequent
circulation and cardiac function defects as well.
The last aspect of our proposed model pertains to the OF BM degradation
mechanism. It had been suggested that vasculature may be the source of BM degradation
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activity during OF fusion [119]. To that end, we have discovered that mmp2 is expressed
within the hyaloid vasculature during OF fusion (Figure 3.5). In fact, timing of mmp2
expression correlates with the expected timing for initiation of BM degradation
(Appendix 2.5). When we examine pax2a mutants or inhibit hyaloid vasculature
completely (DMH4 treatment) we no longer detect expression of mmp2 or mmp14a and
14b. Delayed treatment with DMH4 also resulted in absence of mmp2 expression (90% of
embryos after 24-32hpf treatment (n=10) and 63% in 28-32hpf treated embryos (n=11).
Furthermore, using ARP101, a specific mmp2 inhibitor, we showed that mmp2 activity is
necessary for OF BM degradation, specifically between 26-32hpf (Figure 3.6). Mmp2 has
been implicated in OF fusion previously. Mouse studies have shown mmp2 expression
within macrophages residing in the OF. Furthermore, recent examination of mmp2
activity, using a reporter construct, indicates that mmp2 is active in the eye and likely the
OF [181]. Mmp14 is a known to activate mmp2 activity by cleaving the inhibitory propeptide of mmp2 [183, 184]. As such, co-expression of mmp2 and 14 is further indicative
of mmp2 playing a functional role in OF BM degradation. In the current study we did not
directly assay the functional role of mmp14, but based on previous work linking mmp2
activation to mmp14, it is likely that mmp14 is also going to be necessary for zebrafish
OF fusion.
To date, the only BM degradation enzyme to be associated with OF fusion is
adamts16. Loss of adamts16 function in zebrafish, via morpholino, led to a coloboma like
phenotype which the authors credited to the inability to degrade laminin in the fissure
[192]. We have not been able to reproduce adamts16 expression within the fissure.
Recent studies in mice, zebrafish and chick have compared expression in OF cells pre,
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during and post fusion [168, 191, 197, 198]. Surprisingly, none of these studies identified
any obvious candidates for carrying out BM degradation, including mmp2 and mmp14.
However, it remains possible that the OF tissue examined lacked the hyaloid vasculature
and therefore prevented the identification of mmp2 and mmp14 as candidates. In addition,
expression of mmp2, 14a and 14b is transient in the fissure which may have contributed
to their OF expression being missed by other groups. Our data indicate mmp2 activity is
necessary for BM degradation of the OF, but it does not rule out a role for additional
proteases. There may be several proteases involved in OF BM degradation, such as
adamts16, mmp2 and others, yet inhibition of just one could trigger failure of the
degradation process and lead to fissure fusion failure. Continuing studies into matrix
protease activity will be needed to fully characterize the degradation mechanism(s)
during OF fusion.
Recent studies of hyaloid vasculature during OF fissure fusion have also included
examination of the cloche mutant line, which is considered to be avascular. Importantly,
cloche mutants (clom39) display a delay but not a complete lack of OF fusion [119]. This
fact confounds our and other’s results that suggest hyaloid vasculature plays a role in OF
fusion [139]. With our new finding that mmp2 plays a significant role in OF fusion we
therefore examined mmp2 expression in clom39 mutants (Appendix 2.8). Interestingly,
clom39 embryos did display mmp2 expression within the OF, albeit at visibly reduced
levels. This finding suggests that clom39 embryos either still retain a population of cells
(possibly POM or NCC) that are found within the fissure and express mmp2, or that not
all vasculature is eliminated in these mutants. On that note, previous examination of
vasculature markers in clom39 mutants indicated that fli1 was still expressed in the retinal
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region suggesting some degree of vasculature may remain [199]. The persistence of even
low levels of mmp2 may explain why OF fusion is delayed, but not eliminated in clom39
mutant embryos. Furthermore, we also note that in our DMH4 treatments, which generate
an avascular phenotype, we appear to block OF fusion completely, which is also in
contrast to clom39 mutants. This discrepancy may result from the absence of VEGF
signaling which may be playing a secondary role to that of angiogenesis. An angiogenesis
independent role of VEGF may involve signaling in other cell types such as the POM or
NCC which are known to migrate through the OF. Future studies into mmp2 activity and
VEGF signaling as well as interaction of POM and NCC with the OF will be of high
priority.
In conclusion, we present a new model for the mechanism of OF BM degradation
where pax2a functions to enable hyaloid vasculature invasion of the OF. Once in the
fissure, vasculature cells express mmp2, 14a and 14b to initiate BM degradation. As soon
as fusion begins, vasculature becomes restricted from the fissure and ultimately the two
retinal lobes fuse. Our model aligns with the molecular events observed in the fissure,
including accumulation of F-actin at the time of vasculature migration through the fissure
(24-28hpf), expression of mmps (26-36hpf) and subsequent BM degradation (32-48hpf).
In the current study we relied on pharmacological inhibition of VEGF signaling and
mmp2 activity. Pharmacological inhibition can have potential off target effects, in
particular developmental delays or toxicity. While we have partially controlled for these
potential off target effects our future plans are to extend the analysis of these pathways
with the use of genetic tools as to minimize potential for off target effects.
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Figure 3-1 An increase in F-actin dynamics preceding laminin degradation during optic
fissure fusion is disrupted in pax2a-/- embryos.
A) Whole mount immunohistochemistry was used to simultaneously visualize F-actin (red) and laminin
(green) during OF fusion, 24-72hpf. Central-proximal sections obtained using confocal imaging were
collected and quantified. Scale bar = 50𝜇m. B) Whole mount Immunohistochemistry was used to
simultaneously visualize F-actin (red) and laminin (green) during OF fusion, 24-72hpf, in pax2-/- embryos.
Central-proximal regions of the OF are displayed. Scale bar = 50𝜇m. C) Quantification of laminin signal
intensity within the OF, normalized to regions of laminin staining juxtaposed to the lens. Relative pixel
intensities are displayed. ANOVA p<0.0001. D) Quantification of F-actin intensity (phalloidin staining)
within the OF, normalized to regions of F-actin signal within the lobe of the retina. Relative pixel
intensities are displayed. ANOVA p<0.0001.
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Figure 3-2 Pax2a is necessary for recruitment of hyaloid vasculature into the optic
fissure.
A) In vivo 4D confocal imaging of Tg[kdrl:mCherry] pax2a+/+,+/- or pax2a-/- embryos. Time lapse series
depicting the region of the OF (dotted white lines) and mCherry positive vasculature endothelial cells
migrating through the fissure from 24-29hpf. Scale bar = 10m. B) Comparison of pax2a +/+,+/- and pax2a-/vascularization during OF fusion, 24-48hpf. 3D reconstructions of whole mount Tg[kdrl:mCherry] (red)
pax2a+/+,+/- or pax2a-/- embryos with DAPI (blue) stained DNA. Scale bar = 50𝜇m. C) Quantification of the
number of mCherry positive cells from 3D confocal stacks within the region of the OF. Individual embryo
results are depicted. ANOVA p<0.0001. D) Whole mount in situ hybridization comparing tln1 expression
between pax2a+/+,+/- and pax2a-/- embryos at 28 and 32hpf. tln1 signal within the OF (yellow arrowhead)
appears reduced in Pax2a-/- embryos (red *). E) qPCR analysis of tln1 expression from heads of pax2a+/+
and pax2a-/- embryos at 32hpf confirms a reduction in tln1 expression.
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Figure 3-3 Inhibiting angiogenesis disrupts optic fissure fusion mechanics.
A) Fluorescent whole mount in situ hybridization of vegfaa, vegfab and vegfc at 32hpf in WT and pax2a-/embryos. Loss of pax2a results in decreased vegfaa, ab and c expression. DAPI is depicted in blue. Scale
bar = 100𝜇m. B) qPCR results for vegfaa, vegfab and vegfc expression from heads of pax2a+/+ and pax2a-/embryos at 32hpf. C) 3D confocal images of Tg[kdrl:mCherry] (red) embryos treated with 100𝜇M DMH4
between 24-72hpf. DNA was stained with DAPI (blue). Scale bar = 50𝜇m. D) Quantification of 48hpf
DMH4 treated embryos for fissure fusion (absence of laminin signal), partial fusion (partial retention of
laminin) or failure to fuse (retention of laminin throughout the fissure). n= 22 (DMSO), 52 (100𝜇M), 22
(50𝜇M), 24 (25𝜇M) ANOVA p<0.0001. E) Quantification of laminin signal intensity within the centralproximal region of the OF, normalized to regions of laminin staining juxtaposed to the lens. Relative pixel
intensities are displayed. ANOVA p<0.0001. F) Quantification of F-actin signal intensity (phalloidin
staining) within the central-proximal region of the OF, normalized to regions of F-actin signal within the
lobe of the retina. Relative pixel intensities are displayed. ANOVA p<0.0001.

77

Figure 3-4 VEGF signaling is plays a role in optic fissure fusion.
A) Whole mount Immunohistochemistry was used to visualize laminin (green) at 48hpf after DMSO or
DMH4 treatment. Central-proximal regions of the OF are displayed depicting fused, partially fused or
unfused optic fissures. Scale bar = 50m. B) Quantification of 48hpf DMH4 treated embryos for fissure
fusion (absence of laminin signal), partial fusion (partial retention of laminin) or failure to fuse (retention of
laminin throughout the fissure). n= 41 (12-48hpf), 38 (24-48hpf), 38 (28-48hpf), 44 (32-48hpf), 40
(DMSO). ANOVA p<0.0001. C) 3D reconstructions of whole mount Tg[kdrl:mCherry] embryos treated
with 100 M DMH4 at various time points. Broken white line outlines the retina. Scale bar = 50m. D)
Quantification of the number of mCherry positive cells from 3D confocal stacks within the region of the
OF after DMSO or DMH4 treatment. Individual embryo results are depicted. ANOVA p<0.0001. E)
Fluorescent whole mount in situ hybridization of pax2a or tln1 probe at 32hpf in DMSO or DMH4 treated
embryos. OF expression is indicated with a yellow arrowhead. DMH4 treatment does not appear to alter
pax2a expression but eliminates tln1 expression from the OF. Broken white lines outline the retinal lobes.
Scale bar = 50m F) qPCR results for tln1 expression in DMH4 treated embryos.

78

Figure 3-5 Hyaloid vasculature is a source of mmp2 during optic fissure fusion.
A) Fluorescent whole mount in situ hybridization comparing mmp2, mmp14a and mmp14b expression in
WT vs pax2a-/- and DMSO vs DMH4 treated embryos at 32hpf. Broken white lines outline the OF retinal
lobes. mmp2, 14a and 14b expression within the OF is reduced in pax2a-/- and DMH4 treated embryos.
Scale bar = 50m. B) qPCR analysis confirms a decrease in expression of mmp2, 14a and 14b in both
pax2a-/- and DMH4 treated embryos. C) Two color whole mount in situ hybridization simultaneously
examining mmp2 and kdrl, or mmp2 and rorB expression at 32hpf. DNA was stained with DAPI. Scale bar
= 50m. Clear overlap of signal is observed for mmp2 and kdrl, but not mmp2 and rorB.
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Figure 3-6 Proper timing of mmp2 activity is required for optic fissure fusion.
A) Whole mount Immunohistochemistry was used to visualize laminin (green) and DAPI (blue) in ARP101
treated Tg[rx3:GFP] embryos at 32, 36 and 48hpf. Stacks of central-proximal regions of the OF are
displayed. Scale bar = 50m. B) Quantification of 48hpf ARP101 treated embryos for fissure fusion
(absence of laminin signal), partial fusion (partial retention of laminin) or failure to fuse (retention of
laminin throughout the fissure). n= 41 (10M), 38 (15M), 42 (20M) ANOVA p<0.0001. C) 3D
reconstructions of whole mount Tg[kdrl:mCherry] (red) embryos treated with 20 M ARP101 from 24-32,
36 or 38hpf. DNA was stained with DAPI (blue). Scale bar = 50m. D) Quantification of the number of
mCherry positive cells from 3D confocal stacks within the region of the OF after DMSO or 20 M
ARP101 treatment. Individual embryo results are depicted. E) Quantification of 48hpf ARP101 treated
embryos for fissure fusion, partial fusion or failure to fuse after various treatment initiation times from 2432hpf. n= 42 (24-48hpf), 29 (26-48hpf), 29 (28-48hpf), 23 (30-48hpf), 37 (32-48hpf). ANOVA p<0.0001.
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TRANSCRIPTOMIC PROFILING OF ZEBRAFISH OPTIC FISSURE CLOSURE IN
PAX2 MUTANTS REVEALS NOVEL ANTI-ANGIOGENIC AND ACTIN ASSOCIATED PROTEIN
TRANSCRIPTS.

4.1

Abstract
Prevalent throughout embryogenesis, the fusion of epithelial tissue to seal

naturally occurring gaps is critical for proper organogenesis. One such event occurs
during vertebrate eye development and involves fusion of the optic fissure. The optic
fissure forms as a consequence of optic cup morphogenesis and serves as a conduit for
the migration of endothelial vasculature during hyaloid angiogenesis. Failure of optic
fissure fusion results in a congenital blinding disorder known as coloboma. Recent
studies have linked hyaloid vasculature precursor cells to be potential triggers for
initiating optic fissure fusion. In order to examine this link, we analyzed the
transcriptional and molecular events associated with optic fissure fusion and hyaloid
angiogenesis in the zebrafish pax2anoi mutant coloboma model. To examine how the
fusion process is disrupted in the absence of pax2a function, we compared transcriptomic
profiles between pax2a-/- and wildtype (WT) whole retinas. We sought to validate and
investigate those targets which were thought to be of importance to the molecular
machinery involved in fusion, particularly those involving the actin cytoskeleton and
angiogenesis. This analysis uncovered a novel connection between regulation of
angiogenesis and fusion. Loss of pax2a resulted in increased expression of an antiangiogenic protease, ADAMTS1. Injection of ADAMTS1 mRNA into one cell
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Tg[kdrl:mCherry] embryos, attempting to mimic the pax2a increase in expression,
resulted in decreased hyaloid vasculature which phenocopies the pax2a-/- phenotype.
Based on the ability of migrating endothelial cells to activate integrin signaling we also
began looking for the possibility of reduced actin associated transcripts in our RNA
sequencing data. We uncovered preliminary evidence that certain actin associated
proteins are also differentially regulated, particularly rho-associated protein kinase
(ROCK). Taken together, we propose that Pax2a negatively regulates ADAMTS1
expression. This enables timely hyaloid vascularization of the retina which in turn
directly signals to initiate fissure fusion via cytoskeletal rearrangements and subsequent
basement membrane remodeling.

4.2

Introduction
Epithelial fusion is the process by which two distinct populations of epithelial

cells become apposed and eventually fuse to create a single continuous sheet. This
process can be observed at several stages during development, including the closure of
the neural tube, the palatal shelf, presumptive genitalia, eyelids, and the optic fissure of
the developing retina [27, 200-202] Formation of a fully functioning human eye requires
precise and coordinated cellular mechanisms during very early development. One such
mechanism is responsible for the formation of the eye, which forms a 3D structure from a
flat sheet of cells. This leads to the creation of a gap (fissure), at the ventral region of the
eye. This fissure, the optic fissure, remains open during morphogenesis of the eye to
allow the establishment of the hyaloid vasculature. The hyaloid vasculature is a
temporary circulatory system developed during eye morphogenesis [122]. As soon as the
hyaloid vasculature has been established, the two opposing retinal epithelial sheets of the
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optic fissure will undergo fusion to seal the optic stalk which houses the retinal ganglion
cell axons. Failure of optic fissure fusion leads to a congenital blinding disorder known as
coloboma [30, 130]. Coloboma is a leading cause of pediatric blindness, accounting for
approximately 10% of cases worldwide [152, 154]. Coloboma is a spectrum disorder
presenting unilaterally or bilaterally and ranging in severity from minor visual
impairment, to complete blindness in the affected eye [155]. This spectrum of severity is
associated with the location and degree to which the optic fissure was able to fuse and the
severity of subsequent loss of ganglion cell axons [153]. Epithelial fusion has been
studied for over a century, and is known to involve transcriptional regulation, cell
signaling pathways, and morphogen gradients [160, 161]. However, in regard to the optic
fissure we are still lacking a basic understanding of how these molecular mechanisms
coordinate and directly facilitate fusion. Recent work has begun to implicate some of the
cellular processes involved in optic fissure fusion. For example, the actin cytoskeleton is
known to be a crucial component of the machinery driving fusion of the optic fissure as
well as other tissues [162]. The actin cytoskeleton is thought to be involved in fusion by
the formation of lamellipodia and filopodia projections between the apposing epithelia. It
is thought that these projections help to “zipper” the cells together [164-166]. It has been
observed that fusion often fails when lamellipodial and filopodial projections are
precluded [163]. However, while it has been observed that actin protrusions likely play a
functional role during optic fissure fusion, it still remains to be determined what actin
cytoskeletal components are required during optic fissure fusion. Another cellular
mechanism known to be directly involved in epithelial fusion is the breakdown of the
basement membrane (BM). During epithelial fusion, the BM acts as a physical barrier
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which must be removed in order for fusion to complete. Recent work, including our own,
across several species has characterized progressive removal of the BM during choroid
fissure fusion [88, 119, 167, 168]. However, the molecular mechanisms facilitating this
process, in particular BM breakdown, remain largely unknown. James et al. 2016,
showed that zebrafish cloche mutants, which lack all early hyaloid vasculature, have
delayed basement membrane breakdown in the region of the choroid fissure [119]. James
et al. 2016 also reported that talin1 mutants, an actin scaffolding protein required for
migration, fail to breakdown the basement membrane resulting in coloboma [119]. This
finding was the basis of our investigation into vasculature in our pax2a coloboma model.
Our previous work has shown a direct requirement for migrating endothelial cells. In the
absence of all vasculature through the use of drug inhibition results in a retention of the
basement membrane [203]. There is therefore a clear link between optic fissure fusion
initiation and hyaloid vasculature migration through the fissure. There are two proposed
mechanisms that hyaloid vasculature regulates optic fissure fusion, the secretion of
proteins involved in the fusion process, as observed in our previous work showing
vasculature supplied mmp2 [203]. Another role that the vasculature could be playing is
through angiocrine signaling. Angiocrine signaling is known to provide growth factors
and other proteins capable of stimulating epithelial cells to modify themselves, including
the stimulation of actin cytoskeletal rearrangements [136, 138]. Finally, the sheer
presence of the endothelial cells themselves could initiate fusion by exerting force on the
rim cells of the optic fissure while passing through [135]. This could lead to
mechanosensation by the basement membrane of the rim cells which would induce
intracellular signaling via integrin receptors linked to the actin cytoskeleton. Coloboma
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has been studied for many decades in many different species. This has led to a general
outline of the signaling and morphogenetic pathways required for proper optic fissure
formation and fusion (recently reviewed in [156]). This study aims to further analyze
zebrafish optic fissure fusion comparing WT and the pax2a-/- coloboma model to expand
upon our previous findings [203]. Using transcriptomic analysis to compare WT and
pax2a-/- eyes we discovered misregulation in angiogenic signaling, resulting in decreased
vascularization of the early retina and optic fissure fusion failure. In particular we found
that pax2a-/- embryos exhibit an increase in A disintegrin and metalloproteinase with
thrombospondin motifs 1 (ADAMTS1) expression, an anti- angiogenic protease [204,
205]. Overexpression of ADAMTS1 both phenocopied the pax2a-/- hyaloid vasculature
and coloboma phenotypes. Once we knew how crucial migrating endothelial cells were to
the fusion process and how this process could possibly be disrupted in a coloboma model,
via ADAMTS1, we next sought to understand potential mechanisms that these
endothelial cells act through. We decided to specifically look at actin cytoskeleton and its
accessory proteins since the actin cytoskeleton is essential for cell signaling and several
studies have shown how endothelial cells contribute angiocrine signaling to the actin
cytoskeleton [135, 136, 138]. Looking at the transcriptomic data again several actin
associated transcripts which were differentially expressed between WT and pax2a-/embryos, in particular (ROCK). This led us to propose a novel pathway for the regulation
of optic fissure fusion where pax2a mediates proper regulation of anti-angiogenic factors
in order to facilitate hyaloid vasculature migration through the optic fissure.
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4.3

Results
4.3.1

Pax2a retinal transcriptomic profile during optic fissure fusion.

Although pax2 has been studied in many systems, there are currently no obvious
transcriptional targets of pax2 that would directly point to the mechanistic regulation of
optic fissure fusion. In an effort to understand the absence of vasculature and F-actin (as
discussed in previous published work [203]) observed in pax2a-/- embryos we compared
retinal transcriptomic profiles between WT and pax2a-/- embryos. Eyes from 48hpf WT
and pax2a-/- embryos were isolated and total RNA was subsequently purified and
sequenced using Illumina sequencing. 48hpf was chosen for our experimental time point
as pax2a-/- embryos are easily phenotyped at this age thanks to observable heart
malformations. When comparing three replicates for WT and pax2a-/- embryos using
RSEM software, we detected 1215 transcripts significantly upregulated (>95%
confidence interval) and 1202 transcripts significantly downregulated (Figure 4.1A, D).
Gene ontology analysis indicated a wide spread of biological function being affected,
including cytoskeletal signaling, adhesion and developmental processes (Figure 4.1B, E).
In support of our previous publication we found that tln1, an actin scaffolding protein
known to be required for cell migration, was significantly down regulated in pax2
mutants. The distribution of biological function between up- and down-regulated genes
was highly similar (Figure 4.1B, D). When comparing gene ontology between up- and
down-regulated genes in pax2, they shared a similar pattern and trend. Among the most
commonly represented biological function from both lists were cellular processes, which
included signal transduction, actin-based processes, cell communication, and cellular
organization. There were only two biological pathways that showed a disproportionate
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favor, the angiogenesis pathway which was more heavily represented in the genes downregulated in pax2 mutants. This further confirms results in our previous work that pax2
mutants have reduced vasculature. The other biological pathway heavily favored genes
up-regulated in pax2 mutants, the Wnt signaling pathway. One gene of interest that came
out of this data was a gene labelled as a metalloprotease called ADAMTS1 which was
up-regulated in pax2 mutants, however, it was also associated with the angiogenesis
pathway through its antiangiogenic capacity [204, 205]. Actin cytoskeletal proteins were
evenly represented amongst the two groups, perhaps representing the loss of vasculature
associated actin related proteins. However, two different genes which perform similar
functions as down-stream effectors of the Rho signaling pathway were down-regulated in
pax2 mutants, ROCK1 and ROCK2b [206]. A list of top 20 up and down regulated genes
is outlined in Figure 4.1C and F. Results of all the statistically significant up and
downregulated genes identified in our assay are presented as supplementary data
(Appendix Tables 1.1 and 1.2).

4.3.2

Anti-angiogenic protease adamts1 is upregulated in optic fissure of pax2a mutant
embryos.
Having previously established a connection between pax2a function and

recruitment of hyaloid vasculature cells into the optic fissure [203], we next sought to
examine the mechanism. To do so, we examined our transcriptomic comparison of WT
and pax2a-/- eyes, with a focus on angiogenic regulation. This examination revealed
misexpression of a disintegrin and metalloproteinase with thrombospondin motifs 1
(adamts1), a secreted protease known to be involved in regulating VEGF signaling [207].
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Being a member of the ADAMTS family, adamts1 contains three thrombospondin motifs
enabling it to directly bind and sequester VEGF [205]. Furthermore, the protease activity
of adamts1 has bene shown to target thrombospondin 1 and 2 for cleavage, ultimately
liberating their active forms which bind to and block VEGF from binding the VEGF
receptor [204]. Our RNA sequencing data indicated that adamts1 expression was
upregulated almost two-fold in pax2a-/- eyes. This would suggest that the expression of
adamts1, and therefore its anti-angiogenic activity, is normally somehow kept in check
by pax2a. Pax2a has not been reported to harbor transcriptionally repressive function, so
this may involve an indirect mechanism. To confirm our RNA sequencing results we
performed WISH, examining adamts1 expression at 28 and 36hpf. In agreement with our
transcriptomic analysis, we observed an upregulation in adamts1 in the ventral region of
pax2a-/- eyes, specifically surrounding the optic fissure (Figure 4.2A). This was further
confirmed using qPCR (Figure 4.2B). To test whether upregulation of adamts1
expression would have direct effects on hyaloid vascularization and optic fissure fusion
we injected Tg[kdrl:mCherry] embryos with adamts1 mRNA. We subsequently
examined hyaloid vasculature using 3D confocal imaging between 24-48hpf. Injection of
adamts1 mRNA resulted in a significant decrease in the number of kdrl:mCherry cells
found within the optic fissure (Figure 4.2B, C). The observed decrease mirrored the
results from pax2a-/- embryos (Figure 4.2C). Our findings therefore suggest that adamts1
expression needs to be tightly regulated in order to ensure proper vascularization of the
retina, including the optic fissure. Furthermore, the observed up-regulation of adamts1
expression in pax2a-/- embryos may explain the resulting optic fissure hyaloid vasculature
deficiency.
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4.3.3

Overexpression of adamts1 inhibits optic fissure fusion mechanics.

Having mimicked the vasculature phenotype of pax2a mutants by over expressing
adamts1, we next examined whether it had any effects on optic fissure fusion. To do so,
we performed whole mount laminin and F-actin staining in adamts1 mRNA injected
embryos at 24, 32, 36, and 48hpf (Figure 4.3A). Confocal imaging of the fissure
indicated that adamts1 mRNA injection also phenocopied pax2a-/- associated persistence
of laminin and therefore failure of optic fissure fusion. Quantified levels of laminin
persisting at 48hpf was similar to pax2a-/- embryos (Figure 4.3B). Similar to pax2a-/embryos, we again noted a lack F-actin accumulation between 24-32hpf in adamts1
overexpressing embryos (Figure 4.3C). As was observed with pax2a-/-, timing for
apposition of the lobes was not affected in adamts1 overexpressing embryos (Appendix
2.2). Taken together, our data suggest that maintaining proper levels of adamts1
expression is necessary to enable VEGF signaling and subsequent recruitment of hyaloid
vasculature required for initiation of optic fissure BM remodeling.

4.3.4

Rho-associated protein kinase (ROCK) is down-regulated in pax2 mutants

Having established a definitive link between the hyaloid vasculature cells and
optic fissure fusion, we next sought to understand how migrating endothelial cells operate
during optic fissure fusion. I felt there was a high probability that these migrating
endothelial cells were eliciting cytoskeletal responses in and around the fissure, as these
endothelial cells have been shown to act in a number of processes which require the actin
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cytoskeleton, including mechanosensation and angiocrine signaling [135, 136, 138].
Angiocrine signaling has also been shown to contribute to integrin signaling, which
activates the Rho family of GTPases and subsequently mediates cytoskeletal responses
[138]. To investigate whether the actin cytoskeleton and/or its accessory proteins were
impacted in pax2 mutants, we turned once again to the RNA sequencing data. When
comparing WT and pax2a-/- whole retina RNA sequencing data two particular transcripts
were of interest, Rock1 and Rock2b. Rho-associated Protein Kinase (ROCK) is a downstream target of RhoA, B, and C. ROCK’s have a diverse range of function, of interest for
this work was their involvement in actin cytoskeleton organization, cell adhesion, and
extracellular matrix remodeling [116]. ROCK1 had over a 25 fold change, showing a
dramatic reduction of ROCK1 expression in pax2 mutants. ROCK2b was also downregulated in pax2 mutants with an approximately 6 fold reduction. To validate these
results, we performed qPCR on cDNA of dissected eyes from WT and pax2 mutants for
all known ROCK’s in zebrafish, ROCK1, ROCK2a, and ROCK2b. qPCR results
validated down-regulation of ROCK’s in pax2a mutant eyes (Figure 4.4A). We next
performed whole-mount in situ hybridizations for Rock1 and Rock2b using embryos
from an in-cross of pax2a+/noi heterozygous fish. The results show that in approximately
25% of embryos, expected mendelian ratio, the expression appeared reduced compared to
the other 75% of embryos, indicating that these 25% were likely homozygous pax2
mutants (Figure 4.4B). To examine the functional consequence of Rock down regulation,
I attempted ROCK inhibition using a drug called Y-27632 which is a selective ROCK
inhibitor, previously having been successfully used in zebrafish [208]. Y-27632 inhibits
both ROCK1 and ROCK2 by competing with its ATP binding sites. I performed the drug
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treatment using Y-27632 at various concentrations starting at 24 to 48 hpf, and from 32 to
48 hpf. This experiment, however, has so far been unsuccessful, with almost zero
phenotypic abnormalities across the entire embryo even at concentrations of up to 100
𝜇M. ROCK is expressed ubiquitously throughout the entire zebrafish embryo and the
odds ROCK inhibition having no effect on the embryo seems unlikely. I have therefore
concluded it is possibly an ineffective batch of the drug and warrants further study using
fresh inhibitor or trying other ROCK inhibitors. In the future, if drug inhibition is still
unsuccessful the most effective way to understand ROCK’s function during optic fissure
fusion would be to create a transgenic line of zebrafish which would express a dominant
negative form of ROCK, lacking a kinase domain, under the control of a heat shock
promoter [209]. It is likely a ROCK CRISPR mutant would not survive the earlier stages
of development and would thus be unsuitable for studying optic fissure fusion.

4.4

Discussion
While optic fissure fusion has been studied extensively, spanning decades and

across many different species, we still lack the functional knowledge of the mechanics
driving this process. We have previously characterized some aspects of optic fissure
fusion in zebrafish and found a definitive link between the hyaloid vasculature and fusion
of the optic fissure, where without vasculature fusion fails to occur. It is becoming widely
accepted now that vasculature (or the POM cells which contribute to the hyaloid
vasculature) is involved in this process, however, it still remained unknown as to why
vasculature would be affected in coloboma, specifically in pax2 mutants. It became the
focus of this study to investigate how a transcription factor could control angiogenesis
during optic fissure fusion. We characterized a pax2a driven mechanism that ensures
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proper vascularization of the optic fissure by restricting anti-angiogenic activity of
adamts1 to enable hyaloid vasculature invasion of the optic fissure. Proper
vascularization of the eye is crucial to optic fissure fusion. We have shown here and
previous work that a reduction in vasculature leads to fusion failure, however, it has also
been reported that hypertrophic hyaloid vasculature also results in fusion failure likely
due to the increased distance between the lobes of the fissure [210].
In our transcriptomic comparison of WT and pax2a mutants we discovered a
connection between fissure fusion and angiogenesis. In the absence of pax2a function we
observed an upregulation of adamts1, an anti-angiogenic regulator. Examining adamts1
expression in the eye further confirmed an upregulation of expression in the ventral
regions of pax2a-/- retinas. Encoding 3 thrombospondin (thsb) motifs able to directly bind
and sequester VEGF, in addition to targeting thsb1 and 2 for cleavage into their active
VEGF inhibiting form, adamts1 is well known for its anti-angiogenic function in cancer,
aortic and renal biology [211]. In our study, we show that upregulating adamts1
expression reduces the number of hyaloid vasculature cells in the OF. Up regulation of
adamts1 also prevents the accumulation of F-actin and subsequent BM remodeling.
Taken together we propose that the reduction in hyaloid vasculature observed in pax2a-/embryos likely stems from an upregulation of adamts1 leading to suppressed VEGF
signaling and therefore limited vascularization of the optic fissure.
In our transcriptomic comparison we also uncovered a potential connection
between optic fissure fusion and the actin cytoskeleton. In the absence of pax2 there was
a marked decrease in the expression of two up-stream activators of actin based focal
adhesions, ROCK1 and ROCK2b. This was further validated by both qPCR and WISH.
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So far this is one of the few correlations to have been made between an actin cytoskeleton
regulator and a coloboma model. I speculate that ROCK is required in the epithelium of
the fissure, previously a study revealed its requirement during fusion of the eyelid and
ventral body wall in mice [116]. When ROCK is knocked out in mice, the contractile ring
surrounding the eyelid epithelium fails to contract resulting in an inability to close the
gap [116]. ROCK1 is a negative regulator of VEGF endothelial cell activation, it has
been previously reported that ROCK inhibition stimulates the migratory behavior of
various cell types including endothelial cells [212]. Since ROCK inhibition has a
stimulatory effect on endothelial cell migration it seems unlikely that hyaloid vasculature
cells are the contributors of ROCK expression in the optic fissure. During palatal fusion
in mice it has also been observed that when inhibiting ROCK the epithelia still appose,
however, cell intercalation and neighbor exchange fail to occur resulting in cleft palate
[213]. It is therefore plausible that ROCK activity is required to begin the actual
combining of the two epithelial sheets in the optic fissure and that the activation of
ROCK could be triggered by the migrating endothelial cells. This preliminary data will
hopefully provide the groundwork for future studies involving ROCK activity during
optic fissure fusion.
Taken together, these findings further validate the knowledge that hyaloid
vasculature is an active component of the machinery driving optic fissure fusion in
zebrafish. We present a new piece of data to add to our model for the mechanism of optic
fissure fusion, where pax2a restricts expression of adamts1 in the ventral retina to enable
hyaloid vasculature invasion of the optic fissure. Once in the fissure, vasculature cells
express mmp2, 14a and 14b to initiate BM remodeling. Once fusion begins, vasculature
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becomes restricted from the fissure and ultimately the two retinal lobes fuse. For future
studies it will be important to understand how pax2a regulates adamts1 expression and to
examine whether mutations in adamts1 resulting in mis-expression of this transcript are
potential markers for coloboma. It will be equally important to further investigate the
mechanisms behind actin cytoskeletal rearrangements with an emphasis on ROCK. I
believe ROCK is vital to the actual combining of the two sheets of epithelium, to test
whether ROCK acts in this manner it would be most effective to create a transgenic line
of zebrafish to express a dominant negative version of ROCK under the control of a heat
shock promoter. This would then allow us to assess the effects of ROCK inhibition on the
removal of the basement membrane and whether or not the hyaloid vasculature is
affected. If the vasculature is not affected by the knock down of ROCK but still results
fusion failure it would support this hypothesis. If this connection were to be made, it
would be the first direct link between an actin cytoskeleton protein and coloboma.
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Figure 4-1 Retinal transcriptomic comparison between WT and pax2anoi/noi.
A) Heat map representing transcripts found to be significantly down regulated in pax2a -/- embryos. B) Gene
ontology for pax2a-/- downregulated transcripts. C) Top 20 downregulated transcripts are outlined in order
of fold change. D) Heat map representing transcripts found to be significantly upregulated in pax2a-/embryos. E) Gene ontology for pax2a-/- upregulated transcripts. F) Top 20 upregulated transcripts are
outlined in order of fold change.
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Figure 4-2 ADAMTS1 inhibits retinal vascularization.
A) Wholemount in situ hybridization comparing ADAMTS1 expression between WT and pax2a-/- embryos
at 28 and 32hpf. ADAMTS1 signal within the optic fissure (yellow arrowhead) is clearly increased in
Pax2a-/- embryos. B) qPCR results for ADAMTS1 expression from heads of pax2a+/+ and pax2a-/- embryos
at 32hpf. C) Comparison of WT and ADAMTS1 mRNA injected embryo vascularization during optic
fissure fusion, 24-48hpf. 3D reconstructions of whole mount Tg[kdrl:mCherry] (red) WT or ADAMTS1
mRNA injected embryos with DNA stained by DAPI (blue). Scale bar = 50um. D) Quantification of
mCherry positive cells from 3D confocal stacks within the region of the optic fissure. Individual embryo
results are depicted. * p<0.001, ANOVA p<0.0001.
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Intensity

Intensity

Figure 4-3 ADAMTS1 misregulation leads to failure of optic fissure fusion.
A) Whole mount Immunohistochemistry was used to simultaneously visualize F-actin (red) and laminin
(green) during optic fissure fusion, 24-72hpf in ADAMTS1 mRNA injected embryos. Central-proximal
sections obtained using confocal imaging were collected and quantified. Scale bar = 50um. B)
Quantification of laminin signal intensity within the optic fissure, normalized to regions of laminin staining
juxtaposed to the lens. Relative pixel intensities are displayed. A green dotted line depicts the trend in
laminin intensity over time, blue line depicts WT trends. ANOVA p<0.0001. C) Quantification of F-actin
signal intensity (phalloidin staining) within the optic fissure, normalized to regions of F-actin signal within
the lobe of the retina. Relative pixel intensities are displayed. A red dotted line represents the trend in Factin intensity over time, blue line represents WT trends. ANOVA p<0.0001.
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A

B

Figure 4-4 Down-Regulation of ROCK1, ROCK2a, and ROCK2b in pax2 mutants.
A) Wholemount in situ hybridization comparing ROCK1 and ROCK2b expression between WT and pax2a/embryos at 32hpf. ROCK1 and ROCK2b signal within the eye is clearly decreased in the suspected
Pax2a-/- embryos. B) qPCR results for ROCK1, ROCK2a, and ROCK2b expression from heads of pax2a+/+
and pax2a-/- embryos at 32hpf.
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DISCUSSION
On the surface, epithelial fusion seems like a simple process: push sheets of cells
close together and glue them. The actual process is anything but simple, requiring precise
coordinated cell movements, specific spatially and temporally controlled expression of
many genetic factors, detailed cell-cell communication and so much more. Many tissues
throughout morphogenesis require epithelial fusion, including the heart, neural tube, eye,
and more [27, 200-202]. For almost every epithelial fusion event there is an associated
congenital birth defect: malformed hearts, spina bifida and coloboma to name a few [27,
200-202]. Often times these congenital defects present themselves as part of syndromes,

as is the case in CHARGE syndrome where many epithelial fusion events have failed to
occur [31]. Based on the presence of these syndromes where multiple fusion events fail to
occur properly it is highly reasonable to assume that these events share some core
common mechanisms. Therefore studying one fusion event could potentially be
advantageous for understanding the mechanisms governing other fusion events as well.
Optic fissure fusion presents a unique system to be able to understand the
mechanisms governing epithelial fusion. In zebrafish fusion of the optic fissure occurs
rapidly, retinal morphogenesis is completed by 72 hours post fertilization. Eye
development is easily accessible to study as it develops peripheral to the organism,
allowing for detailed analysis of the mechanisms that occur during fusion. Like with most
fusion events, failure of optic fissure fusion results in a congenital disorder, in this case
coloboma [57]. Coloboma is a prevalent cause of pediatric blindness, accounting for
approximately 10% of all pediatric blindness cases worldwide [58]. This blindness is due
to the open fissure which exposes the retinal ganglion cell axons to the external
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environment resulting in neuronal death preventing the transduction of signals from the
eye to the brain. While some colobomas can be traced back to environmental causes, such
as in the case of vitamin A deficiency resulting in a failure to activate the RA pathway
[78]. Most causes of coloboma, however, are the result of genetic aberrations.
Unfortunately, only approximately 30% of non-syndromic coloboma cases have a
definitive genetic link, and of those 30% many do not reveal a functional explanation as
to their requirement in fusion [140]. Pax2 is one of the 30% of known genetic
abnormalities which lacks a functional explanation to its requirement in optic fissure
fusion [174]. Nevertheless, pax2 is a cause of coloboma across many species, including
humans [173]. Approximately 50% of renal coloboma cases in humans can be traced
back to a mutation in pax2, of which 92 mutations have been found and one particular
mutation has been reported 57 times [61]. This makes pax2 mutants an effective model to
study coloboma and the mechanisms which go awry during the process of optic fissure
fusion.
Much of the decades of previous work on optic fissure fusion has focused on the
genes and genetic pathways required for this process to occur. Most of these mutations
result in a morphological coloboma, where failure of the proper patterning and
morphogenetic movements of the eye fail to occur resulting in a large morphological gap
between the lobes of the fissure and not due to any defects in the actual epithelial fusion
process. This morphological based coloboma also presents difficulty when trying to
understand the direct mechanisms involved in the actual joining of the two tissues. It has
been reported in some species, such as mouse and chick, that mechanisms such as
apoptosis and cell proliferation play a role in fissure fusion [168, 214]. However, due to
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their involvement in optic fissure formation and growth it is nearly impossible to say
whether these mechanisms are directly involved in the fusion process or are the result of
morphogenesis [88]. The direct cellular machinery is still the most poorly understood
aspect of optic fissure fusion. What is known about the cellular machinery driving this
process can be summed up in three broad mechanisms. Two mechanisms have long been
accepted to be involved in epithelial fusion in general, basement membrane removal and
actin cytoskeletal rearrangements. The basement membrane that surrounds epithelial
tissue performs important tasks, one of which is to provide a barrier that distinguishes the
boundaries of tissues [90]. This important role for the basement membrane becomes
problematic when epithelial fusion needs to occur as it keeps the tissues separate and
within separate boundaries. It also hinders the actin cytoskeleton from being able to form
necessary structures to contact and communicate between the fusing sheets [90]. The
requirement of basement membrane removal has been the consensus and commonality
amongst all vertebrate species studied to date [140].
The actin cytoskeleton has been observed during epithelial fusion across many
different fusion events such as Drosophila dorsal closure and mouse neural tube
development, to name a few [162]. It is generally accepted that the actin cytoskeleton
forms critical structures to aid in fusion by forming lamellipodia and filopodia [163].
These structures help to connect and communicate to the apposing tissue and acts as a
zippering-type mechanism, seaming the tissues together along the length. In a recent
study, RNA sequencing was performed comparing human and murine laser captured
microdissections of the optic fissure and found that there was high conservation in their
gene set enrichment patterns [215]. Patel, et al. discovered that genes involved in the
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epithelial to mesenchymal transition were enriched in the human optic fissure during the
fusion process [215]. Patel, et al. further showed that cells at the fissure margins
delaminate and create cellular protrusions which then go on to rearrange to create a
continuous sheet [215]. It was also noted that apoptosis was not observed in the human
optic fissure during fusion [215].
The third mechanism, specifically in optic fissure fusion, has only recently been
elucidated and is still in its infancy, the hyaloid vasculature. For many decades it was
believed that the hyaloid vasculature was only a passive process, merely taking advantage
of the open fissure to establish the vasculature network at the back of the lens. However,
it is now understood that migrating POM-derived endothelial cells forming the hyaloid
vasculature are critical to the fusion process [139]. With these cells’ ability to produce
secreted factors which could affect fissure fusion they are quickly becoming a key area of
study. James et al. showed that in zebrafish talin1 mutants, an actin scaffolding protein
known to be required for cell migration, the hyaloid vasculature was greatly reduced and
optic fissure fusion failed to occur [119]. In this same work James et al. also showed that
in cloche mutants, which lack all early vasculature, basement membrane degradation was
delayed compared to normal optic fissure fusion [119]. Basement membrane degradation,
actin cytoskeletal rearrangements, and the establishment of the hyaloid vasculature
painted the backdrop to our understanding of the cellular machinery involved in optic
fissure fusion. This, however, was merely a beginning, so much was still left unanswered.
Which cellular mechanism is the initiating factor? How is the basement membrane
removed? What kind of changes happen to the actin cytoskeleton? Why are migrating
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vasculature cells required during optic fissure fusion? These questions were the basis of
this dissertation.
Our broad hypothesis was that basement membrane removal, actin cytoskeletal
rearrangements, and migrating vasculature cells were intimately connected to one
another, without one, the others fail to occur. The beginning of this research was
performing a detailed analysis of the three known mechanisms involved in optic fissure
fusion. We needed to pinpoint the precise timing and behaviors of each of these
mechanisms before we could even begin to understand and test how they interact with
one another. Through whole mount immunohistochemistry using wild-type embryos and
staining for laminin, a marker for the basement membrane, we discovered that
degradation of the basement membrane begins at approximately 32 hours post
fertilization (hpf). This degradation begins medially and the epithelial sheets fuse along
the ventral axis proximally and distally from this median. The degradation continues until
around 48 hpf around the time which laminin can longer be detected within the vast
majority of the optic fissure. We also characterized the actin cytoskeleton through
phalloidin staining. We discovered that an increase in f-actin staining immediately
preceded (between 24 to 32 hpf) basement membrane degradation in the lobes of the
optic fissure. This suggests that actin remodeling plays some part in initiating basement
membrane degradation. The final mechanism we extensively characterized was the
establishment of the hyaloid vasculature and its relationship to the other mechanisms.
Using a transgenic line of zebrafish which fluorescently tags the VEGF receptor kdrl, we
determined that endothelial cells begin migrating into the optic cup before 24 hpf, as
development continues the number of vasculature cells continues to increase until by 48
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hpf individual cells are no longer distinguishable. One of the major challenges in this
characterization was examining the actin cytoskeleton. This was due to the presence of
these migratory cells, it became nearly impossible to distinguish the behavior of the actin
cytoskeleton associated to the epithelial cells surrounding the optic fissure and the actin
cytoskeleton associated to the migrating endothelial cells. Regardless of our inability to
distinguish the individual behaviors of the actin cytoskeleton we knew that migrating
endothelial cells were the first to appear in the optic fissure, ever before increases in factin and basement membrane degradation occur. We now felt we had a clear
understanding of the behavior of these three cellular mechanisms during optic fissure
fusion, but it told us little in the way of their function. We next wanted to see if in fact
these three cellular mechanisms were involved in optic fissure fusion by doing the same
analysis in a coloboma model, pax2a. We hypothesized that since we feel the three
cellular mechanisms are intimately linked, that in coloboma all three mechanisms would
be aberrant. By performing the same analyses on pax2a mutants that were performed on
wild-type embryos we confirmed our hypothesis that in coloboma these cellular
mechanisms show great irregularities. In pax2a mutants we observed a retention of the
basement membrane up to and including 72 hpf, well beyond the time when the basement
membrane has been completely degraded in wild-type. The actin cytoskeleton, also, fails
to undergo the required rearrangements, as an increase in f-actin staining could not be
detected in the optic fissure when it was detected in wild-type. Finally, in pax2a mutants
the hyaloid vasculature is malformed compared to wild-type and through cell counting
we were able to confirm that there is a significant reduction in the number of endothelial
cells migrating through the optic fissure. And further confirmation was provided through
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qPCR analysis which showed that several transcripts specifically associated to the
hyaloid vasculature were down-regulated in pax2a mutants, including the actin
scaffolding protein talin1. Due to the findings from pax2a mutants, and the fact that
endothelial cells are the first to arrive on scene, we hypothesized that these endothelial
cells were crucial and were possibly the catalyst that initiates the subsequent mechanisms
involved in optic fissure fusion. One of the most well-known mechanisms for the growth
of vasculature is VEGF signaling (vascular endothelial growth factor), interestingly it
was discovered that several VEGF ligands are down-regulated in pax2 mutants when
compared to their wild-type counterpart. This allowed us to test our hypothesis of
vasculature being required for optic fissure fusion by inhibiting VEGF signaling. To do
so we used DMH-4 which blocks VEGF signaling and we then were able to assess the
consequences to optic fissure fusion. We found that when vasculature is precluded from
the optic cup the basement membrane fails to degrade and an increase in f-actin is unable
to occur and ultimately resulting in coloboma. By performing a drug inhibition time
course for the spatial requirement of these vasculature cells we also found that these cells
are required early in optic cup morphogenesis to complete optic fissure fusion, when
treated from 12 hpf to 48 hpf this resulted in a 100% inhibition of optic fissure closure.
However, when treatment began at 24 hpf almost 25% of fissures were able to fuse,
beginning at 28 hpf approximately 50% were able to fuse, and beginning at 32 hpf
approximately 90% were still able to fuse. By this point we had been able to provide a
considerable amount of evidence to show that these migrating endothelial cells are
undoubtedly required for proper optic fissure fusion. Although we knew that vasculature
cells were involved in the fusion process and suspected they might be the initiating
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mechanism, we still didn’t know why these vasculature cells were involved. Previous
literature searches had revealed that endothelial cells participate in angiocrine signaling, a
process in which endothelial cells can deposit proteins which aid in development and
repair, including extracellular matrix components (ref). We wanted to test the possibility
of endothelial cells providing extracellular matrix remodelers like metalloproteases,
which would contribute to basement membrane degradation in the optic fissure. To test
this we first had to determine which metalloproteases had expression in the fissure. To do
so we performed whole mount in situ hybridizations (WISH) and further performed
whole mount fluorescent in situ hybridizations (FWISH) on the potential targets. From
these experiments we were able to uncover three promising metalloproteases which show
expression at the appropriate time during optic fissure fusion, mmp2, mmp14a and
mmp14b. Interestingly, mmp14 is an activator of mmp2 so it seemed promising that these
metalloproteases showed strong expression in the optic fissure together. We wanted to
ascertain which cells were providing this metalloprotease, the epithelial or endothelial
cells. We performed two-color FWISH probing for mmp2 and an eye specific promoter
(rorB), and mmp2 and kdrl. From this we saw an overlapping expression between mmp2
and kdrl, providing evidence to our presumption that endothelial cells could participate in
angiocrine signaling while passing through the optic fissure by depositing mmp2 to
degrade the basement membrane. However, this didn’t reveal if mmp2 is actually
involved in fusion, it could simply be a metalloprotease which the migratory cells use to
help them detach from their temporary connections to basement membranes along their
migration path. To test whether mmp2 activity is required for optic fissure fusion, we
obtained an mmp2 specific inhibitor ARP101. When treated at concentrations of 20 𝜇M
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from 24 to 48hpf approximately 90% of embryos had either partial or complete retention
of the basement membrane, suggesting that 90% of embryos treated with the mmp2
inhibitor developed coloboma. This showed the first direct evidence of possible
endothelial cell contribution to optic fissure fusion, showing for the first time a functional
component of these cells.
After these findings, where we showed direct functional evidence to the
requirement of endothelial cells in optic fissure fusion, we wanted to understand how it
was possible for vasculature to be impacted by pax2 function or lack thereof. To do so we
undertook the painstaking task of collecting zebrafish eye tissue at 48 hpf and extracting
RNA for sequencing. Once the bioinformatic analyses were complete we began
separating our results into separate groups based on their gene ontology looking at the
pathways and biological processes these genes could be separated into. Based on this we
made a novel discovery of a possible mechanism through which pax2 can modulate
hyaloid vasculature establishment. What we initially thought was a metalloprotease
actually had ability to function as an anti-angiogenic protein called ADAMTS1.
ADAMTS1 was up-regulated in pax2a mutants by about 2-fold, suggesting that pax2a
directly or indirectly inhibits the expression of this anti-angiogenic protein. ADAMTS1
has been implicated in cancer metastasis when there is a loss of its function, showing that
there is indeed a role for ADAMTS1 in the regulation of angiogenesis. One we had
validated this finding through qPCR, we wanted to see if we could mimic the effect by
performing overexpression experiments. Upon analysis of ADAMTS1 injected embryos
we were amazed to see almost a direct imitation of the pax2a mutant phenotype.
ADAMTS1 mRNA injected embryos showed a reduced number of endothelial cells
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entering through the optic fissure, and when comparing cell counts there was not a
significant difference to that in pax2a mutant. We also performed immunohistochemistry
on these injected embryos and discovered that just as in pax2 mutants there is a failure to
degrade the basement membrane as well as the failure to dramatically increase f-actin
accumulation in the optic fissure. So now we felt we knew, at least in part, how the
endothelial cells were being modulated during optic fissure fusion. At this point we also
felt we had a firm grasp on the impact the endothelial cells have on the basement
membrane of the optic fissure. One area that we felt we still lacked any concrete evidence
for was the potential effects the migrating endothelial cells have on the actin
cytoskeleton. After searching the RNA sequencing data again and separating out actin
associated proteins, we became interested in two genes that were down-regulated in
pax2a mutants, ROCK1 and ROCK2b. These two genes caught our attention for their
involvement in many epithelial fusion events, when mutated across different species and
under different circumstances it has resulted in open eyelids, open ventral body wall, and
has a diverse range of functions from cell adhesion to extracellular matrix remodeling.
Through qPCR and WISH staining of a clutch of pax2a mutant in-cross embryos I was
able to validate our RNA sequencing data. This showed promising results leading toward
a link between coloboma and the actin cytoskeleton, but further work needs to be done to
further this work.
This dissertation made a novel discovery in the field of coloboma, one of the first
direct links to the cellular mechanisms used during fusion (Figure 5.1). We found that
slightly before 24 hpf in zebrafish embryos the endothelial cells begin migrating through
the open optic fissure. These endothelial cells are required for fusion to occur, when
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precluded fusion fails to occur. In the pax2a coloboma model we also discovered a novel
technique in which pax2a modulates the migration of these cells. These endothelial cells
contribute both directly and indirectly to the fusion process by providing a source of the
metalloprotease mmp2 which is one of the components required for basement membrane
degradation in the optic fissure beginning at 32 hpf. These endothelial cells might also
possibly contribute to the actin cytoskeletal dynamics in the epithelial cells via integrin
signaling, activating Rho signaling to ROCK, though further work needs to be done. At
48 hpf we see a complete lack of the basement membrane in the fissure region, a
continuous sheet of epithelial cells, and a formed vasculature network at the back of the
lens, and thus completing eye morphogenesis. This work begins to uncover the cellular
machinery involved in fusion. This provides advantages in the fight against coloboma as
it specifies cellular markers that could potentially contribute to genetic screening for this
disease and others. In the past, we’ve relied on single gene studies which contribute only
a single gene to screening efforts. By finding the cellular mechanisms used during this
process a large scale screening can be done for genes associated with all the cellular
machinery involved.
Future work in the field of optic fissure fusion should focus on endothelial cells
and their mechanisms for regulating this process. It is my belief these cells are the crux of
optic fissure fusion and more work needs to be done to investigate how they do what they
do. Firstly, I believe it would be beneficial to perform single cell RNA sequencing on
FACS sorted eye cells, separating endothelial cells (kdrl transgenic line) from epithelial
cells (rx3 transgenic line). The biggest challenge here are the technical aspects, to once
again compare wild-type and coloboma transcriptional differences the most beneficial
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time to examine them would be at 32 hpf when fusion is just beginning, this puts timing
to the early evening when accessing the required materials is difficult. This is also
challenging at 32 hpf as pax2a mutants do not have a visible phenotype until 48 hpf so a
wide scale genotyping on live embryos would have to be undertaken. Further work also
needs to focus on differentiating hyaloid endothelial cells’ actin cytoskeleton from the
fissure epithelial cells’ actin cytoskeleton. Talin1 is thought to be associated to the
endothelial cells and is required for their migration, and I hypothesized that ROCK is
associated to epithelial cells and is required for cytoskeletal dynamics involved in fusion
of the tissue. However, these cannot be fully resolved without the ability to distinguish
the actin cytoskeleton of endothelial cells from the actin cytoskeleton of epithelial cells. It
is highly probable that integrin signaling is involved in fusion through angiocrine
signaling from endothelial cells. By examining integrin mutants we could begin to
uncover the potential mechanisms through which endothelial cells contribute to
cytoskeletal dynamics in optic fissure fusion. Additional validation also needs to be
performed on this dissertation’s findings by examining mmp2 and ADAMTS1 mutants. I
have generated CRISPR mutants for both of these genes that are currently maturing. The
mmp2 line needs to be examined to ensure that knock-out of mmp2 results in coloboma
as was observed in the inhibitor study. It will be interesting to see if ADAMTS1 mutants
also develop coloboma. It has been observed that pax2 levels need to be precisely
controlled, we’ve shown that lack of pax2a function results in coloboma, however,
overexpression of pax2 also results in coloboma [216]. It has also been reported that over
production of vasculature in the retina also results in coloboma [210]. By observing
ADAMTS1 mutants we can discern if reduction of ADAMTS1 results in hypertrophic
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vascularization of the retina resulting in coloboma, requiring a precise concentration of
expression much like pax2. Along these same lines it would also be beneficial to
investigate if overexpression of pax2a will result in a down-regulation of ADAMTS1.
Not only is this dissertation an advancement for our understanding of optic fissure
fusion, but also could be the advancement for other epithelial fusion events as well. Our
finding of endothelial cell requirement in optic fissure fusion is not unique to optic fissure
epithelial fusion. In mouse neural tube closure endothelial cells were shown to be
required, when endothelial cells were not properly modulated and directed this resulted in
severe phenotypes one being neural tube defects [217]. Angiogenesis has also been
shown to be required during wound healing, and is thought to be due to angiocrine
signaling leading to proliferation and differentiation of progenitor cells [136]. This
dissertation further confirms and expounds upon the idea of endothelial cell requirements
during epithelial fusion. It would be very beneficial to our understanding of epithelial
fusion if we began to investigate a potential role for endothelial cells in other epithelial
fusion events
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Figure 5-1Detailed Model of Optic Fissure Fusion.
Proposed model for optic fissure fusion. Magenta marks filamentous actin, green marks the basement membrane.
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APPENDICES
APPENDIX 1: DIFFERENTIAL TRANSCRIPT EXPRESSION PROFILE BETWEEN
PAX2 MUTANTS AND WT.
Table A1.1: Down-regulated genes in pax2 mutants.
Gene ID

PPDE

PostFC

aifm1

1

1223.99707

si:ch211-57b15.1

1

175.669227

si:rp71-36a1.5

1

140.545568

krt96

1

159.577655

si:dkey-9c18.3

1

135.672416

arf5

1

116.803923

dock1

1

111.340616

sumo3a

1

699.778621

lim2.1

1

694.142353

zgc:152951

1

97.6461015

pcbp3

1

93.498624

ddx43

1

47.0232655

abracl

1

78.7184492

tfb2m

1

283.563781

znf1034

1

38.8839082

nsun5

1

17.3779661

tln1

1

249.437187

ptprna

1

173.271619

crygs1

1

65.1862175

mgst2

1

194.272308

si:ch73-7i4.2

1

27.2410028

si:dkey-126g1.7

1

11.3613672
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Table A1.1: Continued
Gene ID

PPDE

PostFC

hn1l

1

12.4968928

zdhhc16a

1

18.0239348

sept9a

1

142.868951

pyroxd2

1

76.7017298

gpsm1b

1

81.5093272

cryl1

1

73.8133177

atp8b1

1

69.0944517

slc16a8

1

11.9456451

zgc:195170

1

8.53785003

si:ch211-180n24.3

1

7.97368407

emc4

1

4.84517879

zgc:158803

1

5.1361905

ccdc15

1

5.36868841

cyp1b1

1

4.84809106

ftr36

1

3.92235

nedd1

1

3.71353033

si:dkeyp-53d3.5

1

3.43253567

gsta.1

1

3.42834504

gsta.1

1

3.42834504

crybb1l3

1

3.31490641

nags

1

2.99342656

trpm2

1

2.61882

yif1b

1

2.56620613

zgc:171242

1

2.50632681

ndufb2

1

2.26997051
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Table A1.1: Continued
Gene ID

PPDE

PostFC

wdr11

1

2.26390257

capn3a

1

2.2636352

nif3l1

1

2.26196314

si:ch73-111m19.2

1

2.19476442

cyp17a1

1

2.13605558

si:ch73-111m19.2

1

2.14361341

si:ch211-210c8.7

1

2.12701659

gja8b

1

2.06529674

crygmxl1

1

2.06431522

lim2.5

1

1.90946226

abhd17aa

1

1.88126807

dnajb6b

1

1.85337252

pabpc4

1

1.82916711

pld3

1

1.82056501

spg20a

1

1.79453331

crygmx

1

1.77666289

si:ch211-152c2.3

1

1.78464777

usp45

1

1.77463243

ccdc85cb

1

1.77711578

cx23

1

1.74621358

slc25a22

1

1.72877889

cryba4

1

1.6950759

tdh2

1

1.70536566

arsj

1

1.65984403

lamp1

1

1.65161519
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Table A1.1: Continued
Gene ID

PPDE

PostFC

lctlb

1

1.63883046

otc

1

1.63219085

gja8a

1

1.59332984

mipa

1

1.59090101

oxa1l

1

1.58340918

sptbn5

1

1.58041002

rps25

1

1.56500706

exoc3

1

1.56852543

scp2a

1

1.55977927

dpp3

1

1.53549039

lim2.1

1

1.52576615

eif4ba

1

1.48108286

daam1b

1

1.48283158

ank3b

1

1.47309668

mipb

1

1.47151262

pitrm1

1

1.44887687

wdr48b

1

1.44611811

si:ch211-214j24.14

1

1.94211311

CU570881.1

1

6.78543573

zgc:92275

1

4.23766612

crybb1

1

1.71609167

slc25a15b

1

3.23368643

rac1b

1

1.60544192

cps1

1

1.60689024

dusp11

1

3.28844067
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Table A1.1: Continued
Gene ID

PPDE

PostFC

si:dkey-221j11.3

1

2.11172447

dennd2db

1

2.43279657

zgc:153929

1

1.98064232

rgs12b

1

62.8409305

srsf2b

1

1.47707825

si:dkey-183c16.7

1

13.0146393

dusp22b

1

2.27505567

asna1

1

56.2488278

cap2

1

1.51908495

fuca1.2

1

1.56651662

map7d1b

1

2.50556695

vamp8

1

1.4582063

p3h3

1

1.71118286

#N/A

1

2.08389311

myo3b

1

2.14868484

rabif

1

2.13834441

si:dkey-105i14.1

1

3.62992484

pebp1

1

1.73882751

rock1

1

25.3621951

agt

1

58.8429679

alg12

1

1.80945907

lman1

1

1.5279362

si:dkey-147f3.4

1

2.09715543

cryba1b

1

1.53629026

lcmt2

1

7.38642605
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CR847505.1

1

2.00613265

gpr22a

1

58.9490895

si:ch211-161h7.8

1

1.83852528

nom1

1

1.47612084

ascc2

1

1.48866247

aifm5

1

1.77670654

tubb6

1

1.81145175

lim2.3

1

1.58248375

cast

1

1.52337612

acad8

1

1.65017367

atp5j

1

58.1667188

si:ch211-271b14.1

1

4.61968968

phkg2

1

1.75324828

ascc1

1

1.79211659

lctla

1

1.66701741

mfsd2b

1

1.86878124

rock2b

1

6.79767627

crybb1l2

1

1.53754283

si:rp71-36a1.5

1

16.6577328

sncga

1

1.74153709

tp53inp2

1

1.45399487

hmbsb

1

55.9932726

fbxl4

1

1.5696002

zgc:193541

1

1.57657677

capn3a

1

1.57116732

118

Table A1.1: Continued
Gene ID

PPDE
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si:dkeyp-80d11.4

1

20.6510718

dap3

1

1.45876876

ncam3

1

2.69695494

rnf146

1

5.81313939

rmdn1

1

3.32221771

cx23

1

1.76681385

sub1a

1

1.85500891

dmrt1

1

51.2481844

itprip

1

2.10199487

UBA6

1

1.62157642

tpi1b

1

1.64792889

cmtm7

1

1.66102804

adgre9

1

18.9178814

bmpr1ba

1

1.48208161

itga2.3

1

9.48822663

coq2

1

1.58976076

snrnp35

1

5.78146624

ppp1r7

1

53.7696831

crygn2

1

1.58095118

engase

0.99999999

1.61017979

crybb1l1

0.99999999

1.48527984

hsf4

0.99999999

1.56782213

cryba2a

0.99999999

1.52431995

ggctb

0.99999999

1.67449333

#N/A

0.99999999

19.1301108
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tbc1d7

0.99999999

2.80969394

coro7

0.99999999

6.18818573

cfl2

0.99999999

1.49370552

CU570881.3

0.99999998

2.11755421

lim2.5

0.99999998

1.91023961

pax2a

0.99999998

6.78650436

kpna4

0.99999998

15.6249193

cbx2

0.99999997

3.99260728

hbbe1.1

0.99999997

105.902985

chfr

0.99999996

2.64468057

srrm1

0.99999996

1.73461837

map2k2a

0.99999996

1.54454791

rab1ab

0.99999995

1.57140359

dnajb11

0.99999994

160.269319

cryba1l1

0.99999994

1.57377739

cars2

0.99999994

2.1521133

alpl

0.99999994

1.87004743

oat

0.99999993

2.05824632

si:dkeyp-73d8.9

0.99999993

15.0767668

alkbh6

0.99999993

1.49683117

gle1

0.99999992

3.14754418

paqr3b

0.99999992

2.48499927

dennd3b

0.99999992

26.293977

npc2

0.99999991

9.37448709

ell2

0.99999989

1.49504146
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grifin

0.99999988

2.02773908

zgc:123295

0.99999987

4.1125871

cyp2k8

0.99999986

1.8099226

psmb7

0.99999986

1.75487666

nrl

0.99999985

1.8069002

TDRD7 (1 of many)

0.99999984

1.73659262

zgc:198419

0.99999983

4.5448607

alkbh1

0.99999983

1.6768179

crybb2

0.99999983

5.18024141

ddx43

0.99999983

17.1825958

mustn1a

0.99999983

8.93863489

polh

0.99999982

4.76200218

krt222

0.99999981

2.05228912

krt5

0.99999979

1.71033081

DNAH10

0.99999978

3.73671831

stk24b

0.99999975

50.6381636

apaf1

0.99999972

45.7857349

nadk2

0.99999969

1.94148452

npm1a

0.99999964

1.8523304

rnf44

0.9999996

2.10459288

cox6b1

0.99999954

1.82301315

ms4a17a.8

0.99999948

3.38703217

plcxd1

0.99999941

1.83893967

gsto2

0.99999939

1.45118731

nucb1

0.99999934

3.78901511
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si:ch211-198g14.4

0.99999929

4.64968836

plcb3

0.99999922

1.89038588

kpnb3

0.99999921

70.5079153

ncs1a

0.99999913

4.77662414

ppp1r13l

0.99999909

1.63056225

gbgt1l3

0.99999895

5.16494507

upb1

0.99999894

1.83222994

fah

0.99999888

2.10977636

crygm2d10

0.99999873

1.6257291

aatf

0.99999871

1.81229155

lim2.4

0.99999866

1.55456654

b3gat3

0.99999856

1.56667896

rnf213a

0.99999855

1.75125497

CU929052.1

0.99999851

1.59986814

krt222

0.99999806

2.08429438

si:dkey-66a8.7

0.99999801

3.37314446

cryba2b

0.9999977

1.62916318

tssc4

0.99999762

2.28817405

dhx40

0.99999758

2.69060175

dnase1l4.2

0.99999747

1.65174174

fli1b

0.99999746

2.13903918

vetz

0.99999737

6.9774706

slc25a15b

0.99999733

1.63327092

gtf2f2a

0.99999733

1.48762735

CABZ01009708.1

0.99999729

7.32508867
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yif1b

0.99999719

1.87811913

elovl8b

0.9999971

3.08625651

arl16

0.99999632

4.30365674

rpl30

0.99999572

3.73752824

si:ch211-110e21.4

0.99999494

1.9678438

tsen54

0.99999443

1.56210688

grtp1a

0.99999429

3.93572394

fbxl3b

0.99999413

6.77888696

CABZ01084225.1

0.99999385

47.2480885

si:dkeyp-73d8.6

0.99999299

45.9496467

si:dkey-13n23.3

0.99999296

2.5385895

zgc:100832

0.99999245

1.47224445

si:ch211-255g12.6

0.99999203

3.81044639

ugt5b2

0.99999102

2.0851078

nnt2

0.99998971

2.6948858

ern1

0.99998941

2.64396353

gmds

0.99998914

4.40703883

mrc1a

0.99998882

1.52029426

pdcd5

0.99998776

1.45326914

si:ch73-204p21.2

0.99998744

2.09409472

si:ch211-157b11.12

0.99998632

3.00711252

tango6

0.99998497

73.7546973

si:ch73-281f12.4

0.99998414

1.81719242

tomm40

0.99998315

10.579481

pdgfaa

0.99998148

1.95182545
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cct8

0.9999793

2.31810813

vdac1

0.99997762

9.86898347

fam161b

0.99997658

4.0967888

ablim3

0.99997505

1.47215069

aifm4

0.99997496

2.66574247

vps26b

0.99997492

2.26824301

cryba2b

0.99997371

1.44821852

vwa1

0.99997347

1.4909354

si:dkey-262k9.4

0.9999716

2.53036937

fam117aa

0.99996981

1.49639138

psip1b

0.99996929

2.99620151

pnp5a

0.99996577

1.67919183

ndufa1

0.99996108

1.92982224

ascc3

0.99996065

1.50769842

foxi2

0.99995996

1.51486128

NAPSA

0.99995937

1.55556349

mylka

0.99995809

1.84965425

chrne

0.99995726

2.12600375

CABZ01094849.1

0.99995647

1.46047706

tmem107

0.99995594

49.6969667

rwdd

0.99995341

1.65893455

plpp1a

0.9999515

1.72251411

sprn2

0.99995112

1.77495768

mettl26

0.99995054

1.69643824

zgc:136439

0.99994981

1.64683941
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ruvbl1

0.9999492

2.93279286

sash1a

0.99994471

1.60057577

cldn12

0.99994412

60.0968843

zgc:101716

0.99994364

1.94767793

CU459012.1

0.9999394

1.48985218

pigr

0.99993628

2.26705729

si:ch211-219a15.3

0.99993415

4.55017415

rbm39a

0.99993037

1.66007852

ints10

0.99992692

11.0237361

pde4cb

0.99992688

5.12396905

si:dkey-79f11.7

0.99992283

5.05453674

si:ch73-111m19.2

0.99992196

1.45434574

prpsap1

0.99991189

1.53003315

mibp

0.99991124

1.69516215

tma16

0.99990892

1.4521418

wdr55

0.99990199

3.56272814

si:ch211-66k16.27

0.99990112

2.84187921

si:dkey-12j5.1

0.99989726

1.66907093

tmem17

0.99988971

1.60818914

ppa1b

0.99988901

4.81460436

slc16a8

0.99988704

43.9083338

pax2a

0.99988662

4.06164295

casp7

0.99987887

1.81812348

atp6v0a1a

0.99986267

1.50149016

rnpep

0.99986265

1.50248073
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PPDE
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si:dkeyp-2e4.3

0.9998582

2.44070041

scaf4a

0.99985144

6.3933154

si:dkey-26m3.3

0.99984702

1.74852389

crygm2d8

0.99984678

1.53097877

prpf8

0.99983712

4.9201693

brf2

0.99983243

2.25170028

cx23

0.99982901

1.60869914

rbpms2b

0.99980491

1.73186733

rab4a

0.99979591

1.6847137

zgc:158846

0.99979367

31.5286328

commd1

0.99979017

1.55930685

itga2.3

0.99978443

4.2771078

cica

0.99976018

41.1959819

malt1

0.999759

3.34750251

bod1l1

0.99975731

9.09496507

si:dkey-261j11.3

0.9997531

1.77944191

42993

0.99973487

1.51714524

rbm39a

0.99973356

1.47439292

rnf34a

0.99973336

1.75915986

dtwd2

0.99972077

1.72006039

mpped2a

0.99972016

32.5580078

CR933791.2

0.99971927

3.27982281

trpv4

0.99971765

2.17703217

ggt1a

0.99970297

1.58616604

tppp

0.99970228

8.25552791
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apooa

0.99965681

2.88784954

si:ch211-264e16.1

0.99963493

2.39559255

tubgcp5

0.99961663

5.32353255

apaf1

0.99958797

2.86180472

CABZ01085177.1

0.99958356

2.58997286

gfap

0.9995812

1.50124367

brf1a

0.99957332

3.57032962

snu13a

0.99956005

1.70802978

col28a1a

0.99952056

1.45732635

ccdc127b

0.99949035

3.11935788

sptlc3

0.99948548

1.73405455

si:ch211-245n8.4

0.9994782

1.57060769

ndufa4

0.99940293

1.83210307

cep97

0.99939637

43.8091499

thyn1

0.99934831

1.70517312

zgc:194125

0.99931666

5.76729451

wnt5b

0.99931648

1.68119178

ehmt1a

0.9993046

1.87654878

cars

0.99929838

1.84299387

dnase1l4.2

0.99929022

5.90812952

gss

0.99926297

1.68269843

tagapb

0.99925649

4.19828835

znf1156

0.99925388

2.7711738

rad51b

0.99924574

1.91152316

neu4

0.99924123

3.0380974
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zgc:171435

0.99923297

2.96143816

borcs7

0.99920318

1.57831473

APBA3

0.99919107

1.58086061

trim2a

0.99913752

1.74917993

gja8a

0.99910053

1.91053323

ppm1bb

0.99909997

6.54259548

mllt3

0.99909297

1.59082337

gemin8

0.99908491

1.72856285

si:dkeyp-41f9.3

0.99902658

2.27342844

pttg1

0.99901023

1.4547877

CABZ01017733.2

0.99898879

2.52185913

si:dkey-250l23.4

0.99897471

1.49278173

bag5

0.99889185

1.45172344

tg

0.99888699

4.16034917

adprh

0.9988756

2.6621234

si:dkey-93n13.1

0.99878054

2.54997607

zgc:101783

0.99873615

2.09015323

crygm2d2

0.99872877

1.7872225

crygm2d18

0.99872235

1.56372307

necab1

0.99871626

6.89174956

crygm2d13

0.9986437

32.172129

flad1

0.9985978

2.81680295

arglu1b

0.99856812

1.54702655

nrp2b

0.99855951

9.23551662

prpf18

0.99852081

2.81507736
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CABZ01056516.1

0.99848177

1.88996358

abcb6b

0.99847751

1.63195204

ghrb

0.99841373

2.1246351

gba

0.99840894

1.5459978

CR388055.1

0.99835951

8.38118796

CABZ01104045.1

0.99822521

3.09104858

cyp1b1

0.99821377

4.23301803

dgcr14

0.99819288

1.4540346

naa15b

0.99816171

2.14548158

zgc:153901

0.99813824

2.37028815

stk25a

0.99811129

1.6808346

hps1

0.99808501

5.20504829

crygm2d10

0.99803451

1.54346497

acox3

0.99798949

1.64901789

sfxn1

0.9979626

3.67337931

dph6

0.99794754

1.66754809

orc3

0.99786918

4.11144521

ftr34

0.99778972

7.12927033

hspa5

0.99776347

1.45900932

CR388166.2

0.99774393

4.80751572

CR847505.1

0.99767147

1.56087377

creb3l3l

0.99763926

28.9280217

klhdc3

0.99754477

1.49959371

plxnb2b

0.99739686

2.8708384

zgc:113333

0.99739433

2.46406697
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lace1a

0.99738843

2.55480026

CABZ01076758.1

0.99738747

2.03221845

b4galt4

0.99734815

1.61207282

hmga1a

0.99733818

27.2336772

GRB14

0.99722118

4.25034902

opa1

0.99720239

7.04487531

hsf1

0.99711966

2.4653613

hagh

0.99711242

42.0700683

aldh1a3

0.99697862

1.73063958

havcr2

0.99691498

2.24716526

adam8b

0.99683177

2.3934117

hao2

0.99667813

1.45767521

anxa11b

0.99665607

1.85238107

pvrl1b

0.9966317

1.50586087

si:ch211-105c13.3

0.99659112

1.58270309

krt1-19d

0.99656907

1.49066487

nudt22

0.99653157

1.54375413

CAPN2 (1 of many)

0.9964168

3.76333227

aifm5

0.99637373

1.5049305

kera

0.99634127

1.46945741

hao2

0.99620531

1.53216224

grhl2a

0.99615744

1.47061948

dctn4

0.99605291

1.93311304

dusp8b

0.9959429

1.70674605

gja8b

0.99592218

5.75569377
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slc8a2b

0.99590537

3.00473688

zgc:110249

0.99585384

1.56521469

srsf1a

0.9957298

2.31580174

zgc:162613

0.99568074

2.42296574

plcd4a

0.99543533

1.88003062

CR759830.1

0.99535448

1.72946897

erbb2ip

0.99515345

7.54838897

hmg20b

0.99512041

1.59115006

gmnn

0.99500198

1.87787088

znf1149

0.99485221

2.27037118

glmp

0.99455088

1.45732006

rhobtb2a

0.99451278

1.7608224

trpc6b

0.99445783

4.48237794

eno1a

0.99440949

46.4447679

MFAP4 (1 of many)

0.99437498

5.34202918

dhrs13a.1

0.99434608

1.52869638

cryba1a

0.99426025

1.81056152

CASKIN2

0.99414096

2.2137431

irf6

0.99390149

1.44744897

selm

0.99383238

1.70120157

crybb1l3

0.99371216

2.97624852

NPNT (1 of many)

0.99362616

1.95726061

zer1

0.99360223

2.80517208

si:dkey-31f5.11

0.99353156

11.1294797

trap1

0.99346372

1.77854316
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ddx3b

0.99333702

1.75648871

hnrpkl

0.99332646

2.45360045

fam198a

0.99303582

2.13154654

si:ch211-284e13.4

0.99283436

8.43875312

crygm2d4

0.99275242

1.46073229

uxt

0.99233654

1.60243282

zgc:101858

0.99209436

1.45613599

taf9

0.99204649

1.97353727

si:ch211-173d10.1

0.99199547

1.68915066

slc5a8

0.99166367

2.12299005

ngfb

0.99166004

1.44577767

arhgef37

0.99164547

1.562217

rpl22

0.99163915

3.13135745

ppp1r13bb

0.99156071

1.56393958

ago4

0.99116545

2.19502113

erf

0.99114441

1.65065804

mecp2

0.99111311

38.6749009

zdhhc15b

0.99090374

4.27276771

map1sb

0.99082125

5.04991096

abi2b

0.99072228

1.69961379

xirp1

0.99059602

1.75159236

akap1b

0.9900875

1.44567166

cryba1a

0.98994725

1.54555777

crygm2d20

0.98980548

1.50404838

si:ch73-134f24.1

0.98963798

3.79514899
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Gene ID

PPDE

PostFC

BX548028.1

0.98945111

3.49002902

kaznb

0.98896385

2.9465309

rpp25l

0.98893984

1.48102682

MFAP4 (1 of many)

0.99437498

5.34202918

dhrs13a.1

0.99434608

1.52869638

cryba1a

0.99426025

1.81056152

CASKIN2

0.99414096

2.2137431

irf6

0.99390149

1.44744897

selm

0.99383238

1.70120157

crybb1l3

0.99371216

2.97624852

NPNT (1 of many)

0.99362616

1.95726061

zer1

0.99360223

2.80517208

si:dkey-31f5.11

0.99353156

11.1294797

trap1

0.99346372

1.77854316

ddx3b

0.99333702

1.75648871

hnrpkl

0.99332646

2.45360045

fam198a

0.99303582

2.13154654

si:ch211-284e13.4

0.99283436

8.43875312

crygm2d4

0.99275242

1.46073229

uxt

0.99233654

1.60243282

zgc:101858

0.99209436

1.45613599

taf9

0.99204649

1.97353727

si:ch211-173d10.1

0.99199547

1.68915066

slc5a8

0.99166367

2.12299005

ngfb

0.99166004

1.44577767
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Gene ID

PPDE

PostFC

arhgef37

0.99164547

1.562217

rpl22

0.99163915

3.13135745

ppp1r13bb

0.99156071

1.56393958

ago4

0.99116545

2.19502113

erf

0.99114441

1.65065804

mecp2

0.99111311

38.6749009

zdhhc15b

0.99090374

4.27276771

map1sb

0.99082125

5.04991096

abi2b

0.99072228

1.69961379

xirp1

0.99059602

1.75159236

akap1b

0.9900875

1.44567166

cryba1a

0.98994725

1.54555777

crygm2d20

0.98980548

1.50404838

si:ch73-134f24.1

0.98963798

3.79514899

BX548028.1

0.98945111

3.49002902

kaznb

0.98896385

2.9465309

rpp25l

0.98893984

1.48102682

grem2b

0.98840721

1.6401085

stat5b

0.98818129

2.2384188

trmt2b

0.98799964

1.62792379

asb8

0.98763456

6.32303274

hsc70

0.98739015

1.49960826

cyp26a1

0.98733145

1.64335689

rpl37

0.98725961

2.92008536

si:ch211-28p3.4

0.98701276

3.0210299
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Gene ID

PPDE

PostFC

zgc:136439

0.98694594

9.58528702

dnaaf2

0.98686954

4.10438419

iqcb1

0.98647642

14.8057006

crygm2d10

0.98626777

1.92092397

btr22

0.98577043

8.44109199

rcn3

0.98499508

1.56897787

ca14

0.9848079

1.7047417

si:ch73-281n10.2

0.98456979

2.76853798

si:dkeyp-89c11.3

0.98431684

1.92360526

agla

0.98413602

1.98005925

zgc:153116

0.98400883

1.70434076

ctbp2a

0.98383447

1.53984914

micu2

0.98366744

1.7372849

clec19a

0.98189703

1.45307978

emc9

0.98158258

1.74015908

nrp1b

0.98123275

1.55739945

gulp1b

0.98112447

1.62498013

ccni

0.98083135

1.5056777

bmp7b

0.98074939

2.11860707

cyb5a

0.98040352

13.7938711

eef2a.1

0.98013775

1.4510759

zgc:172121

0.98000405

1.82363909

tfg

0.9798687

1.58011965

fblim1

0.97979129

1.77328086

abl1

0.9794695

1.50009617

135

Table A1.1: Continued
Gene ID

PPDE

PostFC

cep19

0.97874227

2.4618082

doc2d

0.97848231

3.49920863

znf1073

0.97838562

2.16310443

CABZ01085201.1

0.97830492

2.96636405

tfeb

0.97829145

1.46413418

acp6

0.97792259

1.5256828

znf1118

0.97774921

3.39687326

ilf3a

0.97707425

1.84330217

ptrh2

0.97704389

1.5029118

tgm1

0.97657977

1.5338101

pdlim2

0.9759612

1.59719201

secisbp2

0.97592857

25.5378271

RCCD1 (1 of many)

0.97539801

1.68445582

vac14

0.97488809

5.93408401

zgc:66474

0.97372109

3.39204342

olfml2bb

0.97371175

2.82580675

CABZ01075923.1

0.97274973

2.26923045

tfdp1b

0.97245876

1.55551519

abca4a

0.97225083

4.7715995

CR589875.3

0.97170361

2.75512657

atrn

0.97145862

4.66187743

CABZ01055168.2

0.9714083

1.63583948

cmc2

0.97050977

1.70432897

arv1

0.96991978

1.48332418

CABZ01065076.1

0.96937527

2.19358276
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PPDE

PostFC

hipk1a

0.96877742

1.8625903

si:ch211-223a10.1

0.96857825

5.35573704

znf1152

0.9676443

3.63460721

ggps1

0.96751221

3.70570249

fam173a

0.96744173

3.86747503

crygm2d3

0.96695004

1.60396175

dnmt3bb.3

0.96686231

2.6999396

CU693379.1

0.96668328

1.52661285

tagapb

0.9654193

1.83986801

glb1l

0.96497259

1.85660888

twistnb

0.96435182

1.77734076

ndnl2

0.96381045

2.85173594

si:dkey-82i20.1

0.96380499

2.62985496

kaznb

0.96334556

2.02298041

anapc4

0.9631407

1.56027347

cln8

0.96289215

13.4774094

zgc:112052

0.96139714

1.44930654

zgc:171727

0.96086624

1.70111235

fam49ba

0.95946633

1.855808

tpcn1

0.95910115

1.48385356

wdr48a

0.9589923

1.62285736

cluap1

0.95827713

2.61477459

zdhhc7

0.95786733

1.50000559

flnca

0.95758306

3.23763588

thumpd3

0.95686314

1.50815049
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PPDE

PostFC

slc2a3a

0.95601753

3.34083472

znf1166

0.95598227

4.55499374

frs2a

0.95597591

2.09852415

derl3

0.95435887

1.62321733

ctnna2

0.95395215

2.04026997

csnk2b

0.95359456

2.18662568

cdk4

0.95316458

2.45041839

stat6

0.9526223

2.48125567

map7d1a

0.95201836

2.85615694

dclk2a

0.95168893

3.23282027

txn2

0.95167271

1.95248048

spag9a

0.95122725

1.46292078

zgc:113314

0.95026817

4.54549698

gcnt4a

0.94979986

1.48342598

hccsa.1

0.9496067

1.4601552

si:dkey-245p14.7

0.9489146

1.45676336

sowahab

0.94813264

2.1742691

tshr

0.94716513

2.05431466

gpr31

0.94647795

13.2846251

zfand5b

0.94560466

2.34123755
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Table A1.2: Up-regulated genes in pax2 mutants
Gene ID

PPDE

PostFC

gsta.1

1

0.00605684

gmnn

1

0.00236076

col11a1a

1

0.00254868

fubp3

1

0.0031324

ublcp1

1

0.00443801

smarcal1

1

0.00462374

pde6g

1

0.02375396

tbc1d7

1

0.0062857

aldh2.2

1

0.03090445

scg5

1

0.00674314

ggact.3

1

0.00719755

srek1

1

0.00643062

nppa

1

0.01164394

kat5b

1

0.04170289

ahsa1a

1

0.00758063

eed

1

0.0080722

zer1

1

0.02303175

dpf3

1

0.00797029

tdrd3

1

0.00932432

pcbp3

1

0.01034905

mhc1ula

1

0.01467228

nefmb

1

0.01010116

si:ch211-24o10.6

1

0.01057941

acox3

1

0.01163691

ppdpfa

1

0.12514072
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Gene ID

PPDE

PostFC

polh

1

0.03515468

lin37

1

0.01228555

si:dkey-71b5.3

1

0.01294887

brf2

1

0.05558196

dclk2a

1

0.01219264

rnf17

1

0.01389209

sema3gb

1

0.015136

si:ch211-125e6.8

1

0.03272142

zgc:172253

1

0.01342178

rfx1a

1

0.01294848

anxa11b

1

0.04866037

si:dkey-147f3.4

1

0.02478841

actr2b

1

0.03317023

anxa3a

1

0.00550592

si:dkey-271j15.3

1

0.04660447

si:dkey-26g8.4

1

0.00829112

slc16a3

1

0.00965152

CR550302.3

1

0.01057006

trrap

1

0.21584799

irf6

1

0.01398657

si:dkey-207l24.2

1

0.05698701

nedd1

1

0.07552394

si:dkey-121n8.8

1

0.10626453

zfr

1

0.01319333

si:ch211-149k12.3

1

0.07293431
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Gene ID

PPDE

PostFC

mhc1uma

1

0.06937348

igfbp6b

1

0.07147004

prkcq

1

0.07391903

tnnt2a

1

0.08817417

emc4

1

0.0895896

adh8b

1

0.11792317

si:ch211-181d7.3

1

0.12295161

prl

1

0.12017863

zgc:195023

1

0.12569586

DNAH10

1

0.16942855

znf1105

1

0.13822185

aldh2.2

1

0.15241552

fancl

1

0.1444089

znf1048

1

0.16402274

plin2

1

0.16403027

znf1034

1

0.18687438

gsta.2

1

0.18085137

si:dkey-5i16.5

1

0.18748923

zgc:173714

1

0.20999774

si:ch211-160d14.15

1

0.22822963

eef1db

1

0.22287253

ntrk3a

1

0.27797563

zgc:174703

1

0.29096933

tert

1

0.28974784

arl13a

1

0.31013017

141

Table A1.2: Continued
Gene ID

PPDE

PostFC

si:ch1073-190k2.1

1

0.30376193

il1rapl1a

1

0.3123487

si:ch1073-340i21.3

1

0.31130225

si:ch211-108d22.2

1

0.31005669

CR792418.2

1

0.33536041

srsf2b

1

0.32807851

tbc1d7

1

0.32250552

zgc:158803

1

0.33672707

scg2a

1

0.35062128

KRTCAP2 (1 of many)

1

0.35836328

tenm1

1

0.37730235

rcvrn2

1

0.39002411

nucb1

1

0.39293702

atp1b1b

1

0.43567966

RNPS1 (1 of many)

1

0.44174727

myl9b

1

0.45103869

adamts1

1

0.44705479

slc43a2a

1

0.46419371

agtr2

1

0.46218335

zgc:194627

1

0.48479429

BX936382.1

1

0.48711738

BX324003.1

1

0.4915192

abat

1

0.49261779

adh8b

1

0.50732741

ACTC1 (1 of many)

1

0.07224994
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Gene ID

PPDE

PostFC

znf979

1

0.18126761

nkx2.4a

1

0.2021106

GUCY2C (1 of many)

1

0.3443919

nub1

1

0.14429663

uts1

1

0.06183254

nup43

1

0.11502627

eno1b

1

0.07687637

si:dkeyp-4c4.1

1

0.36378464

phka2

1

0.50035147

slc16a9b

1

0.17178494

htr2aa

1

0.01643461

si:dkey-45h7.1

1

0.47751149

slc43a2a

1

0.30613397

capn12

1

0.3479607

hsbp1b

1

0.05548599

mt2

1

0.26694464

f8

1

0.16074891

BX324179.3

1

0.33614006

BX901907.6

1

0.26215142

slc1a4

1

0.15797326

znf995

1

0.32190552

fgfr1bl

1

0.3510277

ccdc177

1

0.44522542

slc2a3a

1

0.4137739

si:dkey-147f3.4

1

0.0837128
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Gene ID

PPDE

PostFC

lgals1l1

1

0.37934349

znf1147

1

0.08193842

si:dkey-242h9.3

1

0.2540002

si:ch211-223a21.4

1

0.36493309

CR749167.2

1

0.10761652

disc1

1

0.01686798

CABZ01074309.1

1

0.31134412

CABZ01059415.2

1

0.09291659

si:dkeyp-94g1.1

1

0.01445691

grid2ipb

1

0.38371713

add2

1

0.50906471

rps25

1

0.17436522

serpinb1l2

1

0.17340022

CR792418.1

1

0.34514169

flnca

1

0.01318045

BX663613.2

1

0.31368995

znf1121

1

0.10248789

znf395b

1

0.51509725

si:ch211-223a21.6

1

0.01746367

CDHR1 (1 of many)

1

0.22887757

theg

1

0.01879636

zgc:174224

1

0.42871578

srsf2a

1

0.06525884

si:dkey-6f10.5

1

0.29589366

dhdhl

1

0.48421107
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Gene ID

PPDE

PostFC

aptx

1

0.19691078

ch25hl1.1

1

0.33840597

clcn2c

1

0.26789997

gcdhb

1

0.24512506

znf1062

1

0.20305682

si:ch1073-296i8.2

1

0.52581858

tpi1b

1

0.01904369

epb41l3a

1

0.46450579

atp1a1a.2

1

0.36962255

kctd7

1

0.40297206

gpr19

1

0.26318709

nrxn3a

1

0.13405496

acot11b

1

0.18663379

CABZ01088933.1

1

0.45514622

cldn7b

1

0.16934132

si:ch211-111e20.1

1

0.19462454

nup205

1

0.39737498

opn1lw2

1

0.23384836

cgnb

1

0.21116152

mybpc3

1

0.12868531

CR792418.3

1

0.31223861

si:ch211-198c19.3

1

0.22238102

si:ch211-207i1.2

1

0.25235196

BX000534.1

1

0.00372337

CU207221.1

1

0.2039744
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PPDE

PostFC

si:dkey-122c11.8

1

0.31334123

BX649341.2

1

0.35945158

nppb

0.99999999

0.01627465

BX323994.1

0.99999999

0.1114317

otpb

0.99999999

0.45651345

si:ch211-256e16.11

0.99999999

0.1622364

anxa1b

0.99999999

0.5166512

tpm4a

0.99999999

0.1624046

map1lc3b

0.99999999

0.53569482

tnni1b

0.99999999

0.09825563

si:dkey-112g5.13

0.99999999

0.18950452

si:dkey-16p6.1

0.99999999

0.18928537

lingo2a

0.99999998

0.36833509

zgc:174855

0.99999998

0.00604256

FKBP15 (1 of many)

0.99999998

0.12550064

rock2b

0.99999998

0.13597191

si:dkey-84j12.1

0.99999998

0.41554627

hspb11

0.99999997

0.05682637

hydin

0.99999997

0.01887102

slc8a1a

0.99999997

0.29133813

si:dkey-269i1.4

0.99999997

0.00595867

gnb2l1

0.99999997

0.47063333

aspg

0.99999997

0.44627924

astn1

0.99999997

0.27853299

dap1b

0.99999997

0.19655153
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PPDE
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kiaa0907

0.99999996

0.07222343

irbp

0.99999996

0.39165389

znf1106

0.99999996

0.44388768

BX957278.1

0.99999996

0.49481015

impg2b

0.99999995

0.19513826

npdc1a

0.99999995

0.49223924

nsmfb

0.99999995

0.49570044

cx43

0.99999995

0.02002255

he1b

0.99999994

0.00536729

si:dkey-26g8.4

0.99999993

0.00742039

vmhcl

0.99999992

0.16366526

si:ch211-197e7.3

0.99999991

0.52009958

f2r

0.99999991

0.48535001

rps6kl1

0.99999989

0.20512967

nrxn2b

0.99999987

0.33225849

si:dkeyp-82a1.1

0.99999987

0.01904509

cmlc1

0.99999987

0.11093626

si:dkey-92j16.2

0.99999987

0.27043652

znf1157

0.99999986

0.24069362

tor4aa

0.99999986

0.18322423

CT027772.3

0.99999985

0.29867134

pcloa

0.99999984

0.43372962

fam184a

0.99999983

0.26126644

42796

0.99999982

0.53660844

atp1a3b

0.99999981

0.47172488
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BX571711.1

0.99999976

0.32284419

pcdh1g18

0.99999976

0.42250717

zgc:174154

0.99999976

0.00804295

thbs4b

0.99999975

0.23118379

znf977

0.99999974

0.34438838

fhl2a

0.99999973

0.45685578

scn4ba

0.99999972

0.07022859

he1a

0.99999969

0.00819939

dnph1

0.99999968

0.35437231

si:dkey-26g8.5

0.99999961

0.01032659

si:dkey-7j14.5

0.99999954

0.18644607

si:dkey-239j18.3

0.9999995

0.0075251

junbb

0.99999943

0.43790282

ctslb

0.99999942

0.00889435

znfl1

0.99999941

0.20701605

cfap36

0.99999935

0.01958596

gngt2a

0.9999993

0.4050215

znf1119

0.99999925

0.46128681

prpf3

0.99999923

0.50640869

micu3b

0.99999908

0.46813479

syt1a

0.99999904

0.52186761

si:dkey-26g8.4

0.99999904

0.00925787

gpr22a

0.99999888

0.24416183

si:dkey-81e3.2

0.99999882

0.52677003

si:ch211-181d7.1

0.99999879

0.04530496
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cstf2

0.99999877

0.45558629

pdcb

0.9999986

0.26736076

tspan2b

0.99999858

0.51315374

nek7

0.99999857

0.32629349

he1a

0.9999983

0.00762769

npc1

0.99999825

0.01955754

ahdc1

0.99999821

0.5379481

si:ch211-214b16.3

0.99999815

0.29170238

si:ch73-14h1.2

0.99999801

0.18166907

cnksr2b

0.99999781

0.46450493

acin1a

0.99999777

0.02079049

zgc:174855

0.9999976

0.01367869

CR388363.1

0.99999758

0.51692887

c1qtnf4

0.99999741

0.38287378

syngr3a

0.99999728

0.45035044

eif3c

0.99999686

0.48468976

lrfn2b

0.99999684

0.44072086

gsta.1

0.99999647

0.16304539

zgc:172075

0.99999637

0.24973437

CT956057.1

0.99999628

0.17513741

fxyd6l

0.99999607

0.14701245

ndfip1l

0.99999595

0.36873527

si:ch211-223a21.6

0.99999568

0.37847979

CABZ01032454.1

0.99999513

0.21525651

aanat2

0.99999494

0.53106594
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ptprna

0.99999404

0.23099451

sez6l

0.99999386

0.14239586

CR847893.3

0.99999384

0.1665221

fam20a

0.99999377

0.12860207

adar

0.99999348

0.44769287

gle1

0.99999335

0.00801162

sall1a

0.99999331

0.51108119

nadl1.2

0.99999309

0.41834251

rfng

0.99999263

0.14409881

slco5a2

0.99999146

0.53376039

ggact.2

0.99999062

0.19809603

opn1sw1

0.99999056

0.13566756

myl7

0.99999004

0.09274435

bmp7b

0.9999898

0.30189624

nr4a2a

0.99998928

0.17682409

c1galt1a

0.99998925

0.33147259

si:ch211-194h1.2

0.99998909

0.29492706

zgc:174153

0.99998908

0.01571141

mybpc3

0.99998905

0.11037837

BX548044.7

0.99998835

0.05211966

p2ry11

0.99998699

0.15300167

BX511155.1

0.99998606

0.53358307

si:ch211-113d22.2

0.999986

0.37050545

gnb3b

0.99998556

0.02068565

si:ch211-145h19.3

0.9999848

0.39354973
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si:ch1073-155h21.2

0.99998443

0.3588151

sh2b1

0.99998437

0.3860128

fn1b

0.99998428

0.14378086

apobb.1

0.99998229

0.09242128

si:dkey-16b10.2

0.99998093

0.25532652

TTC9

0.9999809

0.52745814

slc43a3a

0.99998036

0.4935222

setd8b

0.99997993

0.28637834

abcb4

0.99997919

0.47901977

lca5

0.99997904

0.02063078

si:dkey-269i1.4

0.99997904

0.01903747

RAC1 (1 of many)

0.99997904

0.32246713

BX324179.1

0.99997888

0.40549971

gria3a

0.99997813

0.34424777

cdkl5

0.99997803

0.420323

plgrkt

0.9999778

0.38095655

col17a1b

0.99997729

0.01314006

si:dkey-286j17.4

0.9999772

0.32145018

atp6v0a1b

0.99997637

0.44181414

oxr1b

0.99997633

0.19362888

zp2l2

0.9999743

0.02199306

si:ch211-256e16.11

0.99997352

0.13986696

he1b

0.99997258

0.02282588

luzp2

0.99997139

0.35329778

hhla2a.2

0.99997104

0.30281634
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si:ch1073-127d16.1

0.99997043

0.32632915

pnp5b

0.99997025

0.29533656

nrxn2a

0.99996873

0.4250459

si:ch1073-366l7.1

0.99996727

0.37106907

prickle2b

0.99996598

0.21852975

aatkb

0.99996537

0.23448957

CR847850.1

0.99996514

0.17674901

bc2

0.99996495

0.05986953

si:ch211-93f2.1

0.99996077

0.50500491

myom1b

0.99995932

0.39651079

fn1b

0.99995762

0.11232947

u2af2b

0.99995593

0.31532612

BX914205.3

0.99995509

0.10837343

adgrb3

0.99995467

0.18501697

BX640584.2

0.99995417

0.53284409

BX322541.1

0.99995356

0.31353973

si:ch211-165i18.2

0.99995176

0.18903043

CR931788.1

0.99995172

0.24675288

atp5o

0.99995136

0.20038995

mpp3a

0.99995021

0.52516293

CABZ01002768.1

0.99994937

0.22169614

arrdc3a

0.99994648

0.51975915

mtmr1a

0.99994502

0.28070692

pou3f3a

0.99994433

0.44230918

zgc:110821

0.99994034

0.49414883

152

Table A1.2: Continued
Gene ID

PPDE

PostFC

BX000703.1

0.99993805

0.34392657

srsf7a

0.99993709

0.01527172

vipas39

0.99993582

0.36641068

gsta.2

0.99993502

0.23226863

atp1a1a.3

0.99993282

0.40810091

git2b

0.99993176

0.16288131

mapta

0.99992941

0.51561394

si:dkeyp-9d4.3

0.99992788

0.41909251

AL928808.1

0.99992644

0.14391856

arr3b

0.99992288

0.25712168

si:ch211-282j17.13

0.99991595

0.04561393

si:ch211-235m3.10

0.9999129

0.51852354

dnase1l4.2

0.99991105

0.05647451

mfap4

0.99991046

0.35300431

eef1db

0.99991019

0.46422003

fli1b

0.99990926

0.01652762

trpm1a

0.99990064

0.4800735

CR388165.2

0.99990014

0.24042398

gnaq

0.99989913

0.33903861

si:dkey-14k9.2

0.99989605

0.42620912

RASSF5

0.9998929

0.02427608

commd1

0.99988542

0.1763567

LHX3

0.99988166

0.51142684

snrnp35

0.99987969

0.43557735

si:dkey-19a16.7

0.99987202

0.07018983
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nrgna

0.99986854

0.36166558

CR361561.1

0.99986302

0.53207609

apof

0.99986096

0.14434438

#N/A

0.99985941

0.32650324

ppp3r1a

0.99985049

0.07054015

si:dkey-103d23.5

0.99984223

0.06579386

cbx5

0.99983682

0.23748332

ppfia3

0.99982417

0.48046714

chd

0.9998145

0.50444185

ilf3a

0.99979959

0.35162936

camta1b

0.9997943

0.50547858

trip10a

0.99979284

0.08712916

fgfr1bl

0.999784

0.07293974

MREG

0.99978366

0.32333976

tmem151a

0.99978327

0.45913585

ctslb

0.9997776

0.01053025

si:dkey-16p19.1

0.9997757

0.11990754

galnt13

0.99977564

0.49255122

gnb5b

0.99976854

0.40939435

ogfrl2

0.99976392

0.30383139

BX005448.1

0.99976207

0.51731988

kcnn3

0.99975601

0.43523744

pde9a

0.99975099

0.40524452

slc16a9a

0.99975002

0.45470445

si:dkey-265e15.2

0.99974628

0.45671906
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si:dkey-63j12.4

0.99974299

0.27294906

BX548067.2

0.99972938

0.41980011

BX571760.1

0.99972549

0.35638927

si:dkey-265c15.6

0.99972421

0.2317945

kbtbd7

0.99972157

0.02098151

zfpm2a

0.99971423

0.12914748

adcy8

0.99971032

0.44743017

cyp2p7

0.9996982

0.14511267

tbkbp1

0.9996973

0.32085361

znf995

0.99969253

0.33400782

si:dkey-207m2.4

0.99969194

0.10649332

pde6c

0.99967916

0.43102165

pik3ip1

0.99965659

0.40449202

CABZ01055017.1

0.99965531

0.16724577

CR450780.5

0.99964515

0.15697399

STX3 (1 of many)

0.99964283

0.54176976

CABZ01076666.1

0.99962856

0.03607037

zgc:56585

0.99962397

0.42477835

capgb

0.99962323

0.17859531

pik3ap1

0.99962049

0.2788905

pcnxl2

0.99961905

0.40958864

si:ch211-111e20.1

0.99960794

0.21902183

smtla

0.99959106

0.13179384

meis3

0.99958584

0.40726959

esr2b

0.99958487

0.19111696
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si:rp71-36a1.3

0.99957462

0.12413078

foxp2

0.99957183

0.17788992

si:ch211-233h19.2

0.9995265

0.29795032

gata5

0.9995221

0.22390887

nrg2b

0.99952022

0.49071232

mamdc2b

0.99951438

0.20066243

palmda

0.99949614

0.53539551

zgc:174650

0.99949605

0.46882009

aatka

0.99948406

0.33106956

robo3

0.99947399

0.52580485

arpp21

0.99946131

0.17905093

ubald1a

0.99943311

0.14558743

plch2b

0.99941744

0.29725076

zgc:174862

0.99941116

0.03098591

ska3

0.99940779

0.33853889

TULP2

0.99940681

0.46356169

sypb

0.99940662

0.45209877

si:ch211-160f23.7

0.99940474

0.32220536

BX569782.1

0.99938975

0.11218363

si:dkey-242h9.3

0.9993791

0.24226441

pimr140

0.99937648

0.34795996

actn2b

0.99936892

0.52684436

si:dkey-17o15.2

0.99935655

0.34166514

tlx1

0.99935163

0.32815912

kank1a

0.99934268

0.15567464
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glrbb

0.99933051

0.39962525

snap25b

0.99932995

0.52458432

si:dkey-17m8.2

0.99931364

0.16763477

and1

0.99929729

0.44088156

si:ch211-137i24.12

0.99922915

0.30406675

CR361561.2

0.99916814

0.51668512

si:ch211-237i5.4

0.99916601

0.46815971

si:dkey-15j16.6

0.99913094

0.05887786

clstn2

0.99910238

0.40919186

fmr1

0.99908162

0.05598639

rock2b

0.99906025

0.25128439

lcat

0.99905384

0.41946461

pgap2

0.99902124

0.18219928

rtn1b

0.99901482

0.14984629

BX548067.4

0.99900623

0.37333621

zgc:172051

0.99896586

0.29981927

upf3a

0.99891803

0.27721657

cyp3c4

0.99891437

0.28911372

gngt1

0.99886624

0.39153483

slc25a23a

0.99885307

0.19903103

zbtb12.1

0.99880117

0.05108555

#N/A

0.99879076

0.29417649

tph1a

0.99876626

0.28592932

gria2a

0.99875441

0.36911053

atp10d

0.99875357

0.53192828
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STK19 (1 of many)

0.99874336

0.42211276

gria2a

0.99868907

0.41654551

lin7b

0.99868348

0.42339228

smc1a

0.99865029

0.21612456

si:dkey-33c12.11

0.99860824

0.24289676

CR361547.1

0.99858121

0.54184368

cpeb1b

0.99856564

0.35662865

vmhc

0.99854042

0.3707909

hadhaa

0.99853789

0.02408856

fam118b

0.99849721

0.2936514

si:ch211-198c19.3

0.9984391

0.17071168

sorbs2a

0.99839987

0.07941511

unc5da

0.99834257

0.46699416

nrsn1

0.99833169

0.4815366

tssc4

0.99829327

0.32854313

cep170ab

0.99824139

0.20235369

BX548173.2

0.99822428

0.48671549

BX088603.1

0.99822417

0.37982781

atp2a2a

0.99821767

0.19310722

pofut1

0.99821104

0.39122323

tmem30c

0.99821082

0.49440203

svopl

0.99803434

0.14001985

si:dkey-199m13.5

0.99796626

0.5338679

usp28

0.99796

0.39340668

sorbs2b

0.99792967

0.49360822
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prss59.1

0.99789646

0.06478723

cnp

0.99788786

0.29033878

clstn1

0.9977331

0.45891161

olfm1b

0.99770209

0.26797938

si:dkey-16p19.1

0.99769172

0.44490378

grtp1a

0.99765923

0.28861649

anos1a

0.9975957

0.48956643

ankrd6b

0.99757064

0.47614088

necab1

0.99756925

0.1677846

fam210aa

0.99756863

0.33668483

EML5

0.9975263

0.28571868

h6pd

0.99747697

0.08355315

si:dkey-72l14.3

0.9974624

0.32762292

si:dkey-247i3.5

0.99745893

0.23279795

si:dkey-106c17.2

0.9973468

0.06308066

tnni1b

0.99722671

0.14537484

foxi1

0.99721862

0.46869515

smc1a

0.99865029

0.21612456

si:dkey-33c12.11

0.99860824

0.24289676

CR361547.1

0.99858121

0.54184368

cpeb1b

0.99856564

0.35662865

vmhc

0.99854042

0.3707909

hadhaa

0.99853789

0.02408856

fam118b

0.99849721

0.2936514

si:ch211-198c19.3

0.9984391

0.17071168
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sorbs2a

0.99839987

0.07941511

unc5da

0.99834257

0.46699416

nrsn1

0.99833169

0.4815366

tssc4

0.99829327

0.32854313

cep170ab

0.99824139

0.20235369

BX548173.2

0.99822428

0.48671549

BX088603.1

0.99822417

0.37982781

atp2a2a

0.99821767

0.19310722

pofut1

0.99821104

0.39122323

tmem30c

0.99821082

0.49440203

svopl

0.99803434

0.14001985

si:dkey-199m13.5

0.99796626

0.5338679

usp28

0.99796

0.39340668

sorbs2b

0.99792967

0.49360822

prss59.1

0.99789646

0.06478723

cnp

0.99788786

0.29033878

clstn1

0.9977331

0.45891161

olfm1b

0.99770209

0.26797938

si:dkey-16p19.1

0.99769172

0.44490378

grtp1a

0.99765923

0.28861649

anos1a

0.9975957

0.48956643

ankrd6b

0.99757064

0.47614088

necab1

0.99756925

0.1677846

fam210aa

0.99756863

0.33668483

EML5

0.9975263

0.28571868
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h6pd

0.99747697

0.08355315

si:dkey-72l14.3

0.9974624

0.32762292

si:dkey-247i3.5

0.99745893

0.23279795

si:dkey-106c17.2

0.9973468

0.06308066

tnni1b

0.99722671

0.14537484

foxi1

0.99721862

0.46869515

ppp1r10

0.9971817

0.31566413

eif3ja

0.99716268

0.10759212

arsh

0.99714327

0.51084012

socs2

0.99707086

0.33862715

zgc:113333

0.99701473

0.48806542

syn2b

0.99697139

0.16181821

CR788231.1

0.99694096

0.46205745

penka

0.99686597

0.24151652

arr3a

0.99674751

0.33671613

rcan3

0.99653441

0.42763208

mdkb

0.99652328

0.4792949

tulp4b

0.99640019

0.3400266

plch2a

0.9963892

0.43414676

si:ch73-366i20.1

0.99626497

0.18688615

pou2f1b

0.9962637

0.02252641

CU570691.1

0.99623741

0.31135079

dnajb4

0.99620725

0.50764527

ildr2

0.99618784

0.429353

tapbp.2

0.99617898

0.28674961
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sept9a

0.9961613

0.27769595

hspb7

0.99615524

0.41688574

cdh18a

0.99609341

0.43477686

BX663505.2

0.99605135

0.29371093

rdh5

0.99604646

0.43069853

CR392001.1

0.99598014

0.45047628

nlgn3a

0.99596324

0.50170763

ckba

0.99595455

0.29232671

celsr3

0.99584857

0.53324135

rcvrn3

0.99578257

0.4186381

slc30a8

0.9957401

0.50888327

si:dkey-238i5.3

0.99562058

0.45159519

eef1da

0.99548107

0.42087634

pkd1b

0.99547678

0.17922092

si:ch73-233f7.1

0.99541097

0.27060703

arpc4l

0.99540159

0.33397983

si:ch211-219a15.3

0.99538616

0.02617741

ypel2a

0.99536953

0.47145165

rtkn2a

0.99533576

0.36806433

akap6

0.99516938

0.47976634

cd3eap

0.99499816

0.1297364

ACTC1 (1 of many)

0.99497978

0.12838549

irs2a

0.99496498

0.32848364

snx19a

0.99494703

0.22426436

atp6v0a1a

0.99486819

0.54378237
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Table A1.2: Continued
Gene ID

PPDE

PostFC

si:ch211-117l17.4

0.99485799

0.53449259

si:ch1073-416d2.4

0.99481988

0.27280906

CABZ01054391.1

0.99476265

0.54061221

CR450780.3

0.99471676

0.45661858

si:dkey-61n16.5

0.99470348

0.4480572

tanc1a

0.99467751

0.22942662

polh

0.99456912

0.32963852

atp2b3b

0.99453908

0.39885767

si:dkey-15j16.3

0.99451645

0.12377964

mcf2la

0.99446661

0.35998886

impg1b

0.99408334

0.5276069

guk1b

0.99399637

0.3992008

casq2

0.99391508

0.25234985

CR293532.2

0.99382183

0.30193611

MPP4 (1 of many)

0.99368021

0.17820716

zgc:113162

0.99365896

0.54493411

si:ch211-260e23.9

0.99363777

0.38735105

spegb

0.99363588

0.49379843

si:ch211-93f2.1

0.99359625

0.540328

gna15.1

0.99356414

0.41281225

ftr19

0.9934938

0.39801259

dpp6b

0.99332427

0.33522735

znf1051

0.99325023

0.3657999

st8sia5

0.99317221

0.11021142

slc18a3a

0.99304098

0.12690647
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Table A1.2: Continued
Gene ID

PPDE

PostFC

serp2

0.99303

0.34916793

fli1b

0.99301507

0.07298589

cep55l

0.99292065

0.25585232

acta1b

0.99281556

0.20926185

rgs8

0.99274697

0.4378912

si:dkey-253d23.3

0.99267489

0.42125889

opn1lw2

0.99261065

0.15683271

fam161b

0.99257004

0.42795112

grm8a

0.99253304

0.44719067

fgfbp2b

0.99242545

0.2897598

rab11bb

0.99220361

0.53381992

twf2b

0.99201412

0.23613863

si:dkey-21e13.3

0.99184247

0.53498727

pou4f3

0.99182861

0.49661927

ccdc25

0.99163652

0.29962577

zgc:162509

0.99146588

0.3126065

tpm4a

0.99145388

0.09958568

42796

0.9912496

0.04546687

si:dkey-222b8.4

0.99113274

0.39885113

hand2

0.9910868

0.47909457

rs1a

0.99088979

0.13095277

chchd6a

0.99060067

0.36740341

tfg

0.9905928

0.26433446

slc38a5a

0.99055222

0.36036061

smpx

0.99048703

0.26622748
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Table A1.2: Continued
Gene ID

PPDE

PostFC

zgc:123105

0.98986653

0.24153466

znrf3

0.98983536

0.04391429

zgc:113531

0.98979116

0.51391876

calb1

0.98975339

0.16767843

c3b.2

0.98957542

0.17765725

si:dkey-66l17.4

0.9893992

0.51583976

sult4a1

0.98928161

0.43535851

hdc

0.98896129

0.06750581

si:ch211-79g12.2

0.98892337

0.26166782

cnih3

0.98881535

0.3110016

noto

0.98863457

0.2052465

drgx

0.98843264

0.30796203

alg12

0.98820982

0.29418768

ppp2r2cb

0.98819323

0.51668074

impg2b

0.98818767

0.34561901

oxct1a

0.98811745

0.54101178

vmhcl

0.98809193

0.20945583

si:dkey-33i11.4

0.98763609

0.35345677

s100u

0.98761248

0.37089481

slc25a15a

0.98755591

0.1897895

fn1b

0.98697321

0.1878315

si:dkeyp-72g9.4

0.98672307

0.21862989

nupr1

0.98652818

0.51315228

si:dkey-147f3.8

0.9864812

0.25121241

pcdh2g1

0.98647784

0.48782806
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Table A1.2: Continued
Gene ID

PPDE

PostFC

nlgn2b

0.98631225

0.49507378

hn1a

0.98610062

0.44222616

ndufb2

0.98587561

0.49353525

trim46a

0.98561541

0.44012316

lztfl1

0.98558362

0.31935219

znf1031

0.98552297

0.27992984

kcnj13

0.98523455

0.54101153

znf1057

0.98521796

0.25606035

fads2

0.98498678

0.49090429

zgc:113142

0.98476021

0.40221139

wdr48a

0.98473442

0.1353603

nlgn3b

0.98464672

0.28900974

plxna4

0.98455123

0.47478424

arl16

0.98427536

0.54250124

ncapg2

0.9842736

0.38835764

FAM184A (1 of many)

0.98426004

0.53075272

abcg2a

0.9837326

0.02346977

ppifb

0.98334978

0.13571935

si:ch211-157b11.12

0.98296842

0.42474795

pde6h

0.98256823

0.16049071

si:dkey-105e17.1

0.98225519

0.24679011

taf8

0.98192987

0.19510277

CABZ01064771.1

0.98176596

0.37632913

c6

0.98164716

0.42118817

ltk

0.9814763

0.4889662
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Table A1.2: Continued
Gene ID

PPDE

PostFC

CR936465.1

0.98135577

0.08774286

zgc:153395

0.98086674

0.23058634

cadm4

0.98058407

0.06138467

camk2n1a

0.98034432

0.41572865

cyp2x7

0.97998169

0.51793515

znf1131

0.97979638

0.4735899

myh7ba

0.97969455

0.22438734

si:dkey-16b10.1

0.97929879

0.44544289

si:ch73-389b16.1

0.97875434

0.23958235

gria4a

0.97861614

0.26259505

itm2ca

0.97753555

0.43704432

cry1ba

0.97666774

0.33856193

znf994

0.97663852

0.46073918

BEGAIN

0.97592993

0.10225209

timp2b

0.97590496

0.52736743

tnk1

0.97588672

0.05899409

si:ch211-129p6.2

0.97586531

0.31341198

ptprea

0.97559587

0.42453101

si:ch211-214b16.4

0.97484417

0.29770599

bub1ba

0.97484319

0.39636886

dhx40

0.97294287

0.30948921

cntn5

0.97287777

0.38254809

iqgap2

0.97247808

0.1843422

rp1l1a

0.97100286

0.40675409

cacng2a

0.97087352

0.4570898
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Table A1.2: Continued
Gene ID

PPDE

PostFC

KDELR3 (1 of many)

0.97085599

0.49625291

terf1

0.97057376

0.37724518

zgc:73340

0.96932261

0.31925491

si:dkey-263j23.1

0.96878114

0.32598928

CABZ01075274.1

0.9685992

0.37816227

si:dkey-7i4.1

0.96805313

0.43934928

scg2b

0.96610063

0.41028188

neflb

0.96601728

0.3631633

arrdc3b

0.96542687

0.41347113

gnat2

0.96537125

0.41841261

si:ch73-190f9.4

0.96520906

0.48903437

dusp3a

0.96520644

0.50400501

si:dkey-121n8.7

0.9649275

0.26397169

znf1037

0.9644884

0.49286282

wu:fb15h11

0.96443468

0.51443917

dcxr

0.96400181

0.23025058

best2

0.96360649

0.17632091

HAPLN1 (1 of many)

0.96300039

0.53719484

dpf1

0.96269164

0.48531478

txnipb

0.96253993

0.40760013

si:dkey-71l4.4

0.96251744

0.16573605

si:dkey-19b23.7

0.96242286

0.08607903

CU019657.1

0.96148095

0.0815658

tfa

0.96097901

0.05897177

slc6a1a

0.96074925

0.4744116
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Table A1.2: Continued
Gene ID

PPDE

PostFC

s100s

0.96023075

0.52694675

stat5b

0.9598209

0.23982466

marveld2a

0.95959336

0.34466221

lactbl1a

0.95938868

0.34126686

zgc:112285

0.95909538

0.48311105

gria3a

0.95878225

0.48271079

znf1045

0.9587422

0.28303742

CABZ01007222.1

0.95873271

0.37222436

wdcp

0.95868921

0.30433753

aldoaa

0.95812396

0.13957413

fam19a5a

0.95732088

0.23665981

flnb

0.95683468

0.48648732

atoh1a

0.95633242

0.46995944

nudt4a

0.95556182

0.05090048

slc25a36a

0.95552038

0.31423411

si:dkey-84j12.1

0.95546887

0.3112841

syncripl

0.95540168

0.53187346

ext1c

0.95491243

0.32431173

stmn4l

0.95463368

0.43816975

si:dkey-92i17.2

0.95445004

0.4047597

slc4a4a

0.9540154

0.49042554

rwdd

0.9535332

0.45741438

lbr

0.95348921

0.07580637

nsfa

0.95291503

0.31128612

trpc1

0.95290547

0.43829102
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Table A1.2: Continued
Gene ID

PPDE

PostFC

bmf2

0.95256271

0.34001067

tbk1

0.95190409

0.45565895

si:dkey-179k24.5

0.95178885

0.25049258

sfxn2

0.95168976

0.20745988

tlx2

0.95150031

0.46849491

rptor

0.95087934

0.52624772

spire1a

0.95035563

0.47267528

si:dkey-14o6.8

0.94906939

0.36394209

acp5a

0.94900787

0.398649

ezra

0.94876884

0.29818762

NR4A2 (1 of many)

0.94826882

0.44024088

nlgn4a

0.94822785

0.14391656

nub1

0.94786208

0.53860431

si:ch73-359m17.2

0.94777675

0.20374278

prdm2a

0.94759204

0.41787615

si:dkeyp-35e5.9

0.94744637

0.53169761

serpini1

0.94722541

0.38752968

rac3b

0.94641459

0.10355966

CR450842.5

0.94549936

0.41332942

si:dkey-20i20.10

0.94533106

0.51265615

bves

0.94513289

0.1359183

camkk1b

0.94483436

0.35851054

ppp1r14ba

0.94473267

0.47664948
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APPENDIX 2: SUPPLEMENTARY FIGURES

Appendix 2.1: Optic Fissure quantification
A) Graphical representation of the region of OF analyzed using confocal microscopy. B)
Sample image depicting regions of the OF (1), laminin normalization (2) and F-actin
normalization (3) used for signal intensity quantification. C) Quantification of laminin
and F-actin signal intensity in wild type embryos within the distal, medial and proximal
regions of the OF, normalized to regions of laminin staining juxtaposed to the lens and Factin signal within the lobe of the retina. Relative pixel intensities are displayed. ANOVA
p<0.0001. D) Quantification of laminin and F- actin signal intensity in pax2a-/- embryos
within the distal, medial and proximal regions of the OF, normalized to regions of
laminin staining juxtaposed to the lens and F-actin signal within the lobe of the retina.
Relative pixel intensities are displayed. ANOVA p<0.0001.
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Appendix 2.2: Optic Fissure apposition measurements.
Measurements of the distance between retinal lobes (apposition) in WT, pax2a-/- or
DMH4 treated or embryos at 48hpf. Measurements were made using laminin staining as
reference for edges of retinal lobes. Distance was measured as pixels.

172

Appendix 2.3: pax2a and tln1 expression during development
A) Whole mount in situ hybridization of pax2a probe at 24, 48, 54 and 72hpf. Lateral
(top) and ventral (bottom) images depicting OF expression are shown. Pax2a expression
persists in the fissure up to 54hpf. B) Whole mount in situ hybridization of tln1 probe at
24, 48, 54 and 72hpf. Lateral (top) and ventral (bottom) images depicting OF expression
are shown. tln1 expression is detected in the OF from 24-48hpf (yellow arrowheads).
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Appendix 2.4: DMH4 dose response
A) 3D reconstructions of 48hpf whole mount Tg[kdrl:mCherry] (red) embryos treated
with 1, 5, 50 or 100uM DMH4. DNA stained with DAPI (blue). Increasing concentration
of DMH4 eliminates mCherry expressing cells from the OF and retina. Scale bar = 50μm.
B) Brightfield images of DMSO or DMH4 treated embryos at 24, 48 and 72hpf. C) 3D
reconstructions of whole mount Tg[kdrl:mCherry] (red) embryos treated with DMSO or
100μM DMH4 from 12-24, 32, 36, 48 or 56hpf. DNA was stained with DAPI (blue).
Scale bar = 50μm. D) Whole mount Immunohistochemistry was used to simultaneously
visualize F-actin (red) and laminin (green) in DMSO treated embryos from 24-72hpf.
Central-proximal regions of the OF are displayed. Scale bar = 50μm. E) Whole mount
Immunohistochemistry was used to visualize laminin (green) and DNA (blue) 25 or
50μM DMH4 12-72hpf treatment. Central-proximal regions of the OF are displayed.
Scale bar = 50μm.
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Appendix 2.5: Time course of mmp2, mmp14a and mmp14b ocular expression
A) Whole mount in situ hybridization of mmp2, mmp14a, mmp14b probes at 24, 26, 30
32, 34, 36 and 38hpf. Mmp2 expression is present in the OF from 26-34hpf (yellow
arrowheads). Mmp14a expression is present in the OF from 32-36hpf (yellow
arrowheads). Mmp14b expression is present in the OF from 32-36hpf (yellow
arrowheads). B) Whole mount in situ hybridization comparing mmp2, mmp14a and
mmp14b expression in WT vs pax2a-/- and DMSO vs DMH4 treated embryos at 32hpf.
Mmp2, 14a and 14b signal within the OF (yellow arrowhead) appears decreased in pax2a/- and DMH4 treated embryos.
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Appendix 2.6: ARP101 treatment dose response
A) Brightfield images of DMSO and ARP treated embryos at 48hpf. Concentrations of
ARP101 exceeding 20uM result in toxic effects. B) Whole mount Immunohistochemistry
was used to visualize laminin (red) in ARP101 treated Tg[rx3:GFP] embryos at 48hpf.
Central-proximal and distal regions of the OF are displayed. Scale bar = 50μm. C)
Fluorescent whole mount in situ hybridization of pax2a probe at 32hpf in DMSO or
20μM ARP101 treated embryos. OF expression is indicated with a yellow arrowhead.
ARP101 treatment does not appear to alter pax2a expression in the OF. Broken white
lines outline the retinal lobes. Scale bar = 50μm.
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Appendix 2.7: mmp2 Alt-R crRNA injection results in OF fusion failure phenotypes.
Brightfield images of A) uninjected, B) mmp2 crRNA or C) pax2a-/- embryos at 72hpf.
OF fusion failure is observed as a notch in the ventral retina in both mmp2 crRNA
injected embryos as well as in pax2-/-. Confocal stacks of laminin stained embryos at
72hpf from D) uninjected, E) mmp2 crRNA and F) pax2a-/- embryos. Pax2a-/- embryos
display a clear fissure at 72hpf, while mmp2 crRNA injected embryos achieve only
partial fusion when compared to uninjected controls. G) mmp2 crRNA efficacy was
assayed using PCR flanking the region targeted. Lanes 1-8 represent gDNA assays from
individual embryos assayed at 72hpf. Control is found in well 9. ** indicate changes in
band size compared to control. $ corresponds to embryo imaged in B and E.
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Appendix 2.8: mmp2 expression in cloche mutants
Whole mount in situ hybridization of mmp2 expression at 32hpf in clo+/+ and clom39/m39
embryos. Individual dissected eyes were imaged at 20X using DIC optics. Yellow
arrowheads indicate OF expression in wholemount samples. Magenta arrowheads
indicate expression within the OF as observed at higher magnification in dissected eyes.
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APPENDIX 3: TEMPORAL CHARACTERIZATION OF OPTIC FISSURE
BASEMENT MEMBRANE COMPOSITION SUGGESTS NIDOGEN MAY BE AN
INITIAL TARGET OF REMODELING.
MW Contributions: Figure 5.
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APPENDIX 4: SPATIOTEMPORAL CHARACTERIZATION OF ANTERIOR
SEGMENT MESENCHYME HETEROGENEITY DURING ZEBRAFISH OCULAR
ANTERIOR SEGMENT DEVELOPMENT
MW Contributions: Bioinformatic analyses for body of work.
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